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ABSTRACT 
 
Periodontal disease is an inflammatory disease caused by polybacterial infection 
and inflammation plays key role that associates periodontal disease with different 
systemic diseases including diabetes and cardiovascular diseases. The main objective of 
this study is to evaluate and explore the association of serum IgG antibodies in four 
distinct clusters that were formed empirically from species specific 19 periodontal 
antibody titers with T2DM and pre-diabetes adjusting for known confounders such as 
age, sex, race-ethnicity, income to poverty ratio, education, smoking and drinking 
alcohol, BMI, WC, physical activity, missing teeth, dentist visits and other nutritional 
factors. 
From the first aim, we formed 4 clusters empirically using cluster analysis from 
19 periodontal antibody titers and named it as Orange-Red, Red-Green, Yellow-Orange, 
and Orange-Blue based on Socransky’s grouping scheme. Using the priory study model, 
theoretically we made 3 groups i.e. Etiologic, Putative and Health related groups from 11 
periodontal bacteria antibody. On the full adjustments for these known confounders, our 
finding showed that Orange-Red cluster that included P gingivalis and Prevotella sps 
were positively associated in moderate level with diabetes but not with pre-diabetes. 
However, the Red-Green cluster which contained T denticola, T forsythia, A 
actinomycetemcomitans and others (as shown in Flow chart 1) were inverse but 
significantly associated to diabetes. The Orange-Blue cluster scores that included A. 
naeslundii and E. Nodatum showed an inverse relation to diabetes and pre-diabetes in the 
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crude analysis but that was attenuated after adjustment  [diabetes: OR 0.935 (0.869- 
1.007), pre-diabetes OR: 0.987 (0.944-1.032) . The Yellow-Orange cluster that included 
majority of Steptococcus sps were not found to be associated with diabetes or pre- 
diabetes.  With the same approach, we found the significant positive association of 
etiologic group with pre-diabetes among the association with the 3 groups. 
In our second aim, we explored the possible interaction between serum IgG antibodies 
and clinical periodontal destruction (as assessed by clinical attachment loss and pocket 
depth)  in association to diabetes. We found that the tertile of pocket depth modified the 
association of Orange-Blue cluster with diabetes upon the full adjustment for the known 
confounders. 
In our third aim, we measured the extent of the association between empirically defined 4 
clusters and theoretically defined 3 groups with each of the five key components of 
cardiovascular risk factors i.e. hypertension, hypertriglyceridemia, low HDL-cholesterol, 
central obesity, and elevated plasma glucose and also the MetS. We found no significant 
association with any of these components and MetS but the elevated plasma glucose. 
Elevated Orange-Red clusters was positively associated whereas Orange-Blue was 
inversely but significantly associated with elevated plasma glucose. The association 
became more prominent when the elevated plasma glucose greater than or equal to 110 
mg/dl. 
These findings show that specific periodontal antibody serological markers may be used 
as predictor of systemic health mainly the diabetes status. 
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CHAPTER 1 
INTRODUCTION 
1.1. Statement of Problem 
Periodontal disease [PD] is a persistent polybacterial infection causing chronic 
inflammation in periodontal tissues (Heller et al. 2012).It is present in up to 1 in 3 adults 
(Dye 2012) and is characterized by local and systemic inflammation, formation of deep 
periodontal pockets and destruction of connective tissue attachment , which may 
eventually lead to tooth loss (Preshaw et al. 2012). Since the onset of disease (dental 
carries or PD) is usually delayed for prolonged periods of time after initial colonization 
by pathogens and the source of infection is often endogenous bacteria and initial 
colonization may persist for years before the development of clinical signs and 
symptoms, PD is also a hidden and neglected disease. However systemic inflammation 
resulting from periodontitis has been found to be associated with several chronic 
inflammatory diseases such as diabetes, vascular disease, and metabolic syndrome 
[MetS] and is increasingly getting attention.  
Although, PD is a polybacterial infection,  majority of such association studies 
have used indirect method to access the periodontal destruction (such as gingivitis 
bleeding, tissue destruction, gum bleeding, pocket depth or attachment loss) to assess 
periodontal disease. The problem in using these clinical parameters to measure the 
periodontal destruction and study with systemic diseases is that these indirect methods 
cannot measure the systemic effect evoked by these periodontal bacteria challenges. In 
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periodontal literature, the direct microbial measures of bacterial challenges or host 
response to periodontitis with these systemic disease are understudied (Lockhart et al. 
2012, Demmer et al. 2012, Lalla and Papapanou 2011, Desvarieux et al. 2010). 
Recently, the longitudinal and cross-sectional findings from the Oral Infections 
and Vascular Disease Epidemiology [INVEST] study (Desvarieux et al. 2005, 
Desvarieux et al. 2013) have shown an association with mean carotid artery thickness by 
clusters of periodontal bacteria that were classified as etiologic, putative or periodontal 
health related. The etiologic group (Actinobacillus actinomycetemcomitans, Tannerella 
forsythensis, Porphyromonas gingivalis ,and Treponema denticola) was strongly 
associated with increased intima-media thickness in the carotid artery. The putative group 
included Campylobacter rectus, Prevotella intermedia, Micromonas 
(Peptostreptococcus) micros, Eikenella corrodens, Fusobacterium nucleatum  while 
Actinomyces naeslundii  and Veillonella  parvula were present in the healthy periodontal 
group. 
In the direct assessment of periodontal disease, serological markers such as 
elevated serum Immunoglobulin A (IgA) or Immunoglobulin G (IgG) levels against those 
periodontal bacteria (Darveau 2010) can measure host disruption of homeostasis. Studies 
have reported that elevated antibody titers to some periodontal bacteria are highly 
correlated with extent and severity of periodontitis while some are associated with the 
healthy periodontal status. Elevated IgA suggests periodontitis that is in the active phase 
while elevated IgG generally suggests past exposure to that specific periodontal bacteria.  
Numerous studies (Holmlund et al. 2011, Pussinen, Alfthan, et al. 2007, Vilkuna-
Rautiainen et al. 2006, Pussinen et al. 2005, Pussinen, Jousilahti, et al. 2003) have used 
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these serological markers to assess periodontal disease and measure the relationship with 
other chronic diseases, particularly vascular diseases(Pussinen, Paju, et al. 2007, Darveau 
2010)(Pussinen, Paju, et al. 2007, Darveau 2010). The clear understanding of the 
association of serological markers with the systemic outcomes is very important to 
understand the extent to which the different groups of periodontal pathogens may 
stimulate immune response in chronic inflammatory disease activity and how these 
periodontal antibody responses are related to systemic outcomes. Additionally, using 
serological markers to assess the periodontal relationship with systemic outcomes could 
be the best way because it measures the direct and cumulative life time systemic effects 
evoked by the periodontal bacteria. 
In this dissertation, we will evaluate the association of serum IgG antibodies 
against periodontal bacteria with the systemic outcomes mainly type 2 diabetes mellitus 
(T2DM), and MetS. We used the third National Health and Nutritional Examination 
Survey (NHANES III 1988-1994) which is a complex, stratified, multistage probability 
sample designed to provide prevalence estimates describing the health and nutritional 
status of the civilian, non-institutionalized US population and which included people 
from different racial/ethnic backgrounds. NHANES III survey has the periodontal IgG 
antibody titers information for 19 periodontal bacteria which we linked with the 
periodontal examination, blood laboratory reports and socio-demographic information in 
40 years or older age groups. 
1.2 Purpose and Objectives 
In this dissertation, we cross-sectionally evaluated serum IgG antibody titers 
against 19 periodontal organisms in relation to T2DM, pre-diabetes and MetS and its 
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components in an adult population. Periodontal antibodies were grouped by two different 
approaches. First, we used the data derived clustering approach (empirical approach) to 
create different clusters, and second, we made three different groups based on a prior 
study (INVEST study) by Desvarieux et al (2005) (theoretical approach).   We 
hypothesized that antibody clusters against periodontal bacteria were associated with 
diabetes, pre-diabetes and MetS as PD and these systemic outcomes are interrelated.  
Aim1: To cluster the 19 species- specific antibody titers against periodontal pathogens 
empirically and theoretically into distinct groups and measure the strength of association 
of these clusters in relation to T2DM, pre-diabetes, and normal plasma glucose levels. 
Research question 1.1: What are the clusters obtained from species specific 19 serum IgG 
antibodies titers? 
Research question 1.2: What are the characteristics of individuals in the tertiles of each 
antibody cluster? 
Research question 1.3: What is the relationship between serum antibody titers against 
periodontal pathogens grouped by empirical and theoretical approaches and type 2 DM, 
pre-diabetes and normal plasma glucose levels? 
Hypothesis: We expect to find out the strength of association of immune response to 
periodontal antibodies in relation to T2DM, pre-diabetes, and normal. 
Aim 2: To investigate the joint association of severity of periodontal destruction (as 
assessed by clinical attachment loss (CAL) and pocket depth) and antibody clusters in 
relation to T2DM and normal plasma glucose. 
Research question 2.1:  What are the profile characteristics of individuals across tertiles 
of clinical periodontal measures? 
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Research question 2.2:  What is the relationship between serum antibody clusters and 
T2DM, and normal glucose stratified and jointly classified by the tertiles of clinical 
attachment loss?  
Research question 2.3:  What is the relationship between serum antibody clusters and 
T2DMT2DM, and normal glucose stratified and jointly classified by the tertiles of pocket 
depth?  
Hypothesis: We expect that the strength of associations varies within strata of periodontal 
destruction.  
Aim 3: To explore the association of serum antibodies titer clusters with selected risk 
markers of cardiovascular disease i.e. MetS and each of its individual components. 
Research question 3.1: Is there a cross-sectional association between clusters of antibody 
titers, MetS and each of key components of MetS (hypertension, hypertriglyceridemia, 
low high density lipoprotein (HDL)-cholesterol, central obesity, and elevated fasting 
glucose)? 
Research question 3.2: Is there a cross-sectional association between etiologic, putative 
and health related groups of antibody titers, MetS and each of key components of MetS 
(hypertension, hypertriglyceridemia, low HDL-cholesterol, central obesity, and elevated 
fasting glucose)? 
Hypothesis: We expect that the specific clusters or groups are associated with these 
cardiovascular risk markers. 
1.3 Significance of Research 
One of the main goals of this research is to determine if the clusters or groups of 
IgG antibody titers are associated with systemic outcomes as evidenced by T2DM and 
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MetS and to examine the confounding or effect modifier role of clinical periodontal 
measures in the association. There are numerous bacteria associated with periodontal 
region as periodontal bacteria coexist in a biofilm. It is therefore difficult to isolate the 
potential effect of a particular pathogen, and studies evaluating the effects of individual 
organisms are prone to type 1 error (Wang et al. 2007). To overcome this limitation, we 
have grouped the periodontal organisms together using both empirical and theoretical 
approaches. The use of cluster analysis helps to minimize the bias and makes the 
interpretation easier. Significant findings from both the approaches would provide the 
additional information on this topic.  
In the first aim, we used cluster analysis to group 19 IgG periodontal antibody 
titers empirically and theoretically and evaluated these in relation to type 2 DM, pre-
diabetes, and normal glucose. This will help in the interpretation of the relation between 
IgG titers of periodontal bacteria and T2DM and pre-diabetes.  In the second aim, we 
examined the joint association between periodontal status based on CAL and Pocket 
Depth and antibody groups in relation to T2DM and normal glucose. The findings of this 
specific aim clarify the extent to which the associations between antibody titers to 
periodontal pathogens and DM are modified by clinical periodontal destruction. 
Similarly, the MetS defined as a cluster or the concurrence of abdominal obesity, 
dyslipidemia, hypertension and hyperglycemia according to the consensus of the National 
Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and is 
associated with a very high risk for cardiovascular diseases and diabetes mellitus 
(Marchesini et al. 2004, Grundy et al. 2004). The knowledge of the extent of their 
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association with the antibodies against periodontal disease will add to the information on 
the systemic disease-periodontal disease relation. 
1.4 Outline of the Study 
Chapter 2 of this dissertation provides background information about T2DM and 
pre-diabetes, periodontal disease, the relation between periodontal disease and systemic 
disease, the relation between antibodies against periodontal disease and systemic disease, 
and gaps in current knowledge.  Chapter 3 is the manuscript for aim 1 ‘The relation 
between Serum Immunoglobulin G (IgG) Antibodies against Periodontal Bacteria and 
Type 2 Diabetes and Pre-Diabetes’. Chapter 4 is the manuscript for aim 2, ‘Effect 
modification of the relation between serological periodontal markers and type2 diabetes 
by periodontal pocket depth.’ Chapter 5 is the manuscript for aim 3, ‘Relationship 
between serological markers of periodontal bacteria and metabolic syndrome and its 
components’. Chapter 6 is an overall summary of the findings from this dissertation and 
includes a strengths and limitations, clinical implications and recommendation to 
clinician and public health professional, suggestions for future research, and conclusions.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Hyperglycemia: Diabetes and Pre-diabetes 
Diabetes, the excess accumulation of glucose in blood has a negative impact on 
mortality, morbidity, and quality of life through its long term complications, which 
include damage and dysfunction of different major organs especially eyes, periodontal 
region, heart, kidneys, nerves and brain(Zarowitz 2011). It has been declared as a global 
public health threat to society (Yang et al. 2012, 2012). 
“The American Diabetes Association (ADA) defines diabetes as a group of 
metabolic diseases characterized by hyperglycemia resulting from defects in insulin 
secretion or its action or both” (Zarowitz 2011). Clinically, diabetes is broadly divided 
into four categories. Type 1 Diabetes Mellitus (T1DM) results from a B-cell destruction 
that leads to an absolute deficiency of insulin. T2DM which is much more prevalent, 
occurs when body cells cannot produce enough insulin or do not react properly to insulin. 
A third category is specific diabetes due to other causes, such as genetic defect of B-cells 
to produce insulin, genetic defects in insulin action, specific disease of pancreas, or 
drug/chemical-induced diabetes. The fourth category is gestational diabetes mellitus 
(GDM), which is diabetes diagnosed during pregnancy (Zarowitz 2011, 2012). Among 
those who are diabetic, T1DM accounts for approximately 5-10% and is mostly 
associated with children while T2DM accounts for 90-95% of diabetic cases and occurs 
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predominantly in adults. Other categories prevalence is in very smaller percentage 
compared to T1DM and T2DM. 
The diagnostic criteria for diabetes developed by the ADA are based on any one 
of four abnormalities: glycemic hemoglobin A1C % (HbA1C) ≥ 6.5%, fasting plasma 
glucose (FPG) ≥ 126 mg/dl (0.7 mmol/l), random elevated plasma glucose (RPG) ≥ 200 
mg/dl (11.1 mmol/l) with symptoms, or a 2 hour oral glucose tolerance test (OGTT) ≥  
200 mg/dl (11.1 mmol/l) (Zarowitz 2011). 
In 1979, the National Diabetes Data Group (NDDG) first introduced the concept 
of a metabolic state intermediate between normal glucose homeostasis and diabetes, 
called glucose intolerance (IGT). The expert committee on diagnosis and classification of 
diabetes later extended this concept in 1997 by recognizing those individuals with 
impaired fasting glucose (IFG). This intermediate stage [IGT and IFG] were referred as 
pre-diabetes (Buysschaert and Bergman 2011). Pre-diabetes is a condition when glucose 
level is not in the diabetic range but is too high to be considered as normal.  Individuals 
diagnosed with pre-diabetes are in increased risk for diabetes as well as cardiovascular 
and possibly, micro vascular complications (Pour and Dagogo-Jack 2011). Data suggest 
that 70% of patients with pre-diabetes will eventually develop diabetes (Tabak et al. 
2012). According to the ADA clinical practice recommendations, current diagnostic 
criteria for pre-diabetes are one of these three criteria. FPG: 100 to 125 mg/dL (5.6–6.9 
mmol/L), A1C between 5.7%-6.4%, or 2-hour plasma glucose values in the OGTT of 140 
–199 mg/dl [7.8 –11.0 mmol/l] (Tabak et al. 2012, Buysschaert and Bergman 2011). 
Globally, the prevalence of diabetes and pre-diabetes has dramatically increased 
with the increase in urbanization, population growth, aging, increasing prevalence of 
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obesity and physical inactivity. According to the World Health Organization (WHO), the 
prevalence of diabetes worldwide is 6.4 %, which varies from 10.2% in the Western 
Pacific to 3.6 % in the African region (Shaw, Sicree, and Zimmet 2010). The prevalence 
of diabetes has been consistently increasing since 1980 (Danaei et al. 2011). There were 
an estimated 30 million diabetes cases world-wide in 1985, which increased to 135 
million by 1995 (King, Aubert, and Herman 1998). The latest WHO estimate is 285 
million in 2010 and has been projected to increase to 438 million by 2030 (Shaw, Sicree, 
and Zimmet 2010).  In the United States alone, 25.8 million (8.3 % of the US population) 
are suffering from diabetes; around 35% of US adults aged 20 & above and 50% of aged 
above 50 have pre-diabetes (Hhs and Ada 2003). The direct and indirect cost associated 
with diabetes is becoming an enormous problem, due to its chronic nature, severity of 
complications and the means to control them.  In the United States, direct cost was $116 
billion and indirect cost was $58 billion.  Dietary change, insulin use, physical activity 
and oral medication help to control diabetes. Further control of blood pressure, blood 
lipids and other preventive care practices of teeth, eyes, skin, feet and kidneys helps to 
prevent complications from diabetes (Zekry et al. 2012, Chudyk and Petrella 2011). In 
order to offer better treatment, prevention and control modalities, a deeper understanding 
of the etiology of diabetes and pre-diabetes is needed. 
2.2 Periodontal Disease 
Periodontitis  is a polymicrobial chronic inflammation (Papapanou 2012, Preshaw 
et al. 2012, Lalla and Papapanou 2011) and is the most common inflammatory disease 
(Dye 2012) in adults. At the same time, it is an often neglected and hidden chronic 
disease because of its slow progressive nature.  Periodontitis is asymptomatic in early 
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stages, and the tissue destruction that occurs during this stage is irreversible (Preshaw et 
al. 2012).   
There is no universally accepted case definition for periodontitis in 
epidemiological studies (Papapanou 2012), hence the prevalence of periodontitis varies 
depending upon the definition. The Centers for Disease Control and Prevention (CDC) in 
partnership with the American Academy of Periodontology (AAP) recently published a 
case definition of periodontitis. The total number of adults in the US with periodontitis 
(i.e. sum of mild, moderate and severe forms) is 64.7 million adults, (47.2%), (8.7% mild, 
30.0% moderate, and 8.5% severe) based on full mouth data. The prevalence is 19.5 % 
when the two-site per tooth examination [as used by NHANES III periodontal 
examination] or 27.1% when the three site half-mouth protocol was used in the sample of 
NHANES 2009-2010 data (Papapanou 2012, Eke, Dye, et al. 2012).  CDC/AAP defines 
periodontitis when clinical attachment loss is ≥ 6mm and pocket depth is ≥ 4mm (Eke, 
Page, et al. 2012).  On the basis of NHANES III survey 1999–2004 data [in which the 
three site half-mouth protocol was used], the prevalence of moderate to severe PD in the 
United States was 5% among those age 35 to 49 years, 11% among those age 50 to 64 
years, 14% among those age 65 to 74 years, and 20% among those age 75 years or over. 
Moderate forms of the disease are even more prevalent, affecting 40 -60% of adults (Dye 
et al. 2007). The combined expenditure for periodontal and preventive dental services in 
the United States was estimated at $14.3 billion in 1999, whereas approximately $4.4 
billion was spent for periodontal procedures. It should be noted that the prevalence of PD 
varies according to socio-demographic and economic status (Papapanou 2012, Eke, Dye, 
et al. 2012).  
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With the advancement of molecular techniques (Socransky and Haffajee 2005, 
Colombo et al. 2009) several bacterial complexes associated with the etiology of 
periodontal healthy and diseased stage have been identified using the whole genome 
DNA probes. The sub gingival biofilm in periodontal plaque constitutes more than 700 
species (Socransky and Haffajee 2002), among which around 300 cultivable species have 
been identified (Sugi et al. 2011).  These species are not uniformly distributed in the 
periodontal sites as multiple factors may impact the distribution of the nature of biofilm 
(Haffajee, Teles, and Socransky 2006b, Socransky and Haffajee 2005, Haffajee et al. 
2005) including the periodontal health or disease stage.  Comparatively little research has 
been done in this area but evidence is strong enough to suggest that the plaque 
community in periodontal area could be a strong predictor of periodontal health or 
disease stage (Haffajee et al. 2008). 
Although many different bacterial species may participate in the destruction of 
host periodontal homeostasis, three red complex periopathogens as described by 
Socransky & Haffajee (Socransky and Haffajee 2002) namely, T forsythensis , P 
gingivalis , P intermedia ,  T denticola  were found to be strongly associated with disease 
stage. Studies have revealed that these bacteria have the ability to impair innate immune 
system (Rescala et al. 2010). Additionally, putative bacterial species which are 
predominantly the orange complex bacteria such as C rectus, F nucleatum,  M micros, 
Eubacterium nodatum , and Prevotella nigrescens are also thought to play an important 
role in shifting the plaque microbial community from periodontal healthy to diseased 
stage(Haffajee, Patel, and Socransky 2008, Socransky and Haffajee 2002). Red and 
Orange complex bacterial species are found significantly higher in periodontal disease 
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stage (Haffajee, Teles, and Socransky 2006a). In contrast, members of Actinomyces, 
yellow, green, purple complex bacteria and some other species are usually found in 
periodontal healthy as well as diseased sites (Socransky and Haffajee 2002, 2005, Dye et 
al. 2009). 
It is generally accepted that periodontitis infection leads to humoral 
immunological response which can be measured by different immunological markers 
including antibodies such as serum or saliva IgG and IgA antibody to periodontal 
bacteria. The increased IgA antibody level in saliva indicates persistent periodontal 
infection while its presence in serum is not fully understood (Pussinen et al. 2005). Serum 
IgG antibodies to periodontal bacteria are stable over time and explain that the individual 
was exposed to that specific bacteria (Papapanou et al. 2004). 
 A recent study by Pussinen and team (Pussinen et al. 2011) in a nationally 
representative sample of 1586 Finnish dentate subjects  found that periodontal pathogen 
Actinobacillus actinomycetemcomitans and P gingivalis carriage rather than periodontitis 
determines the serum antibody level (Sugi et al. 2011). One case control study studied 
IgG antibody titers to 12 periodontal pathogens as a marker to predict the recurrence of 
periodontitis. They found that those who had higher elevated serum IgG antibody (Sugi et 
al. 2011) titers to E corridens FDC 1073, P gingivalis  SU63 and C rectus ATCC 33238 
resulted in recurrent periodontitis.  
However, the discrepancies in findings on the correlation between elevated 
antibody titers to putative pathogens and severity of periodontal disease complicates the 
criteria to identify the antibodies IgG as immunological marker. In addition, the non- 
pathogenic periodontal bacteria can also elicit the serum antibodies and even people with 
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healthy periodontal status also harbor the serum IgG antibodies specific to perio-
pathogens (Papapanou et al. 2001). Nonetheless, the intensity of serum IgG antibody to 
nonpathogenic periodontal bacteria is very nominal and could be due to the certain level 
of cross –reactivity to the common epitopes shared by periodontal bacteria (Dye et al. 
2009). Further complication comes when some findings (Ozmeric 2004) support the 
concept that the humoral immune response plays a protective role, for instance the 
chronic periodontitis patients with greater pocket depths and more gingival inflammation 
had paradoxically lower antibody titers to suspected periopathogens. More research is 
needed to clarify and explore such discrepancies. 
Periodontitis as well as periodontal microbiota are influenced by socio-
demographic variables (Haffajee et al. 2005, Lopez et al. 2004, Dye and Thornton-Evans 
2010, Dye and Selwitz 2005, Beltran-Aguilar et al. 2005, Lalla et al. 2004, Baelum et al. 
2002), life style (Uzel et al. 2011, Bogren et al. 2007, Haffajee et al. 2005)(Uzel et al. 
2011, Bogren et al. 2007, Haffajee et al. 2005),  eating behaviors (Pussinen, Laatikainen, 
et al. 2003, Ervin and Dye 2009), anthropometric measures(Desvarieux et al. 2010), 
fitness (Haffajee and Socransky 2009, Roberts et al. 2002), diabetes mellitus and other 
co-morbidities(Roberts et al. 2005, Dye et al. 2005), number of teeth (Sachdeo, Haffajee, 
and Socransky 2008) and dental health (Dye et al. 2007). In nationally representative 
samples of US adults from NHANES III survey (Vlachojannis et al. 2010) found that 
dentate participants had higher elevated IgG antibody titers to A actinomycetemcomitans , 
and red complex species P gingivalis  was twice as high in periodontitis than periodontal 
healthy individuals. Also, Mexican American and Non –Hispanic Black were more likely 
to have elevated serum antibodies than Whites.  
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 Antibiotic use affects the oral microbiota (Haffajee, Patel, and Socransky 2008, 
Haffajee, Torresyap, and Socransky 2007, Socransky and Haffajee 2002) but its impact 
on serum immunoglobulin has not been explored adequately. Nevertheless, a few 
research findings (Papapanou et al. 2004, Darby, Mooney, and Kinane 2001, Alfakry et 
al. 2011) have shown that there is long stability of serum IgG antibody to periodontal 
bacteria even after successful periodontal therapy with antibiotics or scaling, the presence 
of which markedly suggests past history of periodontal infection. 
2.3 Correlation of Periodontal disease with other diseases 
The contribution of periodontitis to a state of systemic inflammation is getting 
considerable attention in recent times (Lalla and Papapanou 2011). Periodontal diseases 
have long been associated with major chronic diseases such as diabetes and vascular 
diseases. 
2.3.1 Periodontal Disease and Diabetes/ Pre-diabetes 
The relation between chronic periodontal diseases and diabetes has been studied 
intensively since 1947 (Glickman 1947). Both the diabetes and periodontal disease are 
multifactorial diseases, and the association is bidirectional i.e. the presence of one disease 
tends to boost the other disease and precise management of either disease tends to assist 
in the treatment of the other (Lalla and Papapanou 2011, Preshaw et al. 2012, Pradhan 
and Goel 2011). Loe was the first to propose periodontal disease as the sixth 
complication of diabetes in 1993 (Loe 1993) and ADA acknowledged that periodontal 
disease is often found in diabetic cases in 2003 (Preshaw et al. 2012).  
In the US NHANES III population, adults with an HbA1c level of ≥ 9% were 
found to have a significantly higher prevalence of severe periodontitis than those without 
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diabetes (OR 2.9; 95% CI 1.40-6.03) after controlling for age, ethnicity, education, sex 
and smoking (Tsai, Hayes, and Taylor 2002). A recent 5 year prospective longitudinal 
study in 2,973 non-diabetic participants from the study of health in Pomerania (SHIP), 
revealed that participants with advanced periodontitis at baseline showed an 
approximately fivefold higher increase in HbA1c after 5 years when compared to those 
with no periodontitis at baseline, which suggest the impact of periodontitis on diabetes 
(Demmer et al. 2010). 
The outcome of a meta-analysis study from  49 cross-sectional and eight 
longitudinal studies of the 2440 identified studies  published between 1980 to 2007 found 
that periodontitis is a risk factor of T2DM while more studies are needed to confirm the 
harmful effect to T1DM (Chavarry et al. 2009). This is probably due to T1DM being 
more prevalent in young children while middle aged men and women have increased risk 
for periodontitis and T2DM (Merchant et al. 2011).  
Glycemic control with decreased HbA1c levels has been an important marker of 
decreased complications from diabetes. Several different meta-analysis (Teeuw, Gerdes, 
and Loos 2010, Darre et al. 2008, Janket et al. 2005, Jones et al. 2007, Simpson et al. 
2010) outcomes have indicated the reduction of HbA1c% (T1DM or T2DM) around 
0.4% after effective periodontal treatment for at least 3 months. One meta-analysis 
(Janket et al. 2005) of glycemic control after mechanical treatment of periodontal 
diseases showed the weighted average 0.38% decrease in actual HbA1c level for all 
studies, 0.66% when restricted to type 2 diabetic patients, and 0.71% if antibiotics were 
given to them. Although none were statistically significant, clinical significance of these 
results cannot be underestimated. The 2010 systemic review (Simpson et al. 2010) which 
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included seven randomized clinical trials exclusively with type 2 diabetes was similar 
[0.4% reduction of HbA1c; 95% confidence interval (CI) fixed effect -0.78% to -0.01%)] 
to earlier meta-analysis results. Although these randomized clinical trials had 
heterogeneity of data and low power for the statistical analysis, the 0.4 % HbA1c 
reduction value has substantial clinical significance.  Less potent classes of oral glucose –
lowering agents reduce HbA1c % level by 0.5-1% and other classes of oral agents (i.e. 
insulin secretagogues) combined with other methods such as nutritional therapy and 
physical activity increases HbA1c by 1-2% (Santos Tunes, Foss-Freitas, and Nogueira-
Filho Gda 2010).  
Furthermore, many studies have revealed that presence of diabetes and 
periodontal disease combined aggravating the complications of macrovascular and 
microvascular diseases. The recent prospective study of the Gila River Indian community 
with 529 participants unfolded the findings that cardio-renal mortality (combination of 
ischemic heart disease and diabetic nephropathy) was three times more likely in diabetics 
with severe periodontitis compared to diabetics without severe periodontitis after 
adjusting for age, sex, diabetes duration, HbA1c, macroalbuminuria, BMI, cholesterol, 
hypertension, electrocardiogram abnormalities, and smoking (Shultis et al. 2007). 
Prospective diabetes studies (Stratton et al. 2000, Khaw et al. 2004) have revealed the 
finding that every 1% reduction in HbA1c resulted in a 21% reduction in the risk for any 
end point related to diabetes, 21% reduction in deaths related to diabetes, 14% reduction 
in myocardial infarction and a 35% decreased risk of  microvascular complications. 
There is a very limited knowledge about the periodontal bacterial profiles or 
antibody response patterns that are distinctly associated with T1DM or T2DM cases and 
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no large epidemiological studies have focused on this area. In the few studies involving 
culture of oral bacteria, P gingivalis, P intermedia and Capnocytopha species were found 
to be significantly higher in those with diabetes than non-diabetic participants (Zambon et 
al. 1988, Mealey 1999, Sbordone et al. 1998). Among children with T1DM, it was found 
that level of E nodatum antibody was significantly higher in diabetic patients while no 
difference was seen in serum IgG levels to 11 other bacteria (Lalla et al. 2006). These 
findings suggest apparent lack of significant differences in potential pathogens in diabetic 
and non-diabetic participants; however it should be noted that these studies are limited 
with respect to sample size and diversity of bacteria assessed (Lalla and Papapanou 
2011). More detail literature review related to epidemiological studies evaluating the 
relation between periodontal microorganisms with diabetes and periodontitis are shown 
in Table 2.1. 
Inflammation is believed to be the common link which affects glycemic control, 
insulin resistance and periodontal damage. The mechanism is not clearly understood, but 
it includes immune functioning, cytokine and neutrophil activities.  More research are 
needed to understand the biological pathway that links between the periodontitis and 
diabetes (Preshaw et al. 2012). The association of these two chronic diseases provides a 
perfect example of a cyclic association in which systemic diseases predisposes an 
individual to oral infection and once the oral perio-pathogens are established, the 
systemic disease is exacerbated (Pradhan and Goel 2011). Figure 2.1 shows the 
bidirectional relationship of periodontal infection and diabetes contributing to insulin 
resistance. The detail pathological mechanism of periodontitis and diabetes association 
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can be found elsewhere (Lalla and Papapanou 2011, Santos Tunes, Foss-Freitas, and 
Nogueira-Filho Gda 2010, Pradhan and Goel 2011). 
2.3.2 Periodontal Disease and Cardiovascular markers including MetS 
Independent of diabetes, increasing epidemiological evidence suggests an 
association of periodontal disease and atherosclerotic vascular disease (ASVD) due to its 
systemic inflammation.  The American Heart Association (AHA) (Lockhart et al. 2012) 
recently investigated the independent association of periodontal disease and ASVD 
reviewing all the available data from 1950 to 2011. The AHA Scientific committee 
reviewed 473 out of 537 studies that met the inclusion criteria of the association between 
periodontal disease and any cerebrovascular, peripheral vascular or cardiovascular 
disease. Observational studies supported an association between periodontal disease and 
ASVD independent of known confounders (age, diabetes mellitus, and smoking); 
however causation was not supported. Periodontal intervention helps in a reduction in 
systemic inflammation and endothelial dysfunction but there is no evidence to suggest 
intervention prevents ASVD or modify its outcomes.   
Out of hundreds of studies that have investigated the association with 
cardiovascular diseases, very few studies have explored the direct linkage with 
periodontal microbes or host immune response to these periodontal microbes. Periodontal 
pathogens such as P gingivalis, A actinomycetemcomitans, P intermedia, T forsythia, and 
Streptococcus mutans have been found to be associated with atherosclerotic plaques. 
Desverieux et al (Desvarieux et al. 2005) assessed 11 known periodontal microorganisms 
from 657 dentate subjects enrolled in  INVEST and found that overall bacterial burden 
was related to carotid artery intima-media thickness (IMT) after adjusting for age, race, 
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gender, education, BMI, smoking, diabetes, blood pressure, and Low density lipoprotein 
(LDL) and HDL cholesterol. Adjusted mean IMT values of etiologic bacterial burden 
with four organisms, P gingivalis, A actinomycetemcomitans, T forsythia and T denticola 
were found to have significant increasing trend across tertiles. Spahr et al, 2006 
investigated an association of combined colonization of five periodontal bacteria [P 
gingivalis, A actinomycetemcomitans, P intermedia, T forsythia and T. denticola to 
Cardiovascular diseases (CHD) and revealed that for each 1 unit log increase in total 
burden, the OR increased by 1.83 times (95% CI 1.23-2.71). 
  Pussinen et al in Finland investigated an association of combined serum IgG 
antibody titers of P gingivalis and A actinomycetemcomitans to ASVD and found 
significantly higher titers [Hazard Ratio (HR):1.87 (1.13-3.08)]. In a separate study 
(Pussinen, Jousilahti, et al. 2003), the same team investigated serum IgG antibody titers 
of P gingivalis and A actinomycetemcomitans individually to CHD.  The association was 
significant with each of high titers of bacteria [Relative risk (RR) for high A 
actinomycetemcomitans: 2.0 (1.2-3.3) and RR for P gingivalis: 2.1 (1.3-3.4)] after 
adjusting for potential confounders. Currently, attention has been paid to the applicability 
of anthropometric markers to measure diabetes complications, cardiovascular risks and 
their control. 
MetS is associated with a very high risk for cardiovascular diseases and diabetes 
mellitus (Marchesini et al. 2004, Grundy et al. 2004). In the NHANES III study in US 
population, participants older than 45 suffering from severe periodontitis were 2.31 times 
(95% CI 1.13-4.73) more likely to have MetS than unaffected individuals after adjusting 
for confounders (D'Aiuto et al. 2008). Poor periodontal health conditions were found in 
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patients with diabetes. Periodontal disease association with MetS was found true in other 
study populations independent of other risk factors (Li et al. 2009, Han et al. 2012, Kwon 
et al. 2011, Yu et al. 2012); however no recent studies have investigated the role of 
periodontal microbiota with MetS.  
Waist circumference (WC) is recognized as one of key component of MetS and 
also provides a better measurement of cardiovascular risk and obesity. WC represents 
central adiposity and is measured using a steel measuring tape to the nearest 0.1 cm at the 
high point of the iliac crest at minimal respiration when the participant was in a standing 
position (Wood, Johnson, and Streckfus 2003).  A recent meta-analysis revealed a 
significant association between periodontitis and obesity (OR 1.35; 95% CI 1.23, 1.47), 
suggesting that abdominal obesity is independently associated with periodontitis(Chaffee 
and Weston 2010). Evidence is increasing for an association of gut microbiota with 
obesity (Le Chatelier et al. 2013) while no study has explored the association with 
periodontal microbiota.  
There is evidence that supports a correlation of periodontitis with other markers of 
MetS such as hypertension(Desvarieux et al. 2010, Bonato et al. 2012, Vidal et al. 2009), 
LDL (Itabe 2012), HDL (Pussinen, Jauhiainen, et al. 2004, Wu et al. 2000), Total 
Cholesterol (TC) (Wu et al. 2000), and Triglycerides (TG) (Banihashemrad, 
Moeintaghavi, and Rafighdoost 2008, Cutler and Iacopino 2003, Morita et al. 2004) 
individually but none of epidemiological studies have investigated the role of periodontal 
microbiota or the host response with these metabolic complication markers.  
Since both the periodontitis and MetS are associated with systemic inflammation and 
insulin resistance, these two diseases may be linked through a common 
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pathophysiological pathway (D'Aiuto et al. 2008). Oxidative stress may act as a potential 
common link to explain relationships between each component of MetS and periodontitis. 
Both conditions show increased serum levels of products such as elevation of C-reactive 
protein and fibrinogen derived from oxidative damage, with a pro-inflammatory state 
likely influencing each other bidirectionally (Bullon et al. 2009).  
2.4 Gap in the Knowledge 
The possible association between periodontal disease and other diseases has been 
studied extensively assessing periodontitis with self-reported periodontal disease or 
clinical periodontal examination, but periodontal microflora associated with periodontitis 
as a marker of periodontal disease is understudied. There are very few large studies 
(Pussinen et al. 2011, Papapanou et al. 2000) which have combined clinical, bacterial and 
immunological data which could elucidate the possible role of these periodontal bacteria 
in systemic immune response and periodontitis. The need to understand the periodontal 
microbiota profile and its immunological marker is important primarily to measure direct 
systemic activity, but also to comprehend increasing evidence of periodontal disease 
being a potential modulator of diabetes mellitus(Dye and Genco 2012, Lalla and 
Papapanou 2011), obesity (Chaffee and Weston 2010, de Castilhos et al. 2012, 
Jagannathachary and Kamaraj 2010), atherosclerosis (Papapanou and Trevisan 2012, 
Lockhart et al. 2012, Behle and Papapanou 2006, Desvarieux et al. 2005, Beck et al. 
2001), other vascular diseases (Pussinen, Alfthan, Tuomilehto, et al. 2004, Pussinen, 
Alfthan, Rissanen, et al. 2004, Pussinen, Jousilahti, et al. 2003, Papapanou 2009, Beck et 
al. 2005), preterm labor (Pussinen, Paju, et al. 2007, Albert et al. 2011, Michalowicz, 
Novak, et al. 2009, Michalowicz, Hodges, et al. 2009, Jarjoura et al. 2005) and different 
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other systemic diseases(Demmer et al. 2012, Michalowicz et al. 2011, Desvarieux et al. 
2010, Behle et al. 2009, Beck et al. 2005, Zoppini et al. 2012).   
In this dissertation, we analyzed serum IgG antibodies against 19 periodontal 
bacteria from the NHANES III survey dataset. The NHANES III dataset provided a 
unique opportunity to explore these relationships because this survey has data on 
periodontal examination, laboratory assessment of serum IgG antibodies to 19 different 
periodontal bacteria, socio-demographic, anthropometric and nutritional information in 
large number of US adult’s participants. The variables that were used from these different 
NHANES III sub datasets are shown in Table 2.2. Figure 2.2 depicts the phyla (and 
groups as defined by Socransky and Haffajee (Socransky and Haffajee 2002, 2005) of 19 
periodontal bacteria species to which serum IgG antibodies were identified and measured 
by checker board DNA-DNA hybridization in NHANES III survey (Papapanou et al. 
2001). 
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Table 2.1- Epidemiological studies evaluating the relation between periodontal 
microorganisms in individuals with diabetes or pre-diabetes 
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Author , 
Year 
title and 
publication 
Study 
design 
Purpose 
of the study 
Charac
teristic
s of the 
populat
ion 
Method of 
detecting 
microorgani
sms 
& Statistical 
Analysis 
Findings Inferences 
& 
Limitations 
1 Zhou et al 
(2013). 
Investigatio
n of the 
Effect of 
Type 2 
Diabetes 
Mellitus on 
Subgingival 
Plaque 
Microbiota 
by High-
Throughput 
16S rDNA 
Pyrosequen
cing. 
 
PLoS One.; 
8(4): 
e61516. 
 
Cross- 
sectional 
study 
 
Subginival 
biofilm in 
different 
groups of 
periodontiti
s and 
diabetes are 
compared 
within 
different 
groups. 
They 
included 
non-diabetic 
subjects 
without 
periodontiti
s (P-D-), 
non-diabetic 
subjects 
with 
periodontiti
s (P+D-), 
type 2 
diabetic 
patients 
without 
periodontiti
s (P-D+), 
and type 2 
diabetic 
patients 
with 
periodontiti
s (P+D+). 
31 
Chines
e 
subject
s,  
30-65 
years 
old 
 had at 
least 20 
teeth 
without 
any 
clinical 
signs of 
oral 
mucosa
l 
disease 
or root 
caries   
16s rDNA 
Pyrosequenci
ng 
 
Wilcoxon 
rank-sum test  
and Fisher’s 
exact test 
The 
sequencing 
depth was 
similar 
among 
different 
sample 
groups 
although a 
slightly 
smaller 
amount of 
sequences 
were 
generated 
from the 
P+D- group. 
The samples 
in the 
periodontitis-
positive 
groups (i.e., 
P+D- or 
P+D+) are 
well 
separated 
from those in 
the 
periodontitis-
negative 
groups (i.e., 
P-D- or P-
D+) based on 
the 
unweighted 
UniFrac 
distances 
These 
findings 
reflect that 
the bacterial 
compositions 
in 
periodontitis 
and healthy 
samples were 
distinct. 
Furthermore, 
compositiona
l shifts in the 
subgingival 
plaque 
bacterial 
community 
associated 
with 
periodontitis 
also exist in 
diabetic 
patients. 
 
small sample 
size 
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measured at 
the OTU 
level 
 
In the 
subjects with 
healthy 
periodontium
, the 
abundances 
of three 
genera 
(Prevotella, 
Pseudomona
s, and 
Tannerella) 
and nine 
OTUs were 
significantly 
different 
between 
diabetic 
patients and 
their non-
diabetic 
counterparts. 
In the 
subjects 
carrying 
periodontitis, 
the 
abundances 
of three 
phyla 
(Actinobacte
ria, 
Proteobacter
ia, and 
Bacteriodete
s), two 
genera 
(Actinomyces 
and 
Aggregatibac
ter), and six 
OTUs were 
30 
 
also 
significantly 
different 
between 
diabetics and 
non-
diabetics. 
1. 2 2. Casarin et 
al. (2012) 
3. Sub 
gingival 
biodiversity 
in subjects 
with 
uncontrolle
d type-2 
diabetes 
and chronic 
periodontiti
s. 
4. J Periodont 
Res 2013; 
48: 30–36. 
 
Case Only 
study 
[Severe and 
generalized 
periodontiti
s] 
 
Compare 
the sub 
gingival 
diversity in 
deep 
periodontal 
pockets of 
diabetes or 
non diabetic 
subjects 
with chronic 
periodontiti
s. 
Severe 
and 
generali
zed 
periodo
ntitis 
with 
uncontr
olled 
type 2D 
(T2DM
)  
[Hba1c 
>8% , 
n=12 
subjects
] and 
non-
diabetic 
[n=11 
subjects
] were 
consecu
tively 
recruite
d from 
the 
populati
on 
referred 
to the 
Period
ontal 
clinic 
of 
Guarul
hos 
Univer
sity 
Subgingival 
biofilm were 
identified 
and 
quantified 
using 16s 
Rrna Gene 
cloning 
and 
quantified by 
sequencing a 
finite number 
of clones 
from each 
sample. 
 
The 
microbiologi
cal data were 
transformed 
using 
variance-
stabilizing 
transformatio
n and 
proportion of 
each species 
in the 
periodontal 
biofilm 
community 
was 
calculated. 
Two tailed 
student t test 
and chi –
square test 
 
 
Among the 
top 15 
clones, 
subjects with 
uncontrolled 
T2DM 
presented 
higher 
percentages 
of total 
clones of 
TM7, 
Aggregatibac
ter, 
Neisseria, 
Gemella, 
Eikenella, 
Selenomonas
, 
Actinomyces, 
Capnocytoph
aga, 
Fusobacteriu
m, 
Veillonella 
and 
Streptococcu
s genera,  
whereas 
higher 
percentages 
of P. 
gingivalis, T. 
forsythia, 
Filifactor 
alocis and 
Synergistetes 
clone BH017 
were found 
Significant 
differences 
were 
observed in 
subgingival 
microbiota 
between 
uncontrolled 
diabetic and 
nondiabetic 
subjects. 
 
small sample 
size 
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and 
Piracic
aba 
Dental 
school, 
Brazil 
from 
July 
2007 to 
Feb 
2010. 
Mean 
age 
group 
were 
slightly 
higher 
in 
diabetes 
group 
[51.8 
(40-
70)] 
compar
ed to 
non 
diabetic 
group 
[47.8 
(41-
62)]. 
Female 
were in 
higher 
proporti
on in 
diabetic 
group 
than 
non 
diabetic
. 
 
 in the 
periodontal 
pockets of 
Non-DM 
subjects (p < 
0.05). 
 
Moreover, 
some 
phylotypes, 
such as 
Fusobacteriu
m nucleatum, 
Veillonella 
parvula, V. 
dispar and 
Eikenella 
corrodens 
were 
detected 
significantly 
more often in 
diabetic 
subjects than 
in 
nondiabetic 
subjects (p < 
0.05). 
 
5. 3 6. Field et al. 
7. (2012) 
8. Investigatio
Detect the 
quantitative 
differences 
48 
subjects 
who 
Cultivation 
(A 
actinomycete
A 
actinomycete
mcomitans, F 
No 
significant 
difference 
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n and 
quantificati
on of key 
periodontal 
pathogens 
in patients 
with type 2  
Diabetes. 
9. J Periodont 
Res 2012; 
47: 470–
478 
10.  
Matched 
Case -
control 
study 
 
in selected 
periodontop
athogens in 
the sub 
gingival 
plaque of 
diabetes 
patients 
using 
TaqMan 
quantitative 
PCR 
have 
confirm
ed 
T2DM 
with 
(n=9) 
or 
without 
periodo
ntitis 
(n=15) 
were 
recruite
d from 
New 
Castle 
Dentist 
Hospit
a, UK. 
Age, 
sex, and 
smokin
g 
status-
matche
d 
control 
non-
diabetic 
subjects 
(with 
periodo
ntitis 
(n=12) 
and 
without 
periodo
ntitis 
(n=12) 
were 
recruite
d from 
from 
same 
hospital
.  
mcomitans, F 
nucleatum 
and P 
gingivalis)  
and 
quantificatio
n by qPCR 
 
 
One way 
ANOVA 
Bonferroni 
post hoc tests 
 
Mann 
whitney U-
test 
 
nucleatum 
and P 
gingivalis  
were present 
in 
significantly 
different 
quantities 
and 
proportion 
according to 
periodontal 
disease status 
but there was  
no clear 
distinction 
between 
three 
microbiota in 
diabetes and 
non diabetes 
group. 
However, P 
ginivalis 
were higher 
in 
periodontitis 
(diabetic and 
non diabetic 
group) than 
periodontal 
healthy 
subjects. 
A 
actinomycete
mcomitans 
were found 
in lower 
quantities in 
all 
subgroups 
while 
F nucleatum 
were 
abundant in 
all subgroups 
were 
identified 
between the 
sub gingival 
flora 
between 
T2DM and 
non –diabetic 
patients. 
Limited no 
of 
microorganis
m. 
 
 
Control 
Patients with 
T2DM were 
recruited 
who 
currently 
deemed 
stable with 
regard to 
diabetes 
symptoms by 
their medical 
practioner. 
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Majorit
y of 
study 
particip
ants 
were 
Whites 
male 
and Ex 
or non 
smoker
s, over 
18 
years of 
age and 
a 
minimu
m of 20 
teeth. 
with no clear 
distinction. 
4 da Cruz 
et al. (2008) 
Clinical and 
laboratory  
evaluation 
of non-
surgical 
periodontal 
treatments 
in type 2 
Diabetes 
patients. 
J periodont, 
79 :1150-
1157 
 
Longitudin
al follow-
up 
study (3 
months) 
following 
non-
surgical 
periodontal 
therapy 
 
to evaluate 
the clinical 
and 
laboratory 
changes 3 
months after 
full-mouth 
scaling and 
root planing 
in subjects 
with and 
without 
diabetes 
mellitus 
20 
adults 
with 
periodo
ntitis, 
of 
whom  
10 were 
type 2 
diabetes 
mellitus 
who 
require
d 
insulin 
therapy 
(DM) 
and 10 
healthy 
adult 
control 
subjects 
(NDM) 
with 
generali
zed 
chronic 
PCR analysis 
of 
subgingival 
plaque 
samples for 
A. 
actinomycete
mcomitans, 
P. 
gingivalis 
and T. 
forsythia 
 
two-way 
ANOVA 
x2 test 
Periodontal 
status 
improved 
following 
treatment, 
but no 
changes in 
HbA1c 
Occurred.  
 
Reductions 
in the 
frequency 
of bacterial 
recovery 
occurred 
over the 3 
months, but 
there were no 
significant 
differences 
between the 
two groups 
 
Clinical and 
laboratory 
responses 
were similar 
in T2DM and 
NDM groups 
3 months 
after full-
mouth 
scaling and 
root planing. 
 
Small 
numbers  
 
Uncontrolled 
diabetes 
subjects who 
required 
insulin 
therapy 
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 periodo
ntal 
disease 
were 
recruite
d from 
dental 
clinic, 
Univers
ity of 
Campin
as, 
Brazil 
Age 
ranged 
from 
30-70 
years 
and had 
at least 
20 
teeth. 
Subject
s were 
evaluat
ed 3 
months 
(Oct-
Dec 
2006) 
5 Ebersole 
et al. 2008 
Microbiolo
gic and 
Immunolog
ic 
Characterist
ics of 
Periodontal 
Disease in 
Hispanic 
Americans 
With 
Type 2 
Diabetes 
 
comparison 
of sub 
gingival 
plaque 
samples and 
serum 
antibody 
levels to 
selected oral 
microorgani
sms  in 
T2DM 
suffering 
Hispanic 
population.  
 
39 
Hispan
ic  
Americ
ans 
with 
T2DM, 
and 24 
non-
diabetic 
controls 
were 
recruite
d from 
Brady 
Green 
DNA 
checkerboard 
hybridization 
of plaque 
samples, 
 and ELISA 
analysis of 
serum IgG 
levels were 
performed 
 
two-way 
ANOVA 
x2 test 
 
Similar 
pathogens 
were found 
in 
periodontitis 
sites in 
subjects with 
and without 
T2DM, 
though 
P.gingivalis, 
A. 
actinomycete
mcomitans 
and 
Campylobact
poor oral 
hygiene, 
site-specific 
samples 
should be 
considered 
35 
 
J 
Periodontol  
Vol74 (4) 
 
Cross-
sectional 
clinic, 
Texas, 
US in 
1994 
Mean 
age of 
diabetic 
groups 
54.2 
(39-72) 
while 
non 
diabetes 
group 
was 
47.4 
(33-68) 
years.  
Female 
were in 
higher 
proporti
on in 
diabetes 
groups.  
In 
T2DM 
group, 
non 
smoker
s were 
27 out 
of 39 
and in 
non 
diabetic 
non 
smoker
s were 
20 out 
of 24. 
 
er species 
were found 
more 
frequently (p 
< 0.05) in 
subjects with 
T2DM 
compared to 
those 
without. 
Also, serum 
IgG 
responses 
were broadly 
similar 
between the 
two groups, 
apart from a 
significant 
elevation in 
antibody to C 
rectus in the 
diabetic 
subjects 
 
6 Makiura et 
al. 2008 
Relationshi
p of 
assess the 
relationship 
between 
serum 
30 
Japane
se 
adults 
Used 
polymerase 
chain 
reaction  
It was 
observed that 
post-
treatment, P. 
The authors 
postulated 
that glycemic 
control in 
36 
 
Porphyrom
onas 
gingivalis 
with 
glycemic 
level in 
patients 
with type 2 
diabetes 
following 
periodontal 
treatment. 
 
Oral 
Microbiol 
Immunol 
2008: 23: 
348–351. 
 
Prospective 
longitudinal 
study 
 
glycemic 
levels and 
subgingival 
microbial 
profile 
alteration 
following 
periodontal 
treatment in 
patients 
with type 2 
diabetes 
mellitus. 
(14 
male 
and 16 
female) 
sufferin
g from 
chronic 
periodo
ntitis 
and 
T2DM 
were 
recruite
d. 
 
The age 
of the 
subjects 
ranged 
from 41 
to 80 
years 
(mean 
63.9 ± 
9.4 
years) 
and 
duratio
n of 
DM 
was 
betwee
n 3 and 
13 
years 
(8.5 ± 
5.6 
years), 
with 
HbA1c 
values 
ranging 
from 
6.0% to 
10% 
(7.11 ± 
[PCR] 
method,  
 
The target 
microorganis
ms were P  
gingivalis, 
A 
actinomycete
mcomitans, 
T 
forsythensis, 
T denticola, 
and P 
intermedia. 
 
t-test 
 
 
gingivalis 
was detected 
more 
frequently in 
those who 
had 
increased 
HbA1c 
values 
compared to 
those with 
decreased 
values 
relative to 
baseline, and 
more 
specifically, 
P. gingivalis 
with type II 
fimbriae was 
detected only 
in patients 
with an 
increase in 
HbA1c. 
 
patients with 
periodontitis 
and diabetes 
is potentially 
influenced 
by the 
persistence 
of P. 
gingivalis, 
particularly 
clones with 
type II 
fimbriae, 
following 
treatment 
 
Small sample 
size 
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1.16%). 
7 Hintao et 
al. 2007 
The 
microbiolo
gical 
profiles of 
saliva, 
supragingiv
al and 
subgingival 
plaque and 
dental 
caries in 
adults with 
and without 
type 2 
diabetes 
mellitus. 
Oral 
Microbiol 
Immunol 
22: 175–
181 
 
Statified 
Cross-
sectional 
study 
 
determine 
the effect of 
T2DM on 
coronal and 
root surface 
caries and 
to 
investigate 
some 
factors 
suspected of 
being 
related to or 
interacting 
with DM, 
that may be 
associated 
with coronal 
and root 
surface 
caries 
Data 
were 
obtaine
d from 
105 
patients 
with 
T2DM  
and 103 
non-
diabetic 
subjects 
in 
Southe
rn 
Thaila
nd. 
 
Among 
the 
T2DMs
, the 
mean 
duratio
n of 
diabetes 
was 8.7 
years 
(SD 
5.7). 
The 
mean 
HbA1c 
value in 
the 
group 
was 
8.5% 
(SD 
2.1) and 
ranged 
from 
5.6 
to15.8
%. 
17 bacterial 
species using 
the 
Checkerboar
d 
DNA–DNA 
hybridization 
method. 
 
The chi-
squared test 
(Bonferroni 
correction) 
The Mantel–
Haenszel 
odds ratio 
 
 
Significantly 
more 
diabetic 
subjects had 
higher levels 
of T 
denticola, P 
nigrescens, S 
sanguinis, S 
oralis and S 
intermedius 
in their 
supragingival 
plaque than 
non-diabetic 
subjects. 
None of the 
bacterial 
species 
tested in the 
subgingival 
plaque 
samples 
demonstrated 
an 
association 
with T2DM 
No 
significant 
difference 
was found 
for the 
organisms in 
saliva, oral 
rinse and 
subgingival 
plaque 
between the 
two groups. 
 
Possible 
association 
of T2DM 
with some 
specific 
bacteria 
 
Mixture of 
insulin and 
non-insulin 
diabetes 
patients. 
 
When using 
the 
checkerboard 
method in 
patients with 
poor oral 
hygiene, 
site-specific 
samples 
should be 
considered. 
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 85% of 
the 
patients 
were 
receivin
g oral 
anti-
diabetic 
treatme
nt or 
dietary 
controls 
only, 
7.5% 
had 
insulin 
treatme
nt and 
7.5% 
were 
treated 
with a 
combin
ation of 
insulin 
and oral 
antidiab
etic 
agents. 
Mean 
age (54 
in 
T2DM 
and 53 
in Non 
diabtete
s group) 
and sex 
in both 
groups 
were 
similar 
proporti
on 
8 Yuan 
et al. (2001) 
the 
detection 
105 
Taiwan
PCR analysis 
detection 
No 
significant 
No 
difference 
39 
 
 
Detection 
of putative 
periodontal 
pathogens 
in non-
insulin-
dependent 
diabetes 
mellitus 
(NIDDM) 
and 
non-
diabetes 
mellitus by 
polymerase 
chain 
reaction.  
J Periodont 
Res 2001; 
36: 18±24. 
 
 
Case-
Control 
comparison 
 
 
rates of 5 
putative 
periodontal 
pathogens:  
between 
NIDDM 
and non-
DMadults 
were 
compared. 
ese 
adults 
with 
noninsu
lin- 
depend
ent 
diabetes 
and 141 
age- 
and sex 
matche
d 
non-
diabetic 
individ
uals 
ages 
ranging 
from 28 
to 78 yr 
in the 
NIDD
M 
group 
and 21 
to 80 yr 
in the 
non-
DM 
group. 
The 
ratio of 
male to 
female 
in non-
DM and 
NIDD
M 
groups 
were 
1.39 
and 
1.33, 
respecti
vely. 
rates of A. 
actinomycete
mcomitans, 
P. 
gingivalis, E. 
corrodens, T. 
denticola 
and C. 
albicans 
 
Student's t-
test 
 
The chi-
squared test 
 
differences 
in the 
prevalence 
rates of the 5 
microorganis
ms between 
the diabetic 
and non-
diabetic 
individuals 
was found 
between 
subgingival 
micro-
organisms in 
T2DM and 
Non diabetic 
group 
 
Limited set 
of 
microorganis
ms  
 
Age and sex 
were not 
adjusted 
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9 Castrillon 
et al (2013) 
Occurrence 
of red 
complex 
microorgani
sms and 
Aggregatib
acter 
actinomycet
emcomitans 
in patients 
with 
diabetes 
Journal of 
Investigativ
e and 
Clinical 
Dentistry, 
4, 1–7 
 
Cross-
sectional 
study. 
Analyze the 
occurrence 
of red 
complex 
micro-
organisms 
Aggregatib
acter 
actinomycet
emcomitans 
in patients 
with 
diabetes 
(type 1 or 
type 2) 
 
60 
patients 
conﬁrm
ed 
diagnos
is 
(fasting 
glucose 
≥126 
mg/dL 
or 
glycate
d hemo- 
globin 
≥6.5%) 
of type 
I or II 
DM 
with a 
previou
s (>2 
years) 
and 
from 
the 
Hospita
l 
Univers
itario 
San 
Vicente 
de Paul 
(Medell
in, 
Colomb
ia), and 
62 
patients 
without 
diabetes 
from 
the 
School 
of 
Dentistr
Using PCR, 
the 
prevalence of 
red complex 
microorganis
ms 
(P. gingivalis
, T. forsythia, 
and 
T. denticola) 
and 
A. actinomyc
etemcomitan
s were 
determinedP
eriodontitis 
Patients were 
classiﬁed 
according to 
the American 
Academy of 
Periodontolo
gy and Page 
and Eke’s 
classica- 
tions 
 
Kruskal–
Wallis, 
Mann–
Whitney U-
test, and 
Fisher's exact 
test 
Periodontitis 
patients 
presented 
with more 
Bleeding on 
Probing 
(BOP) and 
probing 
depth ( PD) 
than 
systemically-
healthy 
patients 
without 
periodontitis 
(P < 0.05).  
The CAL 
was 
increased in 
DM 
periodontitis 
patients 
compared to 
ND 
periodontitis 
patients, and 
this 
difference 
was 
statistically 
signiﬁcant (P 
< 0.05). 
 In addition, 
patients with 
diabetes and 
periodontitis 
had lost more 
teeth than 
ND 
periodontitis 
patients P < 
0.05) 
Red complex 
microorganis
ms were 
Possible 
association 
of  the 
subgingival 
microbiota 
between 
diabetic and 
non-diabetic 
patients. 
 
 In addition, 
P. gingivalis 
and 
A. actinomyc
etemcomitan
s were 
associated 
with 
periodontitis 
in patients 
without 
diabetes and 
patients with 
diabetes, 
respectively 
 
Small sample 
size 
Limited 
micro-
organisms 
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y at the 
Univers
idad del 
Valle 
(Cali, 
Colomb
ia)  
They 
particip
ated in 
this 
study 
from 
Februar
y 2011 
to 
March 
2012, 
Patients 
had a 
mean 
age of 
47 
years, 
and 
there 
were 
more 
females 
than 
males.  
detected in 
lower 
frequencies 
in patients 
with 
diabetes. The 
detection of 
A. actinomyc
etemcomitan
s was higher 
in patients 
with diabetes 
and 
periodontitis 
compared to 
systemically-
healthy 
patients 
without 
periodontitis 
(P < 0.05). 
P. gingivalis 
was 
associated 
with 
periodontitis 
in non-
diabetic 
patients 
(P < 0.05), 
whereas 
A. actinomyc
etemcomitan
s was 
associated 
with 
periodontitis 
in diabetic 
patients 
(P < 0.05). 
 
10 Vlachojanni
s  et al. 
(20100 
Determinan
ts of serum 
assess the 
distribution 
of elevated 
antibody 
titres to 
>=40-
year-
old 
particip
ants 
checkerboard 
immunoblotti
ng to assess 
serum IgG 
levels to 19 
Edentulous 
individuals 
showed 
lower 
antibody 
Demographic
, 
behavioural, 
and oral- and 
general 
42 
 
IgG 
responses 
to 
periodontal 
bacteria in a 
nationally 
representati
ve sample 
of US 
adults. J 
Clin 
Periodontol 
2010; 37: 
685–696 
 
Cross-
sectional 
study. 
multiple 
periodontal 
bacteria, 
including 
established/
putative 
pathogens 
and health-
related 
species, by 
selected 
demographi
c, 
behavioural, 
and oral- 
and general 
health-
related 
characteristi
cs. 
from 
the 
third 
Nationa
l Health 
and 
Nutritio
n 
Examin
ation 
Survey 
(NHAN
ES III) 
were 
used, 
includin
g 1588 
edentul
ous 
individ
uals. 
periodontal 
species 
two-sided t-
tests 
(p<0.05) 
Multivariable 
logistic 
regression 
modelling 
responses 
than dentate 
participants, 
notably for 
titres to ‘‘red 
complex’’ 
species and A 
actinomycete
mcomitans. 
Elevated P 
gingivalis 
antibody IgG 
titers was 
significantly 
different in 
diabetes 
including 
type 1 or 
type 2 than 
having no 
diabetes 
health-
related 
characteristic
s were strong 
determinants 
of systemic 
antibody 
responses to 
periodontal 
bacteria in a 
nationally 
representativ
e sample of 
US adults. 
Diabetes as 
an exact 
diagnosis on 
the type of 
diabetes was 
not available 
in the present 
analysis 
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Table2.2. Covariates from different data sources of NHANES III 
 
Household 
Adult 
Interview 
Questionnaires 
data file 
NHANES III 
Examination 
Data File 
laboratory 
examination 
data file 
NHANES III Antibodies 
to Periodontal Pathogens 
(SPSDEPPX) 
Dietary 
recall and 
vitamin 
supplement 
dataset 
Age, 
Sex, 
Race/ethnicity 
income-
poverty ratio,  
education, 
smoking,  
Physical 
activity, 
self-reported 
diabetes, 
hypertension 
and frequency 
of dental visits  
BMI, 
Waist 
circumference, 
Blood 
pressure, 
number of 
missing teeth, 
Clinical 
attachment 
loss (CAL), 
Pocket depth 
(PD) 
Plasma 
HbA1c%, 
Plasma 
Blood 
glucose, 
Serum Tri-
glycerides, 
Low 
Density 
Lipoprotein,  
High 
Density 
Lipoprotein, 
Systolic 
Blood 
Pressure, 
Diastolic 
Blood 
Pressure 
 
Aggregatibacter 
actinomycetemcomitans 
mix (ATCC strains 
#43718, #29523 and 
#33384); 
 Porphyromonas 
gingivalis mix (ATCC 
#33277 and #53978); 
 Tannerella forsythia 
ATCC#43037; 
Treponema denticola 
OMGS#3271; 
Campylobacter rectus 
ATCC#33238; 
Eubacterium nodatum 
ATCC#33099; 
Prevotella intermedia 
ATCC#25611; 
Prevotella nigrescens 
ATCC#33563; 
Prevotella 
melaninogenica  
ATCC#25845;  
Fusobacterium 
nucleatum 
ATCC#10953;  
Micromonas micros 
ATCC #33270; 
Selenomonas noxia 
ATCC#43541;  
Eikenella corrodens 
ATCC#23834; 
Capnocytophaga 
ochracea ATCC#33624;  
Streptococcus 
intermedius 
ATCC#27335;  
Streptococcus oralis 
ATCC#35037; 
total fibers 
intake, 
Protein 
intake, 
Carbohydrate 
Intake, 
Fat intake 
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Streptococcus mutans 
ATCC#25175; 
Veillonella parvula 
ATCC#10790; and 
Actinomyces naeslundii 
ATCC#49340 
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Figure 2.1: Model for bidirectional relationship between periodontal infection and 
diabetes, contributing to insulin resistance. (Ozmeric, 2004; Preshaw et al., 2012; Santos 
Tunes, Foss-Freitas, & Nogueira-Filho Gda, 2010) (Santos Tunes, Foss-Freitas, and 
Nogueira-Filho Gda 2010, Ozmeric 2004, Preshaw et al. 2012) (Santos Tunes, Foss-
Freitas, and Nogueira-Filho Gda 2010, Ozmeric 2004, Preshaw et al. 2012) (14, 35, 68) 
(14, 35, 68) (14, 35, 68) (Santos Tunes, Foss-Freitas, and Nogueira-Filho Gda 2010, 
Ozmeric 2004, Preshaw et al. 2012) MMP: Matrix metalloproteinase, IL: Interleukin, 
TGF-β: Transforming growth factor β, TNF-α: Tumor necrosis factor α, PGE2: 
Prostaglandin E2, PMN: Poly morphonuclear leucocyte, AGE: Advanced glycation end 
products, RAGE: Receptor for AGE 
 
46 
 
 
 
 
Figure 2.2: Serum Immunoglobulin (IgG) to 19 periodontal bacteria species and their 
respective phyla identified by Checkerboard hybridization in NHANES III study. 
 
 
 
 
 
 
 
 
 
47 
 
References: 
 
2012. "Introduction: The American Diabetes Association's (ADA) evidence-based 
practice guidelines, standards, and related recommendations and documents for 
diabetes care." Diabetes Care no. 35 Suppl 1:S1-2. doi: 10.2337/dc12-s001. 
Albert, D. A., M. D. Begg, H. F. Andrews, S. Z. Williams, A. Ward, M. L. Conicella, V. 
Rauh, J. L. Thomson, and P. N. Papapanou. 2011. "An examination of periodontal 
treatment, dental care, and pregnancy outcomes in an insured population in the 
United States." Am J Public Health no. 101 (1):151-6. doi: 
10.2105/AJPH.2009.185884. 
Alfakry, H., S. Paju, J. Sinisalo, M. S. Nieminen, V. Valtonen, P. Saikku, M. Leinonen, 
and P. J. Pussinen. 2011. "Periodontopathogen- and host-derived immune 
response in acute coronary syndrome." Scand J Immunol no. 74 (4):383-9. doi: 
10.1111/j.1365-3083.2011.02584.x. 
Baelum, V., S. Pongpaisal, W. Pithpornchaiyakul, S. Pisuithanakan, R. Teanpaisan, P. N. 
Papapanou, G. Dahlen, and F. Ole. 2002. "Determinants of dental status and 
caries among adults in southern Thailand." Acta Odontol Scand no. 60 (2):80-6. 
Banihashemrad, S. A., A. Moeintaghavi, and A. Rafighdoost. 2008. "Relationship 
between cholesterol and triglyceride blood values and periodontal parameters in 
patients of Mashhad health center." N Y State Dent J no. 74 (5):65-6. 
Beck, J. D., P. Eke, G. Heiss, P. Madianos, D. Couper, D. Lin, K. Moss, J. Elter, and S. 
Offenbacher. 2005. "Periodontal disease and coronary heart disease: a reappraisal 
48 
 
of the exposure." Circulation no. 112 (1):19-24. doi: 
10.1161/CIRCULATIONAHA.104.511998. 
Beck, J. D., J. R. Elter, G. Heiss, D. Couper, S. M. Mauriello, and S. Offenbacher. 2001. 
"Relationship of periodontal disease to carotid artery intima-media wall thickness: 
the atherosclerosis risk in communities (ARIC) study." Arterioscler Thromb Vasc 
Biol no. 21 (11):1816-22. 
Behle, J. H., and P. N. Papapanou. 2006. "Periodontal infections and atherosclerotic 
vascular disease: an update." Int Dent J no. 56 (4 Suppl 1):256-62. 
Behle, J. H., M. H. Sedaghatfar, R. T. Demmer, D. L. Wolf, R. Celenti, M. Kebschull, P. 
B. Belusko, M. Herrera-Abreu, E. Lalla, and P. N. Papapanou. 2009. 
"Heterogeneity of systemic inflammatory responses to periodontal therapy." J 
Clin Periodontol no. 36 (4):287-94. doi: 10.1111/j.1600-051X.2009.01382.x. 
Beltran-Aguilar, E. D., L. K. Barker, M. T. Canto, B. A. Dye, B. F. Gooch, S. O. Griffin, 
J. Hyman, F. Jaramillo, A. Kingman, R. Nowjack-Raymer, R. H. Selwitz, T. Wu, 
Control Centers for Disease, and Prevention. 2005. "Surveillance for dental 
caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United 
States, 1988-1994 and 1999-2002." MMWR Surveill Summ no. 54 (3):1-43. 
Bogren, A., R. P. Teles, G. Torresyap, A. D. Haffajee, S. S. Socransky, and J. L. 
Wennstrom. 2007. "Clinical and microbiologic changes associated with the 
combined use of a powered toothbrush and a triclosan/copolymer dentifrice: a 3-
year prospective study." J Periodontol no. 78 (9):1708-17. doi: 
10.1902/jop.2007.070028. 
49 
 
Bonato, C. F., C. C. do-Amaral, L. Belini, L. M. Salzedas, and S. H. Oliveira. 2012. 
"Hypertension favors the inflammatory process in rats with experimentally 
induced periodontitis." J Periodontal Res. doi: 10.1111/j.1600-
0765.2012.01496.x. 
Bullon, P., J. M. Morillo, M. C. Ramirez-Tortosa, J. L. Quiles, H. N. Newman, and M. 
Battino. 2009. "Metabolic syndrome and periodontitis: is oxidative stress a 
common link?" J Dent Res no. 88 (6):503-18. doi: 10.1177/0022034509337479. 
Buysschaert, M., and M. Bergman. 2011. "Definition of prediabetes." Med Clin North 
Am no. 95 (2):289-97, vii. doi: 10.1016/j.mcna.2010.11.002. 
Chaffee, B. W., and S. J. Weston. 2010. "Association between chronic periodontal 
disease and obesity: a systematic review and meta-analysis." J Periodontol no. 81 
(12):1708-24. doi: 10.1902/jop.2010.100321. 
Chavarry, N. G., M. V. Vettore, C. Sansone, and A. Sheiham. 2009. "The relationship 
between diabetes mellitus and destructive periodontal disease: a meta-analysis." 
Oral Health Prev Dent no. 7 (2):107-27. 
Chudyk, A., and R. J. Petrella. 2011. "Effects of exercise on cardiovascular risk factors in 
type 2 diabetes: a meta-analysis." Diabetes Care no. 34 (5):1228-37. doi: 
10.2337/dc10-1881. 
Colombo, A. P., S. K. Boches, S. L. Cotton, J. M. Goodson, R. Kent, A. D. Haffajee, S. 
S. Socransky, H. Hasturk, T. E. Van Dyke, F. Dewhirst, and B. J. Paster. 2009. 
"Comparisons of subgingival microbial profiles of refractory periodontitis, severe 
50 
 
periodontitis, and periodontal health using the human oral microbe identification 
microarray." J Periodontol no. 80 (9):1421-32. doi: 10.1902/jop.2009.090185. 
Cutler, C. W., and A. M. Iacopino. 2003. "Periodontal disease: links with serum lipid/ 
triglyceride levels? Review and new data." J Int Acad Periodontol no. 5 (2):47-
51. 
D'Aiuto, F., W. Sabbah, G. Netuveli, N. Donos, A. D. Hingorani, J. Deanfield, and G. 
Tsakos. 2008. "Association of the metabolic syndrome with severe periodontitis 
in a large U.S. population-based survey." J Clin Endocrinol Metab no. 93 
(10):3989-94. doi: 10.1210/jc.2007-2522. 
Danaei, G., M. M. Finucane, Y. Lu, G. M. Singh, M. J. Cowan, C. J. Paciorek, J. K. Lin, 
F. Farzadfar, Y. H. Khang, G. A. Stevens, M. Rao, M. K. Ali, L. M. Riley, C. A. 
Robinson, M. Ezzati, and Group Global Burden of Metabolic Risk Factors of 
Chronic Diseases Collaborating. 2011. "National, regional, and global trends in 
fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of 
health examination surveys and epidemiological studies with 370 country-years 
and 2.7 million participants." Lancet no. 378 (9785):31-40. doi: 10.1016/S0140-
6736(11)60679-X. 
Darby, I. B., J. Mooney, and D. F. Kinane. 2001. "Changes in subgingival microflora and 
humoral immune response following periodontal therapy." J Clin Periodontol no. 
28 (8):796-805. 
Darre, L., J. N. Vergnes, P. Gourdy, and M. Sixou. 2008. "Efficacy of periodontal 
treatment on glycaemic control in diabetic patients: A meta-analysis of 
51 
 
interventional studies." Diabetes Metab no. 34 (5):497-506. doi: 
10.1016/j.diabet.2008.03.006. 
de Castilhos, E. D., B. L. Horta, D. P. Gigante, F. F. Demarco, K. G. Peres, and M. A. 
Peres. 2012. "Association between obesity and periodontal disease in young 
adults: a population-based birth cohort." J Clin Periodontol no. 39 (8):717-24. 
doi: 10.1111/j.1600-051X.2012.01906.x. 
Demmer, R. T., M. Desvarieux, B. Holtfreter, D. R. Jacobs, Jr., H. Wallaschofski, M. 
Nauck, H. Volzke, and T. Kocher. 2010. "Periodontal status and A1C change: 
longitudinal results from the study of health in Pomerania (SHIP)." Diabetes Care 
no. 33 (5):1037-43. doi: 10.2337/dc09-1778. 
Demmer, R. T., A. Squillaro, P. N. Papapanou, M. Rosenbaum, W. T. Friedewald, D. R. 
Jacobs, Jr., and M. Desvarieux. 2012. "Periodontal Infection, Systemic 
Inflammation, and Insulin Resistance: Results from the Continuous National 
Health and Nutrition Examination Survey (NHANES) 1999-2004." Diabetes 
Care. doi: 10.2337/dc12-0072. 
Desvarieux, M., R. T. Demmer, D. R. Jacobs, Jr., T. Rundek, B. Boden-Albala, R. L. 
Sacco, and P. N. Papapanou. 2010. "Periodontal bacteria and hypertension: the 
oral infections and vascular disease epidemiology study (INVEST)." J Hypertens 
no. 28 (7):1413-21. doi: 10.1097/HJH.0b013e328338cd36. 
Desvarieux, M., R. T. Demmer, T. Rundek, B. Boden-Albala, D. R. Jacobs, Jr., R. L. 
Sacco, and P. N. Papapanou. 2005. "Periodontal microbiota and carotid intima-
media thickness: the Oral Infections and Vascular Disease Epidemiology Study 
52 
 
(INVEST)." Circulation no. 111 (5):576-82. doi: 
10.1161/01.CIR.0000154582.37101.15. 
Dye, B. A. 2012. "Global periodontal disease epidemiology." Periodontol 2000 no. 58 
(1):10-25. doi: 10.1111/j.1600-0757.2011.00413.x. 
Dye, B. A., K. Choudhary, S. Shea, and P. N. Papapanou. 2005. "Serum antibodies to 
periodontal pathogens and markers of systemic inflammation." J Clin Periodontol 
no. 32 (12):1189-99. doi: 10.1111/j.1600-051X.2005.00856.x. 
Dye, B. A., and R. J. Genco. 2012. "Tooth loss, pocket depth, and HbA1c information 
collected in a dental care setting may improve the identification of undiagnosed 
diabetes." J Evid Based Dent Pract no. 12 (2):99-102. doi: 
10.1016/j.jebdp.2012.03.009. 
Dye, B. A., M. Herrera-Abreu, J. Lerche-Sehm, C. Vlachojannis, L. Pikdoken, B. Pretzl, 
A. Schwartz, and P. N. Papapanou. 2009. "Serum antibodies to periodontal 
bacteria as diagnostic markers of periodontitis." J Periodontol no. 80 (4):634-47. 
doi: 10.1902/jop.2009.080474. 
Dye, B. A., and R. H. Selwitz. 2005. "The relationship between selected measures of 
periodontal status and demographic and behavioural risk factors." J Clin 
Periodontol no. 32 (7):798-808. doi: 10.1111/j.1600-051X.2005.00742.x. 
Dye, B. A., S. Tan, V. Smith, B. G. Lewis, L. K. Barker, G. Thornton-Evans, P. I. Eke, E. 
D. Beltran-Aguilar, A. M. Horowitz, and C. H. Li. 2007. "Trends in oral health 
status: United States, 1988-1994 and 1999-2004." Vital Health Stat 11 (248):1-92. 
53 
 
Dye, B. A., and G. Thornton-Evans. 2010. "Trends in oral health by poverty status as 
measured by Healthy People 2010 objectives." Public Health Rep no. 125 
(6):817-30. 
Eke, P. I., B. A. Dye, L. Wei, G. O. Thornton-Evans, R. J. Genco, and Gordon Douglass 
Roy Page on behalf of the participating members of the Cdc Periodontal Disease 
Surveillance workgroup: James Beck. 2012. "Prevalence of Periodontitis in 
Adults in the United States: 2009 and 2010." J Dent Res. doi: 
10.1177/0022034512457373. 
Eke, P. I., R. C. Page, L. Wei, G. Thornton-Evans, and R. J. Genco. 2012. "Update of the 
Case Definitions for Population-Based Surveillance of Periodontitis." J 
Periodontol. doi: 10.1902/jop.2012.110664. 
Ervin, R. B., and B. A. Dye. 2009. "The effect of functional dentition on Healthy Eating 
Index scores and nutrient intakes in a nationally representative sample of older 
adults." J Public Health Dent no. 69 (4):207-16. doi: 10.1111/j.1752-
7325.2009.00124.x. 
Glickman, I. 1947. "The relation of experimental diabetes to periodontal disease." Am J 
Orthod no. 33 (10):703-22. 
Grundy, S. M., H. B. Brewer, Jr., J. I. Cleeman, S. C. Smith, Jr., C. Lenfant, Association 
American Heart, Lung National Heart, and Institute Blood. 2004. "Definition of 
metabolic syndrome: Report of the National Heart, Lung, and Blood 
Institute/American Heart Association conference on scientific issues related to 
54 
 
definition." Circulation no. 109 (3):433-8. doi: 
10.1161/01.CIR.0000111245.75752.C6. 
Haffajee, A. D., M. Japlit, A. Bogren, R. L. Kent, Jr., J. M. Goodson, and S. S. 
Socransky. 2005. "Differences in the subgingival microbiota of Swedish and USA 
subjects who were periodontally healthy or exhibited minimal periodontal 
disease." J Clin Periodontol no. 32 (1):33-9. doi: 10.1111/j.1600-
051X.2004.00624.x. 
Haffajee, A. D., M. Patel, and S. S. Socransky. 2008. "Microbiological changes 
associated with four different periodontal therapies for the treatment of chronic 
periodontitis." Oral Microbiol Immunol no. 23 (2):148-57. doi: 10.1111/j.1399-
302X.2007.00403.x. 
Haffajee, A. D., and S. S. Socransky. 2009. "Relation of body mass index, periodontitis 
and Tannerella forsythia." J Clin Periodontol no. 36 (2):89-99. doi: 
10.1111/j.1600-051X.2008.01356.x. 
Haffajee, A. D., S. S. Socransky, M. R. Patel, and X. Song. 2008. "Microbial complexes 
in supragingival plaque." Oral Microbiol Immunol no. 23 (3):196-205. doi: 
10.1111/j.1399-302X.2007.00411.x. 
Haffajee, A. D., R. P. Teles, and S. S. Socransky. 2006a. "Association of Eubacterium 
nodatum and Treponema denticola with human periodontitis lesions." Oral 
Microbiol Immunol no. 21 (5):269-82. doi: 10.1111/j.1399-302X.2006.00287.x. 
55 
 
Haffajee, A. D., R. P. Teles, and S. S. Socransky. 2006b. "The effect of periodontal 
therapy on the composition of the subgingival microbiota." Periodontol 2000 no. 
42:219-58. doi: 10.1111/j.1600-0757.2006.00191.x. 
Haffajee, A. D., G. Torresyap, and S. S. Socransky. 2007. "Clinical changes following 
four different periodontal therapies for the treatment of chronic periodontitis: 1-
year results." J Clin Periodontol no. 34 (3):243-53. doi: 10.1111/j.1600-
051X.2006.01040.x. 
Han, D. H., S. Lim, D. Paek, and H. D. Kim. 2012. "Periodontitis could be related factors 
on metabolic syndrome among Koreans: a case-control study." J Clin Periodontol 
no. 39 (1):30-7. doi: 10.1111/j.1600-051X.2011.01806.x. 
Hhs, and Ada. 2003. "HHS and ADA warn Americans of "prediabetes". Individuals 
encouraged to take healthy steps to reduce risks." Home Healthc Nurse no. 21 
(3):148-9. 
Itabe, H. 2012. "Oxidized low-density lipoprotein as a biomarker of in vivo oxidative 
stress: from atherosclerosis to periodontitis." J Clin Biochem Nutr no. 51 (1):1-8. 
doi: 10.3164/jcbn.11-00020R1. 
Jagannathachary, S., and D. Kamaraj. 2010. "Obesity and periodontal disease." J Indian 
Soc Periodontol no. 14 (2):96-100. doi: 10.4103/0972-124X.70827. 
Janket, S. J., A. Wightman, A. E. Baird, T. E. Van Dyke, and J. A. Jones. 2005. "Does 
periodontal treatment improve glycemic control in diabetic patients? A meta-
analysis of intervention studies." J Dent Res no. 84 (12):1154-9. 
56 
 
Jarjoura, K., P. C. Devine, A. Perez-Delboy, M. Herrera-Abreu, M. D'Alton, and P. N. 
Papapanou. 2005. "Markers of periodontal infection and preterm birth." Am J 
Obstet Gynecol no. 192 (2):513-9. doi: 10.1016/j.ajog.2004.07.018. 
Jones, J. A., D. R. Miller, C. J. Wehler, S. E. Rich, E. A. Krall-Kaye, L. C. McCoy, C. L. 
Christiansen, J. A. Rothendler, and R. I. Garcia. 2007. "Does periodontal care 
improve glycemic control? The Department of Veterans Affairs Dental Diabetes 
Study." J Clin Periodontol no. 34 (1):46-52. doi: 10.1111/j.1600-
051X.2006.01002.x. 
Khaw, K. T., N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day. 2004. 
"Association of hemoglobin A1c with cardiovascular disease and mortality in 
adults: the European prospective investigation into cancer in Norfolk." Ann Intern 
Med no. 141 (6):413-20. 
King, H., R. E. Aubert, and W. H. Herman. 1998. "Global burden of diabetes, 1995-2025: 
prevalence, numerical estimates, and projections." Diabetes Care no. 21 (9):1414-
31. 
Kwon, Y. E., J. E. Ha, D. I. Paik, B. H. Jin, and K. H. Bae. 2011. "The relationship 
between periodontitis and metabolic syndrome among a Korean nationally 
representative sample of adults." J Clin Periodontol no. 38 (9):781-6. doi: 
10.1111/j.1600-051X.2011.01756.x. 
Lalla, E., S. Kaplan, S. M. Chang, G. A. Roth, R. Celenti, K. Hinckley, E. Greenberg, 
and P. N. Papapanou. 2006. "Periodontal infection profiles in type 1 diabetes." J 
Clin Periodontol no. 33 (12):855-62. doi: 10.1111/j.1600-051X.2006.00996.x. 
57 
 
Lalla, E., and P. N. Papapanou. 2011. "Diabetes mellitus and periodontitis: a tale of two 
common interrelated diseases." Nat Rev Endocrinol no. 7 (12):738-48. doi: 
10.1038/nrendo.2011.106. 
Lalla, E., D. B. Park, P. N. Papapanou, and I. B. Lamster. 2004. "Oral disease burden in 
Northern Manhattan patients with diabetes mellitus." Am J Public Health no. 94 
(5):755-8. 
Le Chatelier, E., T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, G. Falony, M. Almeida, M. 
Arumugam, J. M. Batto, S. Kennedy, P. Leonard, J. Li, K. Burgdorf, N. Grarup, 
T. Jorgensen, I. Brandslund, H. B. Nielsen, A. S. Juncker, M. Bertalan, F. 
Levenez, N. Pons, S. Rasmussen, S. Sunagawa, J. Tap, S. Tims, E. G. Zoetendal, 
S. Brunak, K. Clement, J. Dore, M. Kleerebezem, K. Kristiansen, P. Renault, T. 
Sicheritz-Ponten, W. M. de Vos, J. D. Zucker, J. Raes, T. Hansen, H. I. T. 
consortium Meta, P. Bork, J. Wang, S. D. Ehrlich, and O. Pedersen. 2013. 
"Richness of human gut microbiome correlates with metabolic markers." Nature 
no. 500 (7464):541-6. doi: 10.1038/nature12506. 
Li, P., L. He, Y. Q. Sha, and Q. X. Luan. 2009. "Relationship of metabolic syndrome to 
chronic periodontitis." J Periodontol no. 80 (4):541-9. doi: 
10.1902/jop.2009.080387. 
Lockhart, P. B., A. F. Bolger, P. N. Papapanou, O. Osinbowale, M. Trevisan, M. E. 
Levison, K. A. Taubert, J. W. Newburger, H. L. Gornik, M. H. Gewitz, W. R. 
Wilson, S. C. Smith, Jr., L. M. Baddour, Endocarditis American Heart 
Association Rheumatic Fever, Council on Epidemiology Kawasaki Disease 
Committee of the Council on Cardiovascular Disease in the Young, Council on 
58 
 
Peripheral Vascular Disease Prevention, and Cardiology Council on Clinical. 
2012. "Periodontal disease and atherosclerotic vascular disease: does the evidence 
support an independent association?: a scientific statement from the American 
Heart Association." Circulation no. 125 (20):2520-44. doi: 
10.1161/CIR.0b013e31825719f3. 
Loe, H. 1993. "Periodontal disease. The sixth complication of diabetes mellitus." 
Diabetes Care no. 16 (1):329-34. 
Lopez, N. J., S. S. Socransky, I. Da Silva, M. R. Japlit, and A. D. Haffajee. 2004. 
"Subgingival microbiota of chilean patients with chronic periodontitis." J 
Periodontol no. 75 (5):717-25. doi: 10.1902/jop.2004.75.5.717. 
Marchesini, G., G. Forlani, F. Cerrelli, R. Manini, S. Natale, L. Baraldi, G. Ermini, G. 
Savorani, D. Zocchi, and N. Melchionda. 2004. "WHO and ATPIII proposals for 
the definition of the metabolic syndrome in patients with Type 2 diabetes." Diabet 
Med no. 21 (4):383-7. doi: 10.1111/j.1464-5491.2004.01115.x. 
Mealey, B. 1999. "Diabetes and periodontal diseases." J Periodontol no. 70 (8):935-49. 
doi: 10.1902/jop.1999.70.8.935. 
Merchant, A. T., M. Jethwani, Y. H. Choi, E. H. Morrato, A. D. Liese, and E. Mayer-
Davis. 2011. "Associations between periodontal disease and selected risk factors 
of early complications among youth with type 1 and type 2 diabetes: a pilot 
study." Pediatr Diabetes no. 12 (6):529-35. doi: 10.1111/j.1399-
5448.2010.00736.x. 
59 
 
Michalowicz, B. S., J. S. Hodges, R. C. Lussky, H. Bada, T. Rawson, L. S. Buttross, C. 
Chiriboga, A. J. Diangelis, M. J. Novak, W. Buchanan, D. A. Mitchell, and P. N. 
Papapanou. 2011. "Maternal periodontitis treatment and child neurodevelopment 
at 24 to 28 months of age." Pediatrics no. 127 (5):e1212-20. doi: 
10.1542/peds.2010-3129. 
Michalowicz, B. S., J. S. Hodges, M. J. Novak, W. Buchanan, A. J. DiAngelis, P. N. 
Papapanou, D. A. Mitchell, J. E. Ferguson, V. R. Lupo, J. Bofill, and S. 
Matseoane. 2009. "Change in periodontitis during pregnancy and the risk of pre-
term birth and low birthweight." J Clin Periodontol no. 36 (4):308-14. doi: 
10.1111/j.1600-051X.2009.01385.x. 
Michalowicz, B. S., M. J. Novak, J. S. Hodges, A. DiAngelis, W. Buchanan, P. N. 
Papapanou, D. A. Mitchell, J. E. Ferguson, V. Lupo, J. Bofill, S. Matseoane, M. 
Steffen, and J. L. Ebersole. 2009. "Serum inflammatory mediators in pregnancy: 
changes after periodontal treatment and association with pregnancy outcomes." J 
Periodontol no. 80 (11):1731-41. doi: 10.1902/jop.2009.090236. 
Morita, M., M. Horiuchi, Y. Kinoshita, T. Yamamoto, and T. Watanabe. 2004. 
"Relationship between blood triglyceride levels and periodontal status." 
Community Dent Health no. 21 (1):32-6. 
Ozmeric, N. 2004. "Advances in periodontal disease markers." Clin Chim Acta no. 343 
(1-2):1-16. doi: 10.1016/j.cccn.2004.01.022. 
Papapanou, P. N. 2009. "Periodontal disease and macrovascular disease: what is the 
evidence?" J Dent no. 37 (8):S581-2. doi: 10.1016/j.jdent.2009.05.016. 
60 
 
Papapanou, P. N. 2012. "The Prevalence of Periodontitis in the US: Forget What You 
Were Told." J Dent Res. doi: 10.1177/0022034512458692. 
Papapanou, P. N., A. M. Neiderud, E. Disick, E. Lalla, G. C. Miller, and G. Dahlen. 
2004. "Longitudinal stability of serum immunoglobulin G responses to 
periodontal bacteria." J Clin Periodontol no. 31 (11):985-90. doi: 10.1111/j.1600-
051X.2004.00599.x. 
Papapanou, P. N., A. M. Neiderud, A. Papadimitriou, J. Sandros, and G. Dahlen. 2000. 
""Checkerboard" assessments of periodontal microbiota and serum antibody 
responses: a case-control study." J Periodontol no. 71 (6):885-97. doi: 
10.1902/jop.2000.71.6.885. 
Papapanou, P. N., A. M. Neiderud, J. Sandros, and G. Dahlen. 2001. "Checkerboard 
assessments of serum antibodies to oral microbiota as surrogate markers of 
clinical periodontal status." J Clin Periodontol no. 28 (1):103-6. 
Papapanou, P. N., and M. Trevisan. 2012. "Periodontitis and atherosclerotic vascular 
disease: What we know and why it is important." J Am Dent Assoc no. 143 
(8):826-8. 
Pour, O. R., and S. Dagogo-Jack. 2011. "Prediabetes as a therapeutic target." Clin Chem 
no. 57 (2):215-20. doi: 10.1373/clinchem.2010.149096. 
Pradhan, S., and K. Goel. 2011. "Interrelationship between diabetes and periodontitis: a 
review." JNMA J Nepal Med Assoc no. 51 (183):144-53. 
61 
 
Preshaw, P. M., A. L. Alba, D. Herrera, S. Jepsen, A. Konstantinidis, K. Makrilakis, and 
R. Taylor. 2012. "Periodontitis and diabetes: a two-way relationship." 
Diabetologia no. 55 (1):21-31. doi: 10.1007/s00125-011-2342-y. 
Pussinen, P. J., G. Alfthan, H. Rissanen, A. Reunanen, S. Asikainen, and P. Knekt. 2004. 
"Antibodies to periodontal pathogens and stroke risk." Stroke no. 35 (9):2020-3. 
doi: 10.1161/01.STR.0000136148.29490.fe. 
Pussinen, P. J., G. Alfthan, J. Tuomilehto, S. Asikainen, and P. Jousilahti. 2004. "High 
serum antibody levels to Porphyromonas gingivalis predict myocardial 
infarction." Eur J Cardiovasc Prev Rehabil no. 11 (5):408-11. 
Pussinen, P. J., M. Jauhiainen, T. Vilkuna-Rautiainen, J. Sundvall, M. Vesanen, K. 
Mattila, T. Palosuo, G. Alfthan, and S. Asikainen. 2004. "Periodontitis decreases 
the antiatherogenic potency of high density lipoprotein." J Lipid Res no. 45 
(1):139-47. doi: 10.1194/jlr.M300250-JLR200. 
Pussinen, P. J., P. Jousilahti, G. Alfthan, T. Palosuo, S. Asikainen, and V. Salomaa. 2003. 
"Antibodies to periodontal pathogens are associated with coronary heart disease." 
Arterioscler Thromb Vasc Biol no. 23 (7):1250-4. doi: 
10.1161/01.ATV.0000072969.71452.87. 
Pussinen, P. J., E. Kononen, S. Paju, K. Hyvarinen, U. K. Gursoy, S. Huumonen, M. 
Knuuttila, and A. L. Suominen. 2011. "Periodontal pathogen carriage, rather than 
periodontitis, determines the serum antibody levels." J Clin Periodontol no. 38 
(5):405-11. doi: 10.1111/j.1600-051X.2011.01703.x. 
62 
 
Pussinen, P. J., T. Laatikainen, G. Alfthan, S. Asikainen, and P. Jousilahti. 2003. 
"Periodontitis is associated with a low concentration of vitamin C in plasma." 
Clin Diagn Lab Immunol no. 10 (5):897-902. 
Pussinen, P. J., K. Nyyssonen, G. Alfthan, R. Salonen, J. A. Laukkanen, and J. T. 
Salonen. 2005. "Serum antibody levels to Actinobacillus actinomycetemcomitans 
predict the risk for coronary heart disease." Arterioscler Thromb Vasc Biol no. 25 
(4):833-8. doi: 10.1161/01.ATV.0000157982.69663.59. 
Pussinen, P. J., S. Paju, P. Mantyla, and T. Sorsa. 2007. "Serum microbial- and host-
derived markers of periodontal diseases: a review." Curr Med Chem no. 14 
(22):2402-12. 
Rescala, B., W. Rosalem, Jr., R. P. Teles, R. G. Fischer, A. D. Haffajee, S. S. Socransky, 
A. Gustafsson, and C. M. Figueredo. 2010. "Immunologic and microbiologic 
profiles of chronic and aggressive periodontitis subjects." J Periodontol no. 81 
(9):1308-16. doi: 10.1902/jop.2010.090643. 
Roberts, A., J. B. Matthews, S. S. Socransky, P. P. Freestone, P. H. Williams, and I. L. 
Chapple. 2002. "Stress and the periodontal diseases: effects of catecholamines on 
the growth of periodontal bacteria in vitro." Oral Microbiol Immunol no. 17 
(5):296-303. 
Roberts, A., J. B. Matthews, S. S. Socransky, P. P. Freestone, P. H. Williams, and I. L. 
Chapple. 2005. "Stress and the periodontal diseases: growth responses of 
periodontal bacteria to Escherichia coli stress-associated autoinducer and 
63 
 
exogenous Fe." Oral Microbiol Immunol no. 20 (3):147-53. doi: 10.1111/j.1399-
302X.2004.00196.x. 
Sachdeo, A., A. D. Haffajee, and S. S. Socransky. 2008. "Biofilms in the edentulous oral 
cavity." J Prosthodont no. 17 (5):348-56. doi: 10.1111/j.1532-
849X.2008.00301.x. 
Santos Tunes, R., M. C. Foss-Freitas, and R. Nogueira-Filho Gda. 2010. "Impact of 
periodontitis on the diabetes-related inflammatory status." J Can Dent Assoc no. 
76:a35. 
Sbordone, L., L. Ramaglia, A. Barone, R. N. Ciaglia, and V. J. Iacono. 1998. 
"Periodontal status and subgingival microbiota of insulin-dependent juvenile 
diabetics: a 3-year longitudinal study." J Periodontol no. 69 (2):120-8. 
Shaw, J. E., R. A. Sicree, and P. Z. Zimmet. 2010. "Global estimates of the prevalence of 
diabetes for 2010 and 2030." Diabetes Res Clin Pract no. 87 (1):4-14. doi: 
10.1016/j.diabres.2009.10.007. 
Shultis, W. A., E. J. Weil, H. C. Looker, J. M. Curtis, M. Shlossman, R. J. Genco, W. C. 
Knowler, and R. G. Nelson. 2007. "Effect of periodontitis on overt nephropathy 
and end-stage renal disease in type 2 diabetes." Diabetes Care no. 30 (2):306-11. 
doi: 10.2337/dc06-1184. 
Simpson, T. C., I. Needleman, S. H. Wild, D. R. Moles, and E. J. Mills. 2010. "Treatment 
of periodontal disease for glycaemic control in people with diabetes." Cochrane 
Database Syst Rev (5):CD004714. doi: 10.1002/14651858.CD004714.pub2. 
64 
 
Socransky, S. S., and A. D. Haffajee. 2002. "Dental biofilms: difficult therapeutic 
targets." Periodontol 2000 no. 28:12-55. 
Socransky, S. S., and A. D. Haffajee. 2005. "Periodontal microbial ecology." Periodontol 
2000 no. 38:135-87. doi: 10.1111/j.1600-0757.2005.00107.x. 
Stratton, I. M., A. I. Adler, H. A. Neil, D. R. Matthews, S. E. Manley, C. A. Cull, D. 
Hadden, R. C. Turner, and R. R. Holman. 2000. "Association of glycaemia with 
macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): 
prospective observational study." BMJ no. 321 (7258):405-12. 
Sugi, N., K. Naruishi, C. Kudo, A. Hisaeda-Kako, T. Kono, H. Maeda, and S. Takashiba. 
2011. "Prognosis of periodontitis recurrence after intensive periodontal treatment 
using examination of serum IgG antibody titer against periodontal bacteria." J 
Clin Lab Anal no. 25 (1):25-32. doi: 10.1002/jcla.20381. 
Tabak, A. G., C. Herder, W. Rathmann, E. J. Brunner, and M. Kivimaki. 2012. 
"Prediabetes: a high-risk state for diabetes development." Lancet no. 379 
(9833):2279-90. doi: 10.1016/S0140-6736(12)60283-9. 
Teeuw, W. J., V. E. Gerdes, and B. G. Loos. 2010. "Effect of periodontal treatment on 
glycemic control of diabetic patients: a systematic review and meta-analysis." 
Diabetes Care no. 33 (2):421-7. doi: 10.2337/dc09-1378. 
Tsai, C., C. Hayes, and G. W. Taylor. 2002. "Glycemic control of type 2 diabetes and 
severe periodontal disease in the US adult population." Community Dent Oral 
Epidemiol no. 30 (3):182-92. 
65 
 
Uzel, N. G., F. R. Teles, R. P. Teles, X. Q. Song, G. Torresyap, S. S. Socransky, and A. 
D. Haffajee. 2011. "Microbial shifts during dental biofilm re-development in the 
absence of oral hygiene in periodontal health and disease." J Clin Periodontol no. 
38 (7):612-20. doi: 10.1111/j.1600-051X.2011.01730.x. 
Vidal, F., C. M. Figueredo, I. Cordovil, and R. G. Fischer. 2009. "Periodontal therapy 
reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in 
patients with severe periodontitis and refractory arterial hypertension." J 
Periodontol no. 80 (5):786-91. doi: 10.1902/jop.2009.080471. 
Vlachojannis, C., B. A. Dye, M. Herrera-Abreu, L. Pikdoken, J. Lerche-Sehm, B. Pretzl, 
R. Celenti, and P. N. Papapanou. 2010. "Determinants of serum IgG responses to 
periodontal bacteria in a nationally representative sample of US adults." J Clin 
Periodontol no. 37 (8):685-96. doi: 10.1111/j.1600-051X.2010.01592.x. 
Wood, N., R. B. Johnson, and C. F. Streckfus. 2003. "Comparison of body composition 
and periodontal disease using nutritional assessment techniques: Third National 
Health and Nutrition Examination Survey (NHANES III)." J Clin Periodontol no. 
30 (4):321-7. 
Wu, T., M. Trevisan, R. J. Genco, K. L. Falkner, J. P. Dorn, and C. T. Sempos. 2000. 
"Examination of the relation between periodontal health status and cardiovascular 
risk factors: serum total and high density lipoprotein cholesterol, C-reactive 
protein, and plasma fibrinogen." Am J Epidemiol no. 151 (3):273-82. 
66 
 
Yang, Y., S. Y. Goh, S. B. Tan, H. J. Ho, S. Emmanuel, P. Wang, and H. S. Ng. 2012. 
"The burden of diabetes mellitus in elderly patients from an Asian tertiary 
hospital." Eur J Intern Med no. 23 (1):e1-4. doi: 10.1016/j.ejim.2011.10.017. 
Yu, Z. R., L. S. Liu, Q. X. Luan, X. Y. Wang, P. Li, Y. Q. Sha, and X. Liu. 2012. 
"[Correlation between periodontitis and metabolic syndrome of the middle-aged 
and aged population in Shijingshan community of Beijing]." Beijing Da Xue Xue 
Bao no. 44 (4):633-8. 
Zambon, J. J., H. Reynolds, J. G. Fisher, M. Shlossman, R. Dunford, and R. J. Genco. 
1988. "Microbiological and immunological studies of adult periodontitis in 
patients with noninsulin-dependent diabetes mellitus." J Periodontol no. 59 
(1):23-31. 
Zarowitz, B. J. 2011. "The ADA focus on diabetes 2011." Geriatr Nurs no. 32 (2):119-
22. doi: 10.1016/j.gerinurse.2011.01.003. 
Zekry, D., E. Frangos, C. Graf, J. P. Michel, G. Gold, K. H. Krause, F. R. Herrmann, and 
U. M. Vischer. 2012. "Diabetes, comorbidities and increased long-term mortality 
in older patients admitted for geriatric inpatient care." Diabetes Metab no. 38 
(2):149-55. doi: 10.1016/j.diabet.2011.10.001. 
Zoppini, G., C. Negri, V. Stoico, S. Casati, I. Pichiri, and E. Bonora. 2012. "Triglyceride-
high-density lipoprotein cholesterol is associated with microvascular 
complications in type 2 diabetes mellitus." Metabolism no. 61 (1):22-9. doi: 
10.1016/j.metabol.2011.05.004. 
67 
 
CHAPTER 3 
 
MANUSCRIPT 1 
 
The relation between Serum Immunoglobulin G (IgG) Antibodies against Periodontal 
Bacteria and Type 2 Diabetes and Pre-Diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shrestha, D., Choi, Y.H., Zhang, J., Hazlett, L.J., Merchant, A.T. Submitted in Diabetes 
Medicine
68 
 
ABSTRACT 
Aim: To investigate the association between antibodies against oral microorganisms and 
hyperglycemia in a nationally representative sample.  
Methods: Participants in the NHANES III (1988-1994), aged ≥40 years, who provided 
blood samples that were assessed for serum IgG titers against 19 periodontal bacteria (n = 
8153) were included. Antibody titer z-scores were used to get four clusters (“Orange-
Red”, “Red-Green”, “Orange-Blue” and “Yellow-Orange”) using cluster analysis. 
Logistic regression weighted for complex survey design was used to analyze the 
relationship between the clusters and hyperglycemia.  
Results: The Orange-Red cluster score, that included P. gingivalis and Prevotella sps, 
was positively associated with diabetes [OR 1.08 (1.03-1.13)] while Red-Green score 
(which included A. actinomycetemcomitans mix, S. noxia, E. corrodens, V. parvula, T. 
forsythia, T. denticola, C. rectus) was inversely related to diabetes [OR 0.96 (0.912 -
0.999)] in multivariable analyses. The Orange-Blue cluster (A. naeslundii and E. 
nodatum) was inversely associated with diabetes and pre-diabetes but the relations were 
attenuated after adjustment. The Yellow-Orange cluster, that included predominantly 
Streptococcus sps, was not associated with hyperglycemia. 
Conclusion: Clusters of serum IgG antibodies against periodontal bacteria are both 
positively and negatively associated with diabetes. The relation between periodontal 
bacteria and hyperglycemia is complex and deserves further study.  
Key words: Type 2 diabetes; pre-diabetes;  periodontal bacteria; serum IgG antibody; 
NHANES III  
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Introduction 
Periodontitis is associated with diabetes and  its related outcomes in observational 
studies (Borgnakke et al. 2013). In prospective studies, periodontitis predicted the 
development of type 2 diabetes (Demmer, Jacobs, and Desvarieux 2008), and type 2 
diabetes mellitus at baseline predicted increased risk of incident self -reported 
periodontitis and tooth loss (Jimenez et al. 2012), suggesting that the relation between 
diabetes and periodontal diseases is bi-directional.  However, the question whether 
periodontal treatment improves glycemic control in individuals with diabetes remains 
unanswered with randomized controlled trials (RCT) reporting discrepant results. 
Engebretson et al reported no effect of periodontal treatment on glycemic control  
(Engebretson et al. 2013), but Sun et al found that periodontal treatment improved 
glycemic control, lipid profile, inflammatory cytokines among individuals with type 2 
diabetes, and a systematic review of all RCTs found  periodontal treatment to have a net 
benefit (Engebretson and Kocher 2013, Sun et al. 2011). A possible drawback of these 
studies was that none evaluated immunological changes evoked by periodontal pathogens 
(Holmlund et al. 2011), which may explain the poorly understood mechanism linking 
periodontal disease with glycemic control (Lalla and Papapanou 2011).    
The periodontal environment harbors more than 700 different species of 
periodontal microbiota (Socransky and Haffajee 2002, 2005) making it a potentially 
important site for host microbe interaction (Rams, Listgarten, and Slots 2006). Several 
periodontal bacteria are capable of invading the gingival tissues and initiating robust 
serum antibody responses that are capable of interfering with host defense mechanisms 
and stimulating local and systemic inflammations (Kinane and Lappin 2001). Recent 
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studies (Teles et al. 2012, Socransky et al. 2013, Socransky and Haffajee 2005, 2002) 
showed that periodontitis is associated with higher prevalence of Porphyromonas 
gingivalis, Tannerella forsythia, Treponema denticola, Actinobacillus 
actinomycetemcomitans, Prevotella sps.; whereas Actinomyces groups  are predominantly 
associated with healthy periodontal status. Furthermore, Dye et al (2009) (Dye et al. 
2009) in a large nationally representative US population study from the third National 
Health and Nutritional Examination survey (NHANES III) found that elevated serum 
immunoglobulin (IgG) titers against P. gingivalis are associated with periodontitis while 
elevated IgG titers against against Eubacterium nodatum are associated with healthy 
periodontal status.  There is growing evidence that the relationship between periodontal 
disease and systemic diseases is affected by the profile of periodontal bacteria. For 
instance,  Desvarieux et al., in cross-sectional (Desvarieux et al. 2005) and longitudinal 
(Desvarieux et al. 2013) studies reported that the etiologic group of periodontal bacteria 
which included P. gingivalis, A. actinomycetemcomitans, T. forsythia and T. denticola 
was associated with increased carotid intima media thickness, while the group that 
included V. parvula and A. naeslundii was related with less carotid intima media 
thickness. The humoral response of elevated P. gingivalis and, A. 
actinomycetemcomitans titers has been linked to cardiovascular outcomes (Pussinen, 
Alfthan, et al. 2007, Pussinen, Alfthan, Tuomilehto, et al. 2004, Pussinen et al. 2003, 
Pussinen et al. 2005, Pussinen, Paju, et al. 2007). 
A recent study (Le Chatelier et al. 2013) that linked selected gut microbiota with 
adverse metabolic control markers reinforced our thinking about the possible role of 
periodontal microbiota in hyperglycemia. The altered bacterial composition during 
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periodontitis in reference to diabetes is well studied (Lalla et al. 2006, Li et al. 2013, 
Field et al. 2012, Zhou et al. 2013) but the host response role in hyperglycemia is 
understudied (Vlachojannis et al. 2010, Takahashi et al. 2001). In this study, our main 
aim was to characterize the extent to which serological markers against oral 
microorganisms were associated with diabetes and pre-diabetes. We hypothesized that 
selected oral microorganisms would be positively, while others inversely associated with 
hyperglycemia, based on what is known about the relation between the periodontal 
biofilm clusters and  health and disease (Socransky and Haffajee 2005, 2002, Desvarieux 
et al. 2013), This is a small, but important, first step in our understanding of this question, 
and sets the stage for further studies aimed at better understanding of mechanisms. If it is 
discovered that oral micro-organism affect metabolic parameters, it may be possible to 
impact metabolic parameters by altering the microbial profile.  
Materials and Methods 
Study Population 
  The NHANES III used a multi-stage, probability cluster sampling design to 
provide nationally representative data on a variety of health risks and behaviors, 
including both self-reported and objective estimates of diabetes and clinical and antibody 
information related to periodontal disease. We included participants of the NHANES III 
1988-1994 survey, aged 40 years or above who had complete information on serum IgG 
antibodies titers against periodontal bacteria (Ezzati et al. 1992). Serum antibody titers 
were assessed on stored blood samples and released for the first time in 2008.  
We linked the following datasets from NHANES III public release data files: 
NHANES III Household Adult Data File, NHANES III Examination Data File, 
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NHANES III Laboratory Data File, NHANES III Dietary Recall Data Files, and 
Antibodies to Periodontal Pathogens using a unique de-identified respondent 
identification number provided to each participant. All data for this report are available 
at: http://www.cdc.gov/nchs/nhanes/nh3data.htm 
Out of 33,994 individuals in the NHANES III sample in the six year period 
(1988-1994) 14,464 were aged 40 years or older, of which 11,448 were interviewed, 
9379 were examined and 8153 provided sera that were analyzed for IgG titers against 19 
periodontal bacteria (Vlachojannis et al. 2010). Of the eligible 8153 samples, we 
excluded individuals who reported taking insulin or who had gestational diabetes leaving 
7848 participants in the final sample for analysis.   
IgG assay for periodontal bacteria  
All available sera from NHANES III participants (1988-1994) 40+ years were 
tested for the presence and level of IgG antibodies against a broad panel of periodontal 
bacteria. The following 19 bacterial strains were used to prepare whole cell antigenic 
extracts by checkerboard immunoassay: Aggregatibacter actinomycetemcomitans (ATCC 
strains #43718, #29523 and #33384); Porphyromonas gingivalis (ATCC #33277 and 
#53978); Tannerella forsythia (ATCC#43037); Treponema denticola (OMGS#3271); 
Campylobacter rectus (ATCC#33238); Eubacterium nodatum (ATCC#33099); 
Prevotella intermedia (ATCC#25611); Prevotella nigrescens (ATCC#33563); Prevotella 
melaninogenica (ATCC#25845); Fusobacterium nucleatum (ATCC#10953); 
Micromonas micros (ATCC #33270); Selenomonas noxia (ATCC#43541);  Eikenella 
corrodens (ATCC#23834); Capnocytophaga ochracea (ATCC#33624); Streptococcus 
intermedius (ATCC#27335); Streptococcus oralis (ATCC#35037); Streptococcus mutans 
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(ATCC#25175); Veillonella parvula (ATCC#10790); and Actinomyces naeslundii 
(ATCC#49340).. The laboratory tests were performed at Columbia University College of 
Dental Medicine, using the ‘‘checkerboard’’ immunoassay technique measured in 
gravimetric units (Papapanou et al. 2000)(31)(Papapanou et al. 2000)(Papapanou et al. 
2000). The detailed procedure of assessing IgG by checkerboard immunoassay is 
described in NHANES III documentation:  
ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/nhanes/nhanes3/30a/spsdeppx.pdf  
Cluster Formation and Naming the Clusters 
For each of 19 bacterial species, serum IgG antibody titer values were natural log 
transformed and then standardized by dividing these values by the log-transformed 
population standard deviation (Desvarieux et al. 2005). Standardized z-scores of serum 
IgG of diabetes and pre-diabetes subgroups were used in cluster analysis to derive four 
mutually distinct groups of periodontal bacteria. The standardized z-scores of IgG against 
those periodontal bacteria in the respective clusters were summed to obtain cluster scores 
for each group. These four cluster scores were the main exposure variables used in this 
analysis.  
We used the color scheme of microbial complexes given by Socransky and 
Haffajee (Socransky and Haffajee 2005, 2002) to name these clusters.  In that scheme, 
organisms in the Red and Orange clusters are related to periodontal disease; organisms in 
the Yellow and Purple clusters are associated with a healthy periodontal condition; the 
Blue cluster includes Actinomyces species which is found in both periodontal disease and 
in the healthy state; organisms in the Green cluster may be weakly related to periodontal 
disease (Socransky et al. 1998, Socransky and Haffajee 2005, 2002). In naming the 
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clusters, we put the dominant color of periodontal bacteria first. For example, if cluster 
scores included 4 organisms of which 3 are from the Orange group and one from Red, we 
named that cluster as Orange-Red. If there is a tie (i.e. same numbers of Red and Orange 
cluster organisms then we started with Red). Further details are shown in figure 3.1. This 
way we have four clusters named as “Orange-Red”, “Red-Green”, “Yellow- Orange” and 
“Orange-Blue”.  
Definition of Type 2 Diabetes and pre-diabetes 
We defined pre-diabetes as having HbA1c 5.7 to <6.5% or fasting plasma glucose 
(FPG) 100 to <126 mg/dl (5.6-6.9 mmol/L). Individuals with HbA1c ≥ 6.5% or FPG ≥ 
126 mg/dl [7 mmol/L] or those who self-reported diagnosed diabetes were classified as 
having diabetes (Bullard et al. 2013). 
Covariate Information  
Demographic, lifestyle and anthropometric measures such as gender, age, 
race/ethnicity, education, income-poverty ratio, smoking and alcohol drinking habits, 
physical activity, fiber intake, frequency of regular dentist visits, waist circumference 
(WC) and body mass index (BMI) are used as potential confounders. Race/ethnicity was 
self-reported and was divided into four groups: non-Hispanic white, non-Hispanic black, 
Mexican American and other. Income was grouped into three groups of the income-to-
poverty ratio (≤1.5, >1.5 to ≤3.0, and >3.0), education level into three groups ≤6 years; 7 
to 12 years; and ≥13 years). 
Smokers were defined into three groups (current, past and never smokers). A 
never smoker was defined as an individuals who had smoked <100 cigarettes in his or her 
lifetime. The alcohol drinkers were divided into three groups (current, past and never 
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alcohol drinkers). Individuals who reported consuming less than 12 drinks in their lives 
were “never drinkers”. Physical activity was divided into three groups based on 
metabolic equivalents (METs) (active, ≥6; moderate, ≥4 and <6; and less active, <4).  
People who had regular dental checkups were defined as those who had visited a 
dental clinic at least once in the past year. WC to assess central obesity was measured 
using a steel measuring tape to the nearest 0.1 cm at the high point of the iliac crest at 
minimal respiration when the participant was in a standing position. Central adiposity 
was said to be present if waist circumference was ≥101.6 cm for male subjects and ≥88.9 
cm for female subjects. Missing teeth was categorized into four groups: none, 1-5, 6-10, 
> 10 missing teeth (Choi et al. 2011). Dietary Fibers, carbohydrate, protein, fat, total 
calories intake was assessed based on estimates from the 24-hour dietary recall.   
Statistical Methods 
SAS, version 9.3 (SAS Institute, Cary, NC) was used for data management and 
statistical analyses. SAS survey procedures were used to take into account the complex 
weighted sampling design and yielded unbiased parameter estimates and standard errors. 
Sample weights, cluster, and strata variables provided by CDC were used. A statistically 
significant α level was considered at 0.05.  
Descriptive statistics were estimated using procedures for complex surveys in 
SAS (proc surveymeans and proc surveyfreq). The distribution of socio-demographic, 
lifestyle, anthropometric measures, and other potential risk factors across tertiles of each 
of four cluster scores were estimated.  The mean values of four clusters scores and z 
scores of species –specific serum IgG were evaluated across the diabetes status. 
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The multivariable survey logistic regression model was used. In the diabetes 
status (diabetes, pre-diabetes and normal blood glucose), normal blood glucose group 
was the reference in all analysis. The first model included the four clusters which were 
regressed across the outcomes; in second model, we additionally adjusted for age 
(continuous), sex, race and income-to-poverty ratio. In the third model, we adjusted 
further for smoking and drinking alcohol and in the fourth model we included WC, 
physical activity, BMI (continuous), and dentist visits. Finally, we then adjusted further 
for missing teeth, dietary fibers, total energy, carbohydrate, protein and fat intake.  
We repeated the same analysis by using the standardized z-scores of serum IgG 
antibodies of 11 periodontal bacteria to obtain the 3 groups (etiologic, putative and health 
related) as defined in a priori study by Desvarieux et al.  (Desvarieux et al. 2005).   
Results 
The four mutually exclusive groups; “Orange-Red”, “Red-Green”, “Yellow- 
Orange” and “Orange-Blue” of periodontal bacteria antibodies obtained from cluster 
analysis and their naming pattern are shown in Flow chart 1. In our study population of 
7848 individuals, 9.6% had diabetes, 36.6% pre-diabetes, and 69.7% normal blood 
glucose. The distribution of profile characteristics across the diabetes status are shown in 
Table 3.1.There were higher numbers of Non-Hispanic Whites, females, high school 
graduates, never smokers or past smokers but current or former alcohol drinkers, 
overweight, with sedentary lifestyle and those who didn’t visit dentist at least once a year. 
The general characteristics of study population by tertiles of cluster scores (sum of 
standardized z- scores in periodontal bacteria antibodies in each respective cluster) are 
shown in Table 3.2. There were a higher proportion of individuals with diabetes in the 
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top versus bottom tertiles (11.2 vs 8.1) in Orange-Red cluster (which included P. 
gingivalis and prevotella species), however the opposite trend (8.6 vs 11.1) was observed 
for Orange-Blue (which included A. naeslundii and E. nodatum) and no such difference 
was seen in other clusters and pre-diabetes also showed similar pattern. Whereas 
distribution of participants with normal blood glucose showed an opposite pattern of 
Orange-Red (56.1 vs 50.3) and Orange-Blue clusters (49.0 vs 56.4) when compared in 
top vs bottom tertiles (Table 3.2). Age of the participants was similar across tertiles of all 
clusters (on average 57years) but Orange-Blue had a higher proportion of older 
participants compared to other clusters. BMI and fiber intake were relatively higher in top 
tertiles across all four clusters (Table 3.2).  
The mean z-scores of species specific serum IgG against 19 bacteria and their 
respective four clusters are shown in Table 3.3. Significantly higher trend of z-scores of 
Orange-Red were seen in diabetes compared to pre-diabetes and normal blood glucose 
while decreasing trend of Orange-Blue clusters scores were observed in diabetes groups.  
In this study, we found a one unit higher- Orange-Red cluster score was 
associated with 11% (p value <0.0001) higher odds of type 2 diabetes when other clusters 
scores were held constant. With further full adjustment for age, sex, race and income-to-
poverty ratio, cigarette smoking, alcohol drinking, physical activity, BMI, WC, dentist 
visit, missing teeth, and different nutrients intake, the odds attenuated to 8% (p value 
<0.05) (Table 3.4). With pre-diabetes, there was a 3% increased odds but after adjusting 
for confounders, the association was not statistically significant. In Orange-Blue cluster 
score, one unit increase was associated with 11% (p=<0.001) lowering odds of diabetes 
and 7% (<0.05) lower odds of pre-diabetes holding all other clusters constant. Overall, 
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there was an inverse but insignificant association between this cluster score and diabetes 
and pre-diabetes after adjusting for all the measured confounders evaluated. Similarly, a 
unit increase in Red-Green cluster score (which included A. actinomycetemcomitans mix, 
S. noxia, E. corrodens, V. parvula, T. forsythia, T. denticola, C. rectus) showed an  
inverse relation ) with diabetes but positive association  with pre-diabetes, however 
statistically not significant. Yellow Orange cluster score (which included S. intermedius, 
S. oralis, S. mutans, F. nucleatum, M. micros, C. ochracea) showed no association with 
pre-diabetes and diabetes (Table 3.4). (In a sensitivity analysis comparing dentate 
(n=5458) and edentulous participants (n=2390) Orange-Red scores significantly 
increased the odds of having diabetes by 15% [OR=1.15 (1.046-1.263) in edentulous 
participants whereas Orange-Blue scores decreased the odds by 8% [OR=0.083 (0.80-
0974) in dentate participants after adjusting for all confounders in the full model. 
The relation between periodontal bacteria antibodies grouped in etiologic, 
putative and health related categories (Desvarieux et al. 2005) with diabetes and pre-
diabetes were described in Table 3.5.  A one unit increase in etiologic group (which 
included P. gingivalis, A. actinomycetemcomitans, T. denticola, T. forsythia) score was 
associated with 7% and 4% (both p values <0.05) higher odds of diabetes and pre-
diabetes respectively. The health related group that comprised V. parvula and A. 
naeslundii was inversely related to diabetes (13% lower odds, p value <0.001) and pre-
diabetes (7% lower odds, p value <0.05). After adjustment for measured confounders, the 
etiologic and health related group association remained insignificant for both diabetes 
and pre-diabetes. The putative group that included E. corrodens, C. rectus, F. nucleatum, 
M. micros, and P. intermedia was not associated with diabetes and pre-diabetes.  
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Discussion 
The association between clusters of serum IgG antibodies against periodontal 
bacteria and hyperglycemia varied qualitatively in a large, representative sample of US 
adults. Increased Orange-Red cluster titers were associated with 8% higher odds of 
diabetes while increased Red-Green cluster titers were associated with 4% lower odds 
after adjustment for potential confounders.  The Orange-Red cluster included 
periodontopathic bacteria that are linked to local inflammatory response, hard and soft 
tissue breakdown leading to clinical signs of local periodontitis, and systemic 
inflammation. 
There is a strong biological rationale behind using cluster analysis in this study. 
Since periodontal bacteria coexist naturally in a biofilm, it is therefore to isolate the 
potential effects of particular pathogens; moreover, studies evaluating the effects of 
individual organisms are prone to type 1 error(Wang et al. 2007). To overcome this 
limitation some investigators have grouped the periodontal organisms together either 
using empirical or theoretical approaches (Socransky and Haffajee 2002, Desvarieux et 
al. 2005). Specific clusters of periodontal bacteria profiles for type 2 diabetes have not 
been reported in the literatures. In the current study, we used both empirical as well as 
theoretical approaches to group antibodies against oral pathogens among individuals with 
hyperglycemia and measured the extent of association of these bacteria with diabetes and 
pre-diabetes.  We did this because we were interested in evaluating the relative (rather 
than absolute) contributions of the titers to the overall score. 
The immunological role of some periodontal bacteria such as P. ginigvalis, and A. 
actinomycetemcomitans in relation to periodontitis and other systemic disease has been 
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reported in recent studies. Elevated serum anti- P. gingivalis antibody has been associated 
with ishemic stroke (Pussinen, Alfthan, Rissanen, et al. 2004), myocardial infarction  
(Holmlund et al. 2011, Pussinen, Alfthan, Tuomilehto, et al. 2004) and coronary heart 
disease (Pussinen et al. 2003) but A. actinomycetemcomitans showed inconsistent 
relationships in different populations (Mantyla et al. 2013, Hosomi et al. 2012, Pussinen 
et al. 2005).  
There are few studies evaluating serum antibody titers against periodontal bacteria 
and diabetes. Ebersole et al (Ebersole et al. 2008) compared serum antibody levels of P 
gingivalis, A actinomycetemcomitans,T. denticola, T. forsythia, C. rectus,F. nucleatum, 
E. corrodens, and P.intermedia using standard enzyme-linked immunosorbent assay 
methodology in type 2 diabetes  and non-diabetes group. Antibodies against P gingivalis 
were significantly elevated in the diabetes group while serum IgG responses to other 
microbes were broadly similar between the two groups. However, these studies had small 
sample sizes, differences in characteristics of the study populations, and methods of 
detecting of periodontal microbiota, making it difficult to compare the findings. Another 
study (Vlachojannis et al. 2010) included both type 1and type 2 diabetes cases found 
elevated titers of P. gingivalis  associated with diabetes.  
In our study, the Orange-Red cluster scores and the etiologic group that included 
P. gingivalis were positively associated with hyperglycemia (Table 3.4 and Table 3.5). 
Interestingly, the cluster Red-Green that included antibodies against three organisms that 
have been associated with periodontitis and systemic disease (Desvarieux et al. 2005) 
was inversely related with diabetes in this study (Table 3.4). This may be because this 
cluster also included the purple complex organisms, V. parvula, which has been linked to 
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healthy periodontal status (Desvarieux et al. 2005), and could have shadowed the effect 
of the Red-cluster organisms. There are no specific similar studies related to diabetes to 
compare our findings but a study evaluating serum IgG antibodies against 12 periodontal 
pathogens among Japanese children with type-1 diabetes mellitus found significantly 
higher antibody titers to P. gingivalis, P intermedia and T denticola compared to other 
periodontal bacteria (Takahashi et al. 2001). In a separate recent study (Hosomi et al. 
2012), serum IgG antibody against P. gingivalis was significantly associated with atrial 
fibrillation, and antibody against P. intermedia was associated with carotid artery 
atherosclerosis and  atherothrombotic stroke whereas no such association was seen with 
anti- A. actinomycetemcomitans serum antibody. Our findings support the hypothesis that 
P. gingivalis may have a major role in systemic conditions including diabetes compared 
to other periodontal pathogens (Jeong et al. 2012). 
The Orange-Blue cluster scores that included A. naeslundii and E. Nodatum 
showed an inverse relation to diabetes and pre-diabetes in the crude analysis but that was 
attenuated after adjustment  [diabetes: OR 0.935 (0.869-1.007), pre-diabetes OR: 0.987 
(0.944-1.032) (Table 3.4). Several studies have shown that the higher counts of A. 
naeslundii are associated with periodontal healthy status (Socransky and Haffajee 2002, 
Desvarieux et al. 2005, Socransky and Haffajee 2005, Darveau 2010, Papapanou et al. 
2000) but a case-control study (Haffajee, Teles, and Socransky 2006) reported higher 
level of E. nodatum to be associated with periodontitis and another (Lalla et al. 2006) 
reported an association with type 1 diabetes. The health related group that included A. 
naeslundii and V. parvula was inversely related to pre-diabetes and diabetes (Table 3.4) 
which supports the evidence that long term predominance of A. naeslundii in the 
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periodontal area may be related to healthy clinical outcomes and may play a protective 
role in systemic conditions.  
Yellow-Orange cluster scores which included health-related bacteria, 
Streptococcus species and C. ochracea showed no distinct association with either of the 
outcomes. This might be due to the presence of serum IgG of other periodontal bacteria 
such as F. nucleatum, M. micros in this cluster scores which had the putative role 
(Haffajee, Teles, and Socransky 2006, Shin et al. 2013).  
Our study has some drawbacks. As this was a cross-sectional study, we could not 
verify the temporal sequence of the associations. As is the case with all observational 
studies unmeasured confounding could potentially impact the results. However, we 
adjusted for a number of known potential confounders in our analyses. We did not adjust 
for clinical measures of periodontal disease (such as clinical attachment loss or probing 
depth) because these are on the causal pathway (periodontal microorganisms cause 
attachment loss and periodontal pockets), and adjusting for them would likely introduce 
bias (Cole and Hernan 2002).  This dataset included information from 1988-1994. Even 
though the prevalence of periodontal disease, diabetes and other covariates such as 
smoking have changed over this time, this would not impact our results because change 
in prevalence does not impact the relation between the exposure and outcome (Szklo and 
Nieto 2007). In this dataset, there are information on only 19 periodontal bacteria, hence 
a new sophisticated study that combines the immunological, microbiological and clinical 
information of periodontal disease are needed to provide further insights in systemic 
association and further study of undisputed hypothesis that oral health could be important 
source of chronic inflammation.  
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The study also had some strength. The CDC conducted assays for an expanded 
panel of antibodies against periodontal microorganisms on stored blood samples from the 
NHANES III and released the results in 2008. This was timely, because there is renewed 
interest in studying the relation periodontal microorganisms and the microbiome in 
relation to systemic outcomes. The NHANES III dataset has good quality information for 
periodontal disease, serum IgG antibodies against 19 different periodontal bacteria, 
diabetes, and other covariates of interest in a large, representative number of US adults. 
Serum IgG against A. actinomycetemcomitans and P. gingivalis are stable over at least 15 
years (Lakio et al. 2009), and represent a measure of cumulative lifetime infection of 
periodontal disease and host response towards it. For this reason we included edentulous 
individuals in the main analyses, however, the results did not change materially when 
missing were adjusted (Table 3.4 and Table 3.5). These data have not been reported on 
extensively and hence provide new information.  
The association between antibodies against oral microorganisms and 
hyperglycemia moderately varied by the type of periodontal organisms that are involved 
in a large, representative sample of US adults. Monitoring the type of periodontal bacteria 
in plaque may be important in individuals with diabetes and pre-diabetes.  
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Table 3.1− Profile characteristics of study population NHANES III (1988-1994) 
 
 Normal(n=3424) Pre-diabetes(n=3334) Diabetes(n=1090) 
Age, years, mean (se) 53.85 (0.3) 59.5(0.6) 61.7(0.6) 
Sex: % 
Male 
Female 
 
42.7 
57.3 
 
50.2 
49.8 
 
46.8 
53.2 
Race/ Ethnicity % 
Non-Hispanic Whites 
Non –Hispanic Blacks 
Mexican American 
Others 
 
85.3 
6.1 
2.6 
5.9 
 
76.9 
11.3 
3.9 
7.9 
 
71.6 
14.6 
6.0 
7.7 
Education % 
≤ 6 years  
7 – 12 years 
≥ 13 years 
 
4.7 
50.4 
44.9 
 
8.5 
57.6 
33.9 
 
12.3 
62.2 
25.4 
Income to poverty ratio % 
Lower (≤1.5) 
Middle (≤3.0) 
Higher (>3.0) 
 
15.0 
28.6 
             56.4 
 
22.0 
30.5 
47.4 
 
30.2 
31.5 
38.3 
Smoking % 
Current 
Past 
Never 
 
41.6 
41.7 
16.7 
 
35.1 
46.4 
18.5 
 
37.2 
47.3 
15.5 
Alcohol intake % 
Current 
Past 
Never 
 
13.9 
34.0 
52.0 
 
15.3 
42.2 
42.5 
 
20.0 
48.9 
31.1 
Physical activity % 
Sedentary 
 
54.8 
 
49.3 
 
45.6 
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Moderately active 
Vigorously active 
Missing 
12.3 
              8.0 
24.9 
13.4 
7.4 
29.8 
11.1 
6.7 
36.6 
Missing Teeth, % 
0 
1-5 
6-10 
>10 
 
53.1 
37.1 
7.7 
2.1 
 
51.7 
34.7 
9.3 
4.3 
 
50.5 
29.7 
12.1 
7.8 
Annual visits to dentist % 
Yes 
No   
 
59.1 
40.9 
 
43.9 
56.1 
 
38.4 
61.6 
Waist circumference % 
Normal  
Elevated 
 
60.0 
 
40.0 
 
45.2 
54.8 
 
23.8 
76.2 
Dietary Fibers, g/day, mean (se) 17.2(0.3) 16.4(0.3) 16.2(0.5) 
Total Carbohydrate, g/day, 
 mean (se) 
 
250.5(4.1) 
 
243.9(4.1) 
 
222.7(5.1) 
Proteins, g/day, mean (se) 76.6(1.0) 77.8(1.3) 75.0(2.2) 
Total fats, g/day,mean (se) 77.0(1.3) 75.7(1.6) 70.4(2.8) 
BMI, kg/m2, mean (se) 26.4(0.1) 27.8(0.2) 30.1(0.3) 
Orange-Red score, mean (se) -0.5 (0.1) -0.3(0.1) 0.1(0.2) 
Red-Green score, mean (se) -0.1 (0.3) 0.02(0.3) -0.2(0.5) 
Yellow-Orange score, mean (se) -0.01(0.2) 0.004(0.2) 0.06(0.3) 
Orange-Blue score, mean (se) 0.2 (0.1) 0.07(0.1) -0.04(0.1) 
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Table 3.2− Distribution of general characteristic of study population (n=7848) in the top vs bottom tertiles of four different clusters 
scores 
Variables an Orange-Red Red-Green Yellow-Orange Orange-Blue 
  Tertile1 Tertile3 Tertile1 Tertile3 Tertile1 Tertile3 Tertile1 Tertile3 
Sex (%) 
Male 3677 
 
40.1 50.3 41.3 49.8 
 
42.9 
 
47.0 
 
45.9 46.7 
Female 4171 59.9 49.7 58.7 50.2 57.1 52.4 54.1 53.3 
Education (%) 
≤ 6 years 1403 
 
5.5 9.2 
 
5.7 
 
7.3 
 
7.0 
 
7.1 
 
7.9 5.1 
7 – 12 years 4344 57.2 52.1 58.5 50.5 58.6 52.0 58.7 49.3 
≥ 13 years 2046 37.3 38.7 35.8 42.3 34.4 40.9 33.4 45.6 
bIncome to poverty ratio 
(%) 
Lower (≤1.5) 2387 
 
18.5 20.6 
 
19.3 
 
17.7 
 
22.4 18.4 
 
22.8 15.0 
Middle (≤3.0) 2214 28.8 28.8 30.6 30.4 28.8 30.8 33.0 27.2 
High (>3.0) 2496 52.7 50.6 50.1 51.9 48.8 50.8 44.1 57.8 
Race/ethnicity (%) 
Non-Hispanic Whites 4012 
 
87.6 71.9 
 
85.8 
 
76.2 
 
84.0 76.7 
 
80.4 
 
82.6 
Non-Hispanic Blacks 1817 5.6 13.4 6.8 10.8 7.4 11.2 9.8 8.3 
Mexican Americans 1699 2.2 4.9 2.8 4.1 2.9 3.8 3.1 3.6 
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Other 320 4.6 9.8 4.6 8.9 5.7 8.3 6.7 5.5 
Cigarette Smoker (%) 
Never smoker 
 
3562 
 
39.5 
 
46.3 
 
37.5 
 
45.9 
 
38.7 
 
45.7 
 
38.6 
 
46.5 
Past smoker 2521 33.2 35.5 34.2 36.7 33.3 35.3 32.7 35.4 
Current Smoker 1765 27.3 18.2 28.3 17.4 28.0 19.0 28.7 18.1 
Alcohol (%) 
Never drinker 
 
1480 
 
15.6 
 
15.7 
 
14.7 
 
16.1 
 
15.2 
 
16.2 
 
17.2 
 
13.6 
Past drinker 3185 38.3 37.4 38.5 38.9 38.7 37.6 39.6 38.3 
Current drinker 3031 46.1 46.9 46.7 45.0 46.1 46.2 43.2 48.1 
Dentist visit once in year 
(%) 
Yes 3010 
 
51.7 52.0 49.4 52.2 
 
48.1 
 
54.6 
 
47.9 55.3 
No 4588 48.2 8.1 50.6 47.8 51.9 45.4 52.0 44.7 
Physical Activity (%) 
Sedentary 3550 
 
53.6 51.7 54.4 50.3 
 
51.6 50.5 
 
51.3 54.5 
Active 927 12.3 11.4 11.1 12.3 12.0 11.8 12.1 12.4 
Vigorously active 500 6.8 7.8 7.2 7.8 7.6 8.2 6.8 8.1 
cCentral Obesity (%) 
Normal 3602 
 
52.1 
 
49.4 50.5 49.4 
 
51.9 51.2 
 
50.9 52.0 
Elevated 3904 47.9 50.6 49.5 50.6 48.2 48.8 49.1 48.0 
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Diabetes Status (%) 
Diabetes 1090 
 
8.1 11.2 9.2 9.8 
 
10.4 10.5 
 
11.1 8.6 
Pre-diabetes 3334 35.9 38.5 37.1 37.6 38.1 36.2 39.9 35.1 
Normal 3424 56.1 50.3 53.7 52.6 51.5 53.3 49.0 56.4 
 Mean ± SD (n) 
AGE (years)  56.9±0.5 
 
56.6±0.6 
 
56.8±0.5 
 
56.5±0.6 
 
57.8±0.6 
 
56.2±0.6 
 
58.4±0.6 
 
57.1±0.1 
BMI (kg/m2)  26.9±0.2 
 
27.8±0.2 
 
27.0.9±0.
2 
 
27.7±0.2 
 
26.9±0.2 
 
27.5±0.2 
 
26.9±0.2 
 
27.3±0.2 
 
Fiber Intake (g/day)  16.1±0.3 
 
17.0±0.3 
 
15.8±0.3 
 
17.3±0.3 
 
16.0±0.3 
 
16.9±0.2 
 
16.3±0.3 
 
16.5±0.3 
 
HbA1c (%)  5.5±0.0 
 
5.6±0.0 
 
5.5±0.03 5.5±0.0 
 
5.6±0.0 
 
5.6±0.0 
 
5.6±0.0 
 
5.6±0.0 
 
Fasting Plasma Glucose 
(mg/dl) 
 99.8±0.6 
 
103.5±1.
1 
 
101.7±0.8 
 
101.8±0.
9 
 
102.7±0.
9 
 
102.1±1.
1 
 
103.9±1.
1 
 
101.3±0.
9 
 
aTotals may be different due to missing data 
bIncome-to-poverty ratio: (midpoint family income)/(poverty threshold values based on calendar years and inflation) 
cCentral adiposity present if waist for male subjects ≥101.6 cm and for female subjects ≥88.9 cm 
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Table 3.3− Mean z-score values of four cluster scores and the species-specific IgG antibody titers across diabetes status 
 
Clusters/Periodontal Bacteria Normal blood glucose (N= 3424) 
Pre-diabetes 
(N= 3334) 
Diabetes 
(N= 1090) P-trend 
Clusters z-scores mean (SEM) 
  
Orange-Red -0.45 (0.1) -0.26 (0.1) 0.11 (0.2) 0.0008 
Red-Green -0.11 (0.4) 0.02 (0.3) -0.15 (0.5) 0.7753 
Yellow- Orange -0.01 (0.2) 0.004 (0.2) 0.06 (0.3) 0.7443 
Orange-Blue 0.24 (0.1) 0.08 (0.1) -0.04 (0.1) 0.0009 
Species specific z scores mean (SEM) 
 
Porphyromonas gingivalis -0.22 (0.03) -0.12 (0.03) -0.05 (0.05) 0.0014 
Prevotella intermedia -0.12 (0.02) -0.09 (0.02) -0.02 (0.04) 0.0248 
Prevotella nigrescens -0.06 (0.03) -0.03 (0.03) 0.06 (0.04) 0.0338 
Prevotella melaninogenica -0.05 (0.03) -0.02 (0.03) 0.11 (0.1) 0.0051 
Tannerella forsythia 0.01 (0.1) 0.01 (0.1) 0.03 (0.1) 0.6760 
Veillonella parvula -0.01 (0.04) 0.01 (0.04) 0.003 (0.1) 0.5443 
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Selenomonas noxia -0.004 (0.1) 0.03 (0.04) -0.02 (0.1) 0.7147 
Campylobacter rectus -0.08 (0.1) -0.05 (0.04) -0.01 (0.1) 0.1231 
Treponema denticola 0.02 (0.1) 0.001 (0.04) -0.02 (0.1) 0.4837 
Aggregatibacter actinomycetemcomitans -0.04 (0.1) 0.004 (0.1) -0.04 (0.1) 0.4167 
Eikenella corrodens -0.01 (0.1) 0.01 (0.1) -0.10 (0.1) 0.3792 
Fusobacterium nucleatum -0.02 (0.03) -0.03 (0.03) 0.03 (0.03) 0.6345 
Streptococcus intermedius -0.03 (0.04) 0.01 (0.1) 0.07 (0.1) 0.0084 
Streptococcus oralis -0.02 (0.04) -0.01 (0.1) -0.01 (0.1) 0.8761 
Streptococcus mutans -0.02 (0.04) -0.01 (0.04) 0.01 (0.1) 0.6087 
Micromonas micros 0.05 (0.03) 0.06 (0.03) 0.004 (0.1) 0.6065 
Capnocytophaga ochracea 0.02 (0.03) -0.02 (0.03) -0.04 (0.1) 0.1589 
Eubacterium nodatum 0.12 (0.04) 0.03 (0.04) -0.02 (0.1) 0.0015 
Actinomyces naeslundii 0.12 (0.03) 0.05 (0.03) -0.02 (0.03) 0.0024 
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Table3.4−Odds Ratios (OR) & 95% CI for Type-2 diabetes and pre-diabetes in different clusters scores  
 
Models 
OR 
(95% 
CI) 
Type 2 DIABETES PRE-DIABETES 
Orange-Red Red-Green Yellow-
Orange 
Orange-
Blue 
Orange-Red Red-Green Yellow-
Orange 
Orange-
Blue 
Model1 
 
1.111*** 
(1.067- 1.157) 
0.979 
(0.943 - 1.017 
) 
1.002 
(0.955-
1.051) 
0.888** 
(0.831-
0.949) 
1.035 * 
(1.002- 
1.069) 
1.024 
(0.993 - 1.056 
) 
0.971 
(0.936-1.008) 
0.927 * 
(0.881-
0.949) 
Model2 
 
1.074* 
(1.026-1.124) 
0.963 
(0.925-1.002) 
1.026 
(0.978-
1.078) 
0.962 
(0.901- 
1.028) 
1.014 
(0.981-
1.047) 
1.011 
(0.979-1.044) 
0.988 
(0.951-1.027) 
0.975 
(0.932- 
1.020) 
Model3 
 
1.080* 
(1.029-1.133) 
0.957 * 
(0.919- 0.997) 
1.033 
(0.985-
1.084) 
0.956 
(0.897 -
1.019) 
1.015 
(0.980 -
1.051) 
1.014 
(0.981- 1.047) 
0.983 
(0.948 -
1.024) 
0.983 
(0.939 -
1.029) 
Model4 
 
1.082 * 
(1.032-1.134) 
0.955 * 
(0.912 -0.999) 
1.049 
(0.993-
1.109) 
0.929 
(0.861-
1.001) 
1.022 
(0.988-
1.058) 
1.005 
(0.969 -1.043) 
0.993 
(0.951-1.037) 
0.987 
(0. 942 -
1.033) 
Model5 
 
1.079 * 
(1.031-1.130) 
0.956* 
(0.912 -1.001) 
1.048 
(0.992-
1.108) 
0.935 
(0.869-
1.007) 
1.023 
(0.988-
1.059) 
1.005 
(0.969 -1.043) 
0.993 
(0.951-1.038) 
0.987 
(0. 944 -
1.032) 
Model1 with no adjustment for confounders; Model2 adjusted for age (continuous), sex, education, ethnicity, income-to-poverty; 
Model3 adjusted further for smoking and drinking alcohol; Model4 further for physical activity, BMI (continuous), waist 
circumference [WC],dentist visit and fibers intake. Model5 adjusted further for missing teeth, daily carbohydrate intake, protein 
intake, fat intake, and total calories intake. 
p-value <0.05, **p-value <0.001, *** p-value <0.0001 
Orange-Red: P. melaninogenica, P. intermedia, P. nigrescens, P. gingivalis 
Red-Green: T. forsythia, T. denticola, A. actinomycetemcomitans, E. corrodens, S. noxia, V. parvula, C. rectus 
Yellow-Orange: S. intermedius, S. oralis, S. mutans, F. nucleatum, M. micros, C. ochracea 
Orange-Blue: E. nodatum, A. naeslundii 
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Table 3.5− Odds Ratios & 95% CI for type-2 diabetes and pre-diabetes in different groups of z-scores titers (classified according to 
Desvarieux et al., 2005) 
 
Models 
 
Type 2 DIABETES PRE-DIABETES 
OR  
(95% CI)  
 
Etiologic Putative Health Etiologic Putative Health 
Model1 1.067* 
(1.003 - 1. 135) 
1.003 
 (0.958- 1.050) 
0.871** 
(0.803-0.945) 
1.041* 
(1.002 - 1.080) 
1.001 
 (0.971- 1.031) 
0.927* 
(0.87-0.988) 
Model2 1.047  
(0.980-1.118) 
0.991  
(0.948-1.035) 
0.947 
 (0.87-1.034) 
1.037   
 (0.998-1.077) 
0.989  
(0.957-1.023) 
0.968 
(0.90-1.041) 
Model3 1.044  
(0.976 - 1.115) 
0.995 
 (0.951-1.041) 
0.945  
(0.867-1.029) 
1.040* 
(1.001 - 1.08) 
0.986  
(0.954-1.019) 
0.974  
(0.906-1.051) 
Model4 1.024 
 (0.957 - 1.096) 
1.014 
 (0.958-1.072) 
0.949 
 (0.868-1.039) 
1.044* 
(1.004 - 1. 086) 
0.986  
(0.952-1.021) 
0.980 
(0.906-1.061) 
Model5 1.014 
 (0.948 - 1.084) 
1.019 
 (0.963-1.079) 
0.959 
 (0.880-1.045) 
1.044* 
(1.004 - 1. 085) 
0.987 
(0.954-1.022) 
0.980 
(0.908-1.058) 
Model1 with no adjustment for confounders; Model2 adjusted for age (continuous), sex, education, ethnicity; Model3 adjusted further 
for smoking and drinking alcohol; Model4 further for physical activity, BMI (continuous), WC, dentist visit and fibers intake. Model5 
adjusted further for missing teeth, daily carbohydrate intake, protein intake, fat intake, and total calories intake. 
*P-value <0.05, **P-value <0.001, 
Etiologic: P. gingivalis , A. actinomycetemcomitans, T. forsythia, T. denticola 
Putative: F. nucleatum, M. micros, C. rectus, P. intermedia, E. corrodens 
Health : V. parvula, A. naeslundii 
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Figure 3.1: Composition of mutually exclusive four clusters formed with cluster analysis of z scores of 19 periodontal serum antibody 
titers. Naming of clusters was done using predominant Socransky’s microbial color complexes as shown in parenthesis in the 
respective cluster. 
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Effect modification of the relation between serological periodontal markers and type 2 
diabetes by periodontal pocket depth 
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Abstract: 
Chronic periodontitis is a silent infectious disease that is prevalent worldwide in 
adults and is associated with chronic diseases. Elevated serum IgG markers against 
selected periodontal bacteria are associated with periodontal disease or health.  The 
interaction between the serological markers and clinical periodontal measures is 
understudied in relation to systemic diseases. Our objective was to investigate the joint 
association of clinical periodontal measures and serological markers in relation to 
diabetes. 
We evaluated the interaction in a cross-sectional study among adult participants 
who were 40 years or older from nationally representative NHANES III (1988-1994) 
survey. Serum IgG antibody titers against 19 periodontal bacteria from those participants 
who had glycated hemoglobin ≥5.7 were grouped into four clusters and were named as 
Orange-Red, Red-Green, Yellow-Orange and Orange-Blue according to Socransky & 
Haffagee color complex scheme. Mean clinical attachment loss (CAL) and pocket depth 
(PD) were divided into tertiles. we further defined the periodontal status as moderate to 
severe or normal based on CAL and PD and the outcome was defined as having diabetes 
or normal blood glucose level (n=2908). We performed survey logistic procedures in 
SAS 9.3 to explore the role of clinical periodontal measures on the relations between 
serological clusters and diabetes.  
The inverse association between the Orange-blue cluster score (that included E. 
nodatum and A. neslundii antibody titers) was stronger in the top versus bottom tertile of 
mean periodontal pocket depth ORTertile 1= 1.07, 95% CI (0.89, 1.29), ORTertile 2= 0.84, 
95% CI (0.72, 0.98) and ORTertile 3= 0.74, 95% CI (0.60, 0.91), p-value for 
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interaction=0.07 after multivariable adjustment.   
The relation between IgG antibody groups and diabetes were varied by tertiles of 
periodontal pocket depth.  This suggests that clinical parameters and antibody titers 
against periodontal antibodies in combination can predict the hyperglycemic condition.    
 
Introduction 
Periodontal disease results from low grade chronic inflammation by multiple 
indigenous organisms (Thomas et al. 2012) that leads to tissue destruction. Traditionally, 
diagnostic parameters such as clinical attachment loss (CAL) and probing depths are used 
in assessing the periodontal disease. Despite extensive research in the area of serological 
makers of periodontal pathogens (Albandar et al. 2002, Dye et al. 2005, Dye et al. 2009, 
Mustapha et al. 2007, Papapanou et al. 2004, Pussinen et al. 2011), these are not 
commonly used in periodontal disease assessment. A possible reason may be that the 
interpretation of elevated antibodies titers against specific periodontal bacteria is not 
straightforward (Lockhart et al. 2012); high levels of antibodies may either indicate 
effective host defense, or  chronic failure to control the pathogen and be prognostic of 
major periodontal tissue destruction (Albandar et al. 2002). Hence, both clinical measures 
(CAL and Probing depth), and host defense measures (antibody titers against periodontal 
pathogens), may provide important information about different aspects of the periodontal 
disease process, particularly in relation to systemic disease (Mustapha et al. 2007).  
Elevated serum immunoglobulin G (IgG) antibody titers against specific 
periodontal bacteria e.g. Porphyromonas gingivalis , Prevotella  sps are linked to 
inflammatory diseases such periodontal pathogenesis, coronary heart disease, type 2 
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diabetes, myocardial infraction and others (Ebersole et al. 2008, Mustapha et al. 2007, 
Oppermann, Weidlich, and Musskopf 2012, Pussinen et al. 2007, Pussinen et al. 2004, 
Pussinen et al. 2005, Albandar et al. 2002); elevated IgG titers against E. nodatum are 
linked to periodontal health (Dye et al. 2009). In general there is a shift in periodontal 
microbiota associated with systemic health states (Berezow and Darveau 2011).  It is well 
understood that elevated serum IgG antibody titers against specific periodontal bacteria 
may reflect history of past infection by those bacteria (Lakio et al. 2009, Kinane and 
Lappin 2001); however, there is very limited knowledge about the combined effect of 
periodontal destruction status and elevated antibody titers on systemic disease activity.  
We previously clustered serum IgG antibody titers against 19 periodontal bacteria 
into four empirically derived clusters, and investigated their relation to hyperglycemia. 
We found that measures of hyperglycemia were higher among individuals with high 
antibody titers against certain oral microbes, and lower among others (unpublished 
findings).  In this present study, we used these four clusters of antibodies against 
periodontal microorganisms and investigated if the presence of clinical periodontal 
disease outcome assessed by CAL and PD modified their association with diabetes. This 
finding will increase understanding of the potential combined effect of measures of 
periodontal destruction and antibody titers against periodontal microorganisms in relation 
to diabetes.  
Materials and Methods: 
Data Source and study population: 
The periodontal serum IgG antibody titers analyzed for this cross-sectional study 
were from adult participants who were 40 years or older who participated in the 
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nationally representative NHANES III (1988-1994) survey.  The NHANES III used a 
multi-stage probability cluster sampling design to provide nationally representative data 
on a variety of health risks and behaviors, including both self-reported and objective 
estimates of diabetes and medical conditions, oral health data from dental examination, 
and antibody information related to periodontal disease. The selection and sampling 
methods are described elsewhere (Ezzati et al. 1992).  
We included participants with complete information on serum IgG antibodies 
against 19 oral bacteria (n=8153) and relevant socio-economic, anthropometric, 
laboratory and nutritional data available. For this purpose, we linked the dataset with 
information on antibodies against periodontal pathogens (SPSDEPPX) with the following 
datasets from NHANES III public release data files: NHANES III Household Adult Data 
File (Catalog Number 77560), NHANES III Examination Data File (Catalog Number 
76200); NHANES III Laboratory Data File (Catalog Number 76300); NHANES III 
Dietary Recall Data Files (Catalog Number 76700) using a unique de-identified 
respondent identification number (SEQN NO) provided to each participants. All data for 
this report are available at: http://www.cdc.gov/nchs/nhanes/nh3data.htm 
IgG assay for periodontal bacteria  
Most sampled persons giving blood samples in the mobile examination center 
(MEC) provided additional blood sample that were stored at -70
0
C for future laboratory 
tests. 8153 persons had sera analysed for IgG antibodies to 19 oral bacterial species. The 
following 19 bacterial strains were used to prepare whole cell antigenic extracts by 
checkerboard immunoassay: Aggregatibacter actinomycetemcomitans (ATCC strains 
#43718, #29523 and #33384); Porphyromonas gingivalis (ATCC #33277 and #53978); 
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Tannerella forsythia (ATCC#43037); Treponema denticola (OMGS#3271); 
Campylobacter rectus (ATCC#33238); Eubacterium nodatum (ATCC#33099); Prevotella 
intermedia (ATCC#25611); Prevotella nigrescens (ATCC#33563); Prevotella 
melaninogenica (ATCC#25845); Fusobacterium nucleatum (ATCC#10953); Parvimonas 
micra (previously named Micromonas micros) (ATCC #33270); Selenomonas noxia 
(ATCC#43541);  Eikenella corrodens (ATCC#23834); Capnocytophaga ochracea 
(ATCC#33624); Streptococcus intermedius (ATCC#27335); Streptococcus oralis 
(ATCC#35037); Streptococcus mutans (ATCC#25175); Veillonella parvula 
(ATCC#10790); and Actinomyces naeslundii (ATCC#49340). The laboratory tests were 
performed by the Oral and Diagnostic Sciences Laboratory, Columbia University College 
of Dental Medicine, using the ‘‘checkerboard’’ immunoassay technique measured in 
gravimetric units and these laboratory reports were made available in 2008. The specific 
laboratory method and quality control and monitoring for the measurement of serum IgG 
titers are described in the documentation of NHANES III (National Center for Health 
Statistics 2008). The detailed procedure of assessing IgG by checkerboard immunoassay 
is described in NHANES III documentation: 
ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/nhanes/nhanes3/30a/spsdeppx.pdf  
Cluster Formation and Naming the Clusters 
For each bacterial species, serum IgG antibody titer values were natural log 
transformed and then standardized by dividing these values by the log-transformed 
population standard deviation (Desvarieux et al. 2013, Desvarieux et al. 2005). We then 
selected homogenous subpopulation of those individuals who have blood glucose greater 
than HbA1c ≥ 5.7 (n=3049) and by using cluster analysis we derived four mutually 
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distinct groups of periodontal bacteria. The specific bacteria that were grouped in each 
cluster were shown in Flowchart1.The standardized z-scores of IgG against those 
periodontal bacteria in the respective clusters were summed to obtain cluster scores for 
each group. These four cluster scores were the main exposure variables used in this 
analysis.  
We named each cluster according to the dominant color scheme of microbial 
complexes given by Socransky and Haffajee (Socransky and Haffajee 2005, 2002). For 
instance, if a cluster had bacteria mixture of Red, Orange and other complexes, then the 
cluster was named according to the predominant bacterial complex. We obtained four 
clusters named as “Orange-Red”, “Red-Green”, “Yellow- Orange”, and “Orange-Blue” 
as described in Figure 3.1.  
Measurement of periodontal health 
We assessed periodontal damage by PD and CAL. The detailed method is 
described elsewhere (Choi et al. 2011). CAL of 1–2 mm is considered to be slight, 3–4 
mm moderate, and ≥5 mm severe. Dental examiners trained on the NHANES protocol 
examined all participants at mobile examination centers. Periodontal health assessment 
was based on CAL and pocket depth measurements made at two sites (midbuccal and 
mesiobuccal) on every tooth in each of two randomly chosen quadrants, one in maxilla 
and the other in mandible as described in the NHANES procedures manuals. In total, 28 
sites and 14 teeth per individual were measured if the subject had no history of tooth 
removal excluding third molars (Choi et al. 2011).  
We computed mean CAL and PD and grouped individuals into tertiles; the lowest 
tertile having least periodontal damage as has been describe elsewhere (Choi et al. 2011).  
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Definition of Diabetes 
Individuals were defined as normal (n=2595) if HbA1c was <5.7% or fasting 
plasma glucose (FPG) <100 mg/dl (<5.6 mmol/L). Individuals with HbA1c ≥ 6.5% or 
FPG ≥ 126 mg/dl [7 mmol/L] or those who self-reported diagnosed diabetes were 
classified as having diabetes (n=738) (Bullard et al. 2013).  
Covariate Information  
The covariates included demographic, lifestyle and anthropometric measures such 
as gender, age, race/ethnicity, education, income-poverty ratio, smoking and alcohol 
drinking habits, physical activity, fiber intake, frequency of regular dentist visits, waist 
circumference (WC), body mass index (BMI) and diabetes. Race/ethnicity was self-
reported and was divided into four groups: non-Hispanic white, non-Hispanic black, 
Mexican American and others. Income was grouped into three groups of the income-to-
poverty ratio (≤1.5, >1.5 to ≤3.0, and >3.0), education level into three groups ≤6 years; 7 
to 12 years; and ≥13 year. The number of missing teeth into four groups (0, 1–5, 6–10, 
and ≥11). 
Smokers were defined into three groups (current, past and never smokers). For 
instance, if they said yes to the question “Do you smoke now” then they were defined as 
current cigarettes smokers. If not, then based on the question “Have you smoked 100+ 
cigarettes in life”, we defined them as past smoker or not smoker. Alcohol drinkers were 
divided into three groups (current, past and never alcohol drinkers). If individuals said 
“No” to the question “Had at least 12 drinks in life” were “Never Drinkers”. Those who 
said “yes” were asked next question “Had at least 12 drinks in last 12 months”, if they 
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said yes then were defined as “Current Drinkers”, else were “Past Drinkers”. The 
physical activity into three groups based on metabolic equivalents (METs) (active, ≥6; 
moderate, ≥4 and <6; and less active, <4).  
Fiber intake (grams/day) was assessed based on estimates from the 24-hour 
dietary recall.  People who had regular dental checkups were defined as those who had 
visited a dental clinic at least once in the past year. WC to assess central obesity was 
measured using a steel measuring tape to the nearest 0.1 cm at the high point of the iliac 
crest at minimal respiration when the participant was in a standing position . Central 
adiposity was said to be present if WC was ≥101.6 cm for male subjects and ≥88.9 cm for 
female subjects.  
Statistical Methods 
In this analysis, we excluded insulin users (n=299), pre-diabetic individuals 
(n=3334) and those who had no periodontal examination measures (n=1181); hence the 
final data for analysis were from 3333 participants. 
We used statistical procedures in SAS, version 9.3 (SAS Institute, Cary, NC) to 
analyze complex survey using cluster, weight and strata statements, provided by Center 
for Disease Control for all the statistical analysis. We calculated the weighted means and 
weighted frequencies of serum IgG antibody titers clusters, socio-demographic and other 
risk factors according to the tertiles of periodontal clinical measures (accessed by tertiles 
of Pocket depth and tertiles of CAL).  
To explore the crude association between periodontal clinical measures and the 
four z-score clusters of antibody titers, we first ran crude multivariate logistic regression 
model. The second model was adjusted for age, sex, race-ethnicity, and income-poverty 
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ratio. The third model was additionally adjusted for smoking and drinking alcohol, and 
the fourth model additionally included physical activity, WC, BMI, dentist visits, missing 
teeth, nutrients including intakes of total energy, fibers, carbohydrate, protein, and fat. 
The adjusted odds ratios (ORs), 95% CIs, and P values calculated. 
We stratified the analyses described above by tertiles of PD and CAL. To evaluate 
possible effect modification we created interaction terms for each of serum IgG clusters 
and tertiles of PD and CAL. For example, to evaluate the interaction between Orange-
Red cluster and CAL on diabetes the following variables were included in the model: a 
multiplicative term between Orange-Red cluster and CAL, scores for all other three 
clusters, and covariates including CAL. The interaction was considered statistically 
significant if the p-value for the type III analysis of effect for the interaction term was 
<0.05. 
Results: 
Characteristics of the study population across the tertiles of periodontal clinical 
measures  
The CAL and PD showed positive correlation with Orange-Red and inverse 
correlation with Orange-Blue cluster scores (Spearman correlation coefficients are shown 
in Table 4.1.  
The weighted means (SEs) and weighted frequency percentages of socio-
demographic and other potential risk factors are shown in Table 4.2. Orange-Blue cluster 
scores decreased across the tertiles of clinical attachment loss (p trend =<0.0001) while 
significant trends were not seen in other cluster scores. The mean of Orange-Red cluster 
score increased (p trend =0.03) while Orange-Blue cluster scores decreased (p trend= 
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0.0095) across the tertiles of pocket depth. 
Investigation of confounding and effect modification of clinical periodontal 
destruction measures and serum antibody titers in relation to diabetes 
The extent of association of serum antibody titers and diabetes in a full model 
were not further changed when either of CAL or PD was included (Table 4.3).  Hence, no 
confounding by clinical periodontal destruction was observed.  
The association between diabetes and four serum antibody cluster scores stratified 
by tertiles of mean CAL and PD are shown in Table 4.4 and Table 4.5. The relationship 
between serum antibody cluster scores and diabetes did not vary when stratified by the 
tertiles of CAL (Table4. 4), but approached difference within strata of tertiles of PD 
(Table 4.5). The association between the Orange-Blue cluster score and diabetes was 
stronger in the highest tertile of PD (ORtertile 1=1.07, 95% CI 0.89, 1.29 versus ORtertile 
1=0.74, 95% CI 0.60, 0.91, p-value for interaction 0.07) (Table 5).  The positive 
association between Orange-Red cluster scores and diabetes likewise seemed stronger in 
the highest versus lowest tertiles of PD (Table 4.5). We found the association was 
significantly different in the Orange-Red and Orange-Blue clusters by the periodontal 
status when periodontal status were defined as moderate or severe if the CAL ≥ 4 mm or 
PD ≥ 5mm or else normal.  (Appendix A:Table 1).  
Discussion: 
The association between clusters of IgG antibodies against periodontal 
microorganisms and diabetes was stronger among individuals with greater pocket depth 
suggesting effect modification by PD; there was no evidence of effect modification of 
this association by levels of CAL. The inverse association between the Orange-Blue 
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cluster score and diabetes was stronger in the highest versus lowest tertile of mean PD. 
Similarly the positive association between the Orange-Red cluster score and diabetes 
increased by PD severity. This information is important to consider when information 
from clinical and serologic measures of periodontal disease is combined to evaluate their 
relation with systemic outcomes.     
Serum IgG antibody titers measure the cumulative life time host response due to 
persistent infection of periodontitis and/ or the re-occurrence (Papapanou et al. 2004, 
Rams, Listgarten, and Slots 2006) which tends to remain stable over a longer periods 
even after treatment (Darby, Mooney, and Kinane 2001). Moreover, elevated serum 
antibodies titers may not only reflect the protective effect against periodontal disease, but 
may also indicate active periodontal lesions, in which case antibody titers would be 
indicators of developing periodontal disease (Dye et al. 2009, Lockhart et al. 2012). 
Selected serological markers have been used to assess in periodontal disease (Dye et al. 
2009). The reasons we used cluster analysis to form 4 groups are, first, periodontal 
disease is associated with a shift in balance of microorganisms that are ubiquitous in the 
mouth rather than by any single organism. Second, cluster analysis grouped the 
antibodies against periodontal microorganisms as they naturally occur is explained in our 
previous study. In brief, the Hence by clustering these markers into mutually exclusive 
clusters, we can distinguish whether elevated titers are the markers of systemic health or 
disease status.  
Our findings are consistent with prior reports linking antibodies against 
periodontal pathogens and diabetes. In our previous studies, we observed that the Orange-
Red cluster of antibodies was positively associated with type 2 diabetes and 
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hyperglycemia, while the Orange-Blue cluster of antibodies showed an inverse relation.  . 
The Orange-Red cluster included serum antibodies against P. gingivalis and Prevotella 
sps. The Orange-Blue cluster included E. nodatum and A. naeslundii.   In this current 
study, no notable relationship was observed in Red-Green and Yellow-Orange Clusters. 
There are evidences that the elevated antibody titer of some selected bacteria in these 
clusters is linked to diabetes. The periodontal bacteria of Red-Green cluster score; 
particularly A. actinomycetemcomitans has previously shown inconsistent association 
with other systemic disease (Hosomi et al. 2012, Pussinen et al. 2005). Studies have 
reported that periodontal pathogens P. gingivalis and Prevotella sps and their serum 
antibodies titers are higher in individuals with type 2 diabetes (Casarin et al. 2013, 
Darveau 2010, Darveau, Hajishengallis, and Curtis 2012, Desvarieux et al. 2013, Dye et 
al. 2009). Although the E. nodatum organism is associated with periodontal destruction, 
elevated antibody titers against E. nodatum are associated with periodontal health (Dye et 
al. 2009). Higher concentration of A. neslundii has been associated with periodontal 
health (Williams, Pantalone, and Sherris 1976, Dye et al. 2009, Desvarieux et al. 2005). 
A recent study reported effect modification of the relation between periodontal damage 
and diabetes by levels of serum CRP, and antibody titers against periodontal pathogens 
particularly P. gingivalis and A. actinomycetemcomitans. 
In the present analyses we have built on findings linking antibodies against 
periodontal pathogens and diabetes by studying their interaction with clinically 
determined periodontal destruction. Periodontal destruction has being linked to an array 
of chronic diseases including hyperglycemia through systemic inflammation 
(Oppermann, Weidlich, and Musskopf 2012, Mustapha et al. 2007, Ebersole et al. 2008, 
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Brito et al. 2013). Although unclear, there are four biologically meaningful hypotheses 
(common susceptibility, systemic inflammation, direct infection of blood vessels and the 
cross-reactivity or molecular mimicry) that explain possible mechanisms kinking 
periodontal infection with systemic disease in different people (Seymour et al. 2007, 
Seymour et al. 2009). Understanding the interaction between the clinical periodontal 
destruction, microbiological, serological periodontal parameters will be useful to 
minimize bias and spurious relationship while exploring the complex systemic 
relationship.  
This present study has some drawbacks. First, in NHANES III (1988-1994), 
periodontal examination (CAL and PD) was measured on only 2 sites in each tooth which 
might underestimate the prevalence and severity of periodontal disease (Papapanou 
2012). Although, we measured most of the potential confounders that were examined and 
measured in this dataset, there could be some unmeasured confounding factors such as 
oral hygiene that could bias this cross-sectional analysis. Additionally, we studied the 
commonly identified serum IgG antibody titers of 19 periodontal bacteria but those 
unidentified and unknown periodontal microbes may change the pattern of clusters hence 
we recommend this study findings needs to validated in recent population using 
sophisticated techniques and epidemiological methods. Despite limitations, this study has 
generated a hypothesis that combination of selected serological markers and clinical 
assessment of periodontal destruction increase the prediction of the diabetes.  
The relation between IgG antibody groups and diabetes was found to vary by 
tertiles of periodontal pocket depths. This finding is relevant when clinical parameters 
and periodontal antibodies are studied in combination in relation to systemic disease.    
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Table 4.1: Correlation of the z-scores of serum antibody clusters with clinical attachment 
loss and pocket depth  
 
Spearman’s 
correlation 
(n=3333) 
PD 
Red-Green Orange-Red 
Yellow-
Orange 
Orange-Blue 
CAL 0.57** -0.02 0.07** -0.03 -0.13** 
PD - -0.02 0.11** -0.02 -0.07** 
 
** p value <0.0001 
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Table 4.2: Profile characteristics of study population sample across tertiles of clinical periodontal measures 
 
Clinical Attachment loss (CAL) Pocket Depth (PD) 
 (Total n=3333) Tertile1 (n=1188) 
Tertile II 
(n=1136) 
Tertile III 
(n=1009) P value 
Tertile1 
(n=1111) 
TertileII 
(n=1163) 
Tertile III 
(n=1059) P Value 
Sex: % 
Male 
Female 
40.1 
59.9 
44.3 
55.7 
58.2 
41.8 <0.0001 
39.1 
60.9 
45.8 
54.2 
57.1 
42.9 
<0.0001 
 
 
Race/ Ethnicity % 
Non-Hispanic 
Whiles 
Non –Hispanic 
Blacks 
Mexican 
American 
Others 
84.5 
6.3 
3.5 
5.7 
81.3 
6.5 
3.6 
8.5 
79.1 
10.4 
3.7 
6.8 
0.0734 
86.2 
4.4 
2.6 
6.8 
82.2 
7.2 
3.8 
6.8 
75.2 
12.5 
4.8 
7.5 
<0.0001 
Education % 
≤ 6 years 
7 – 12 years 
≥ 13 years 
3.21 
38.1 
58.7 
4.4 
52.5 
43.1 
8.1 
61.8 
30.1 
<0.0001 
3.5 
42.2 
54.3 
4.1 
47.5 
48.4 
7.9 
61.3 
30.9 
<0.0001 
Income to poverty 
ratio % 
Lower (≤1.5) 
Middle (≤3.0) 
Higher (>3.0) 
10.6 
23.3 
63.1 
14.2 
25.3 
60.5 
20.0 
35.6 
44.4 
<0.0001 
11.5 
26.6 
61.9 
12.2 
27.0 
60.8 
21.1 
32.2 
46.7 
<0.0001 
Smoking % 
Never 
Past 
Current 
55.5 
33.9 
10.6 
37.2 
47.1 
15.7 
24.3 
50.0 
25.7 
<0.0001 
50.4 
3805 
11.1 
40.6 
43.9 
15.5 
29.0 
46.4 
24.6 
<0.0001 
Alcohol intake % 14.0 14.4 12.2 0.3813 14.8 12.7 13.4 0.1986 
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Never 
Past 
Current 
32.5 
53.5 
31.4 
54.2 
37.4 
50.4 
34.9 
50.3 
29.8 
57.5 
35.4 
51.2 
Physical activity 
% 
Sedentary 
Moderately active 
Vigorously active 
Missing 
57.5 
12.9 
8.3 
21.3 
54.7 
13.1 
8.0 
24.1 
54.0 
11.3 
5.8 
28.9 
0.1336 
55.4 
15.0 
9.0 
20.6 
57.2 
11.6 
7.3 
23.9 
54.1 
10.0 
5.8 
30.2 
0.0027 
No of missing 
teeth, % 
“0” 
“1-5” 
“6-10” 
“>10” 
56.1 
37.3 
5.4 
1.1 
40.0 
49.8 
9.2 
0.9 
35.1 
41.2 
17.7 
5.9 
<0.0001 
51.4 
39.6 
7.8 
1.2 
42.3 
47.5 
8.8 
1.3 
40.6 
40.6 
13.8 
5.0 
<0.0001 
Waist 
Circumference 
Normal 
Elevated 
58.3 
41.7 
56.7 
43.3 
49.7 
50.3 0.0270 
60.4 
39.6 
55.5 
44.5 
48.2 
51.8 0.0013 
Annual visits to 
dentist % 
Yes 
No 
71.2 
28.7 
65.1 
34.9 
48.9 
51.1 <0.0001 
72.8 
27.2 
65.8 
34.1 
46.0 
54.0 <0.0001 
Diabetes % 
Normal 
8.9 
91.1 
11.3 
88.7 
25.2 
74.8 <0.0001 
10.1 
89.9 
12.9 
87.1 
20.5 
79.5 <0.0001 
Mean (Se) 
Age, years, mean 
(se) 49.1±0.5 53.9±0.6 59.0 ± 0.6 <0.0001 52.5 ±0.5 53.3 ±0.4 53.8 ±0.5 0.0892 
Fiber intake, 
g/day, mean (se) 27.04±0.3 27.1±0.3 27.1±0.2 0.0528 26.4±0.2 27.1±0.3 28.1±0.3 0.0834 
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Carbohydrate 
Intake, g/day 
mean (se) 
 
258.9±5.5 248.8±5.2 243.4±7.6 0.04 249.3±5.2 254.3±5.1 252.2±9.0 0.69 
Protein Intake, 
g/day mean (se) 
 
79.7±1.8 77.8±1.8 77.5±1.9 0.35 76.2±1.7 79.0±1.8 81.7±2.1 0.07 
Fat Intake, g/day 
mean (se) 
 
80.4±2.6 77.7±2.3 75.3±2.1 0.10 76.5±2.2 80.0±2.1 78.9±2.2 0.41 
BMI, kg/m2, mean 
(se) 17.9±0.5 17.1±0.5 16.4±0.4 0.8527 17.7±0.5 17.4±0.4 16.3±0.6 0.0002 
Red-Green 0.50 ± 0.4 -0.20 ± 0.4 -0.39 ± 0.5 0.0338 0.38 ± 0.4 -0.10 ± 0.5 -0.31 ± 0.4 0.0755 
Orange-Red -0.30 ± 0.2 -0.14 ± 0.1 -0.12 ± 0.2 0.4487 -0.37 ± 0.2 -0.26 ± 0.2 0.15 ± 0.2 0.0264 
Yellow-Orange 0.43 ± 0.3 0.07 ± 0.3 -0.35 ± 0.4 0.0496 0.26 ± 0.3 0.07 ± 0.3 -0.03 ± 0.2 0.2896 
Orange-Blue 0.51 ± 0.1 0.28 ± 0.1 -0.13 ± 0.1 <0.0001 0.39 ± 0.1 0.26 ± 0.1 0.13 ± 0.1 0.0026 
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Table 4.3: Exploring confounding effect (Odds Ratio and 95%CI) of clinical periodontal measures in the relation to serum antibody 
clusters and diabetes 
 
 (n=3333) Red-Green Orange-Red Yellow-Orange Orange-Blue 
Adjustment for age, sex, 
education, ethnicity, smoking , 
drinking alcohol, physical 
activity, BMI WC, missing teeth 
and dentist visit  
(Reference full model) 
0.98 
 (0.92 ,1.03) 
1.04 
(0.98, 1.09) 
1.05 
 (0.97, 1.14) 
0.893  
(0.81,  0.99) 
Additionally adjusted for CAL 0.97  (0.922, 1.036) 
1.03 
(0.968, 1.086) 
1.06  
(0.98, 1.14) 
0.90  
(0.81, 0.99) 
Additionally adjusted for PD 0.98  (0.92, 1.04) 
1.03  
(0.97, 1.09) 
1.06  
(0.98, 1.14) 
0.89  
(0.80, 0.99) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
121 
Table 4.4: Association of the z-scores of serum antibody clusters with diabetes stratified by the tertiles of clinical attachment loss 
 
Serum Antibody  
z-scores Clusters 
Odds Ratio (95% Confidence Interval) 
Clinical Attachment Loss 
Model*  Tertile I Tertile II Tertile III 
Red-Green    
Model1 1.01 (0.93, 1.10) 1.01 (0.91, 1.13) 1.01 (0.93, 1.09) 
Model2 1.06 (0.94, 1.18) 0.96 (0.88, 1.06) 0.99 (0.92, 1.07) 
Model3 1.03 (0.91, 1.15) 0.96 (0.87, 1.06) 0.99 (0.93, 1.08) 
Model4 1.04 (0.92, 1.18) 1.01 (0.88, 1.66) 0.95 (0.86, 1.05) 
Orange-Red    
Model1 1.21 (1.08, 1.36)* 1.08 (0.99, 1.18) 1.09 (0.98, 1.20) 
Model2 1.08 (0.96, 1.23) 1.04 (0.95, 1.13) 1.05 (0.95, 1.17) 
Model3 1.06 (0.91, 1.24) 1.03 (0.94, 1.14) 1.06 (0.96, 1.16) 
Model4 1.001 (0.83, 1.15) 0.98 (0.88, 1.10) 1.07 (0.98, 1.16) 
Yellow-Orange    
Model1 0.94 (0.82, 1.07) 0.97 (0.87, 1.08) 0.97 (0.88, 1.07) 
Model2 0.94 (0.83, 1.07) 1.03 (0.92, 1.13) 1.00 (0.91, 1.10) 
Model3 1.02 (0.89, 1.15) 1.03 (0.93, 1.15) 0.99 (0.91, 1.10) 
Model4 1.05 (0.90, 1.22) 1.02 (0.88, 1.18) 1.08 (0.96, 1.20) 
Orange-Blue    
Model1 0.82 (0.70, 0.96)* 0.88 (0.76, 1.01) 0.97 (0.86, 1.09) 
Model2 0.91 (0.77, 1.07) 0.95 (0.82, 1.09) 0.98 (0.86, 1.12) 
Model3 0.88 (0.74, 1.04) 0.94 (0.83, 1.07) 0.99 (0.86, 1.13) 
Model4 0.87 (0.72, 1.04) 0.87 (0.73, 1.04) 0.95 (0.78, 1.15) 
Model 1: adjusted for the clusters.  
Model 2: Model 1 plus additionally adjusted for age, sex, education, income, race 
Model 3: Model 2 plus additionally adjusted for  smoking, alcohol intake 
Model 4: Model 3 plus additionally adjusted further with missing teeth, dental visit, BMI, central adiposity, physical activity, total 
energy, carbohydrate, fat and protein intake.* p value <0.05 
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Table 4.5: Association of the z-scores of serum antibody clusters with diabetes stratified by the tertiles of clinical pocket depth 
measures 
 
Serum Antibody Clusters Odds Ratio (95% Confidence Interval) Pocket Depth 
Model*  Tertile I Tertile II Tertile III 
Red-Green    
Model1 0.98 (0.88, 1.08) 1.05 (0.93, 1.18) 1.07 (0.97, 1.19) 
Model2 0.97 (0.87, 1.07) 1.02 (0.90, 1.15) 1.03 (0.92, 1.15) 
Model3 0.97 (0.87, 1.08) 1.02 (0.90, 1.13) 0.97 (0.86, 1.11) 
Model4 0.92 (0.82, 1.03) 1.04 (0.91, 1.17) 0.97 (0.84, 1.12) 
Orange-Red    
Model1 1.13 (1.03, 1.23)* 1.10 (0.99, 1.22) 1.16 (1.05, 1.29)* 
Model2 1.01 (0.91, 1.13) 1.03 (0.94, 1.13) 1.12 (1.00, 1.26)* 
Model3 0.99 (0.88, 1.12) 1.03 (0.94, 1.12) 1.15 (1.01, 1.31)* 
Model4 0.97 (0.86, 1.09) 1.03 (0.94, 1.14) 1.10 (0.95, 1.28) 
Yellow-Orange    
Model1 0.99 (0.89, 1.10) 0.96 (0.86, 1.06) 0.92 (0.80, 1.05) 
Model2 1.05 (0.91, 1.13) 0.99 (0.89, 1.09) 0.97 (0.83, 1.12) 
Model3 1.05 (0.94, 1.16) 0.98 (0.88, 1.08) 1.04 (0.87, 1.24) 
Model4 1.13 (1.01, 1.27) 0.97 (0.87, 1.09) 1.10 (0.89, 1.36) 
Orange-Blue    
Model1 0.94 (0.80, 1.09) 0.80 (0.70, 0.89)* 0.86 (0.73, 0.99)* 
Model2 1.06 (0.89, 1.26) 0.88 (0.77, 1.00) 0.89 (0.77, 1.04) 
Model3 1.06 (0.87, 1.29) 0.88 (0.78, 0.99)* 0.84 (0.70, 0.99)* 
Model4 1.07 (0.89, 1.29) 0.84 (0.72, 0.98)* 0.74 (0.60, 0.91)* 
Model 1: adjusted for the clusters. Model 2: Model 1 plus additionally adjusted for age, sex, education, income, race 
Model 3: Model 2 plus additionally adjusted for  smoking, alcohol intake 
Model 4: Model 3 plus additionally adjusted further with missing teeth, dental visit, BMI, central adiposity, physical activity, total 
energy, carbohydrate, fat and protein intake.* p value <0.05 
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Abstract: 
Metabolic syndrome (MetS), a complex cluster of cardiovascular risk factors, has 
been linked to periodontal diseases; however the contribution of periodontal bacteria to 
systemic conditions remains unclear. We studied the magnitude and extent of the relation 
between serum IgG antibody titers against periodontal bacteria and MetS and its 
individual components. 
The study population comprised of 7848 US adults who participated in an 
interview, clinical, oral health examination, and had serum IgG titers measured against 19 
periodontal bacteria as part of the NHANES III survey. The z-scores antibody titers were 
clustered into 4 mutually exclusive groups and named after Socransky’s classification of 
periodontal bacteria (Orange-Red, Red-Green, Yellow-Orange, and Orange-Blue). 
Survey logistic regression was used to investigate the independent associations between 
the cluster scores, and MetS and each component including hypertension, 
hypertriglyceridemia, low HDL-cholesterol, central obesity, and elevated fasting glucose. 
The Orange-Red cluster score (associated with periodontal disease) was positively 
associated [OR: 1·067 (1·02-1·12)]) and Orange-Blue cluster score inversely associated 
[OR= 0·93 (0·88-0·97)] with elevated fasting glucose (≥110 mg/dl) after adjusted for 
clusters and potential confounders. Neither MetS nor its other remaining MetS 
components were associated with a particular cluster score. 
The associations between different antibody clusters against periodontal bacteria 
and elevated plasma glucose were in qualitatively opposite directions after multivariable 
adjustment in a large, adult population. The periodontal bacterial profile was not found 
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associated with metabolic control other than very moderate association with elevated 
plasma glucose. 
Keywords: Metabolic syndrome, hypertension, hyperlipidemia, central obesity, elevated 
fasting plasma glucose, serum immunoglobulinG (IgG), periodontal microbiota 
Introduction: 
Periodontitis is a chronic poly bacterial infection in the tooth-supporting tissues, 
which may lead to tooth loss. Isolation of selected periodontal pathogens such as 
Porphyromonas gingivalis, Prevotella intermedia, Eikenella corrodens, Treponema 
denticola, Campylobacter rectus from atherosclerotic lesions in humans and animals, 
(Kebschull, Demmer, and Papapanou 2010) and the positive association of higher titers 
of antibodies against P gingivalis with  coronary heart disease (Yamazaki et al. 2007), 
stroke  (Pussinen, Alfthan, et al. 2007), and myocardial infraction (Holmlund et al. 2011) 
raised attention to the potential role of periodontal organisms in systemic conditions . 
Recently, a longitudinal study findings showed that improved clinical and microbial 
periodontal profile reduced the progression of carotid atherosclerosis over three years 
(Desvarieux et al. 2013).  These microbiological and, serological evidences (Mustapha et 
al. 2007) have generated interest to better understand related factors underlying the 
relationship between periodontal disease and cardiovascular disease (CVD), including 
chronic inflammation, diabetes and the metabolic syndrome (MetS).  
Diabetes and periodontal disease are common in middle aged persons, share 
common risk factors (Taylor, Preshaw, and Lalla 2013), are associated with CVD 
(Lockhart et al. 2012, Southerland et al. 2012), risk markers of CVD (Oldridge et al. 
2001), systemic inflammation (Oppermann, Weidlich, and Musskopf 2012), and 
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metabolic syndrome (MetS) (Alberti et al. 2009). Diabetes and pre-diabetes prevalence is 
higher among individuals with more severe periodontal disease (Choi et al. 2011). 
However, the role that periodontal microorganisms play in these relationships is 
incompletely understood. A clear insight into this relationship has potential for the 
development of targeted strategies to prevent and manage these conditions.  
In the previous observations, we found that antibody titers against selected 
periodontal microorganisms group into 4 distinct clusters, and that these are related to 
diabetes and pre-diabetes in the third National Health and Nutritional Examination survey 
(NHANES III). In this present study, we aimed to investigate the extent to which clusters 
of serum IgG antibodies against periodontal bacteria were related to MetS and its 
individual components including hypertension, hypertriglyceridemia, low high density 
lipoprotein (HDL)-cholesterol, central adiposity, and elevated plasma glucose. MetS 
intends to identify those who are at risk stage of cardiovascular disease, pre-diabetes, or 
diabetes (Alberti et al. 2009). We hypothesized that specific subsets of serum IgG 
antibodies against periodontal bacteria were linked to periodontal health or disease could 
associated with metabolic control.  
Materials and Methods: 
Data Source:  
The study population consisted of participants of the NHANES III (1988-1994) 
survey who were ≥40 years old, and had complete data for serum IgG antibody titers 
against 19 oral bacteria (n=8153); we excluded those who used insulin (n=299) and/or 
had gestational diabetes (n=6); leaving 7848 participants for the final analysis. The 
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NHANES III sample is representative of the non-institutionalized US population; 
information is collected through interviews, medical and dental examinations, and 
laboratory tests. The de-identified data are available at: 
http://www.cdc.gov/nchs/nhanes/nh3data.htm. For this study we merged the following 
datasets: Periodontal Pathogens (SPSDEPPX), Household Adult Data File (Catalog 
Number 77560), NHANES III Examination Data File (Catalog Number 76200); 
NHANES III Laboratory Data File (Catalog Number 76300); NHANES III Dietary 
Recall Data Files (Catalog Number 76700) using unique de-identified respondent 
identification numbers.  
Assessment of Outcome 
The outcomes were each of five components of metabolic syndrome consistent 
with recent task force guidelines (Alberti et al. 2009): elevated central obesity, 
hypertriglyceridemia, low HDL cholesterol, high blood pressure, and high elevated 
fasting glucose. We categorized these variables after excluding implausible values. 
Central obesity was categorized as elevated if waist circumference was ≥ 90 cm for men 
and ≥ 85 cm for women, else normal. Hypertension was defined as present if systolic 
blood pressure was > 130 mm Hg or Diastolic blood pressure was > 85 mm Hg or if the 
participant reported taking anti-hypertensive medication, or absent otherwise. 
Hypertriglyceridemia was defined as present if triglycerides were >150 mg/dl or else 
normal.  High density lipoprotein was categorized as low if HDL was < 40mg/dl for men 
and <50 mg/dl for women or optimum otherwise. Elevated plasma glucose was defined 
as present if fasting plasma glucose was >100 g/dl or else normal. Additionally, 
participants were assessed as having MetS if they had at least three of these components 
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(Alberti et al. 2009).  
 IgG assay for periodontal bacteria 
Stored sera of NHANES III participants, aged 40 years or older were analyzed for 
IgG antibodies against 19 oral bacterial species, and the data released in 2008 (N=8153). 
The following 19 bacterial strains were used to prepare whole cell antigenic extracts by 
checkerboard immunoassay: Aggregatibacter actinomycetemcomitans (ATCC strains 
#43718, #29523 and #33384); Porphyromonas gingivalis (ATCC #33277 and #53978); 
Tannerella forsythia (ATCC#43037); Treponema denticola (OMGS#3271); 
Campylobacter rectus (ATCC#33238); Eubacterium nodatum (ATCC#33099); 
Prevotella intermedia (ATCC#25611); Prevotella nigrescens (ATCC#33563); Prevotella 
melaninogenica (ATCC#25845); Fusobacterium nucleatum (ATCC#10953); 
Micromonas micros (ATCC #33270); Selenomonas noxia (ATCC#43541);  Eikenella 
corrodens (ATCC#23834); Capnocytophaga ochracea (ATCC#33624); Streptococcus 
intermedius (ATCC#27335); Streptococcus oralis (ATCC#35037); Streptococcus mutans 
(ATCC#25175); Veillonella parvula (ATCC#10790); and Actinomyces naeslundii 
(ATCC#49340). The Oral and Diagnostic Sciences Laboratory, Columbia University 
College of Dental Medicine analyzed the sera The using the ‘‘checkerboard’’ 
immunoassay technique measured in gravimetric units. The detailed procedure is 
described in NHANES III documentation: 
ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/nhanes/nhanes3/30a/spsdeppx.pdf  
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Definition of the periodontal exposures  
The IgG antibody titers were log transformed and then converted to standardized 
z scores (Desvarieux et al. 2010). Participants with hyperglycemia (HbA1c ≥ 5.7) were 
included in cluster analysis to derive four mutually distinct groups of periodontal 
bacteria. The z-scores against periodontal bacteria in the respective clusters were summed 
to obtain cluster scores for each group. These four cluster scores [Orange-Red, Red-
Green, Yellow-Orange, and Orange-Blue] were named according to Socransky’s color 
classification scheme (Figure 3.1) (Socransky and Haffajee 2002).  
Covariate Information  
Demographic, lifestyle and anthropometric measures included gender, age, 
race/ethnicity, education, income-poverty ratio, smoking and alcohol drinking habits, 
physical activity, fiber intake, frequency of regular dentist visits, waist circumference 
(WC), body mass index (BMI), and diabetes. Race/ethnicity was self-reported and was 
divided into four groups: non-Hispanic white, non-Hispanic black, Mexican American 
and others. Income was grouped into three groups of the income-to-poverty ratio (≤1.5, 
>1.5 to ≤3.0, and >3.0), education level into three groups ≤6 years; 7 to 12 years; and ≥13 
years).  
Smoking status was classified into three groups (current, past and never smokers). 
Alcohol consumption was divided into three groups (current, past and never alcohol 
drinkers). Physical activity was divided into three groups based on metabolic equivalents 
(METs) (active, ≥6; moderate, ≥4 and <6; and less active, <4) (Choi et al. 2011).  
Fiber intake was assessed based on estimates from 24-hour dietary recall data. 
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People who had regular dental checkups were defined as those who had visited a dental 
clinic at least once in the past year. WC to assess central obesity was measured using a 
steel measuring tape to the nearest 0.1 cm at the high point of the iliac crest at minimal 
respiration when the participant was in a standing position (Choi et al. 2011). Central 
adiposity was said to be present if WC was ≥101.6 cm for male subjects and ≥88.9 cm for 
female subjects. WC was not included in final adjusted model where WC was the 
outcome variable and similarly, diabetes was not used as confounder when elevated 
plasma glucose was the outcome variable. We defined diabetes status as diabetes, pre-
diabetes and normal blood glucose level. Pre-diabetes was defined as having HbA1c 5.7 to 
<6.5% or fasting plasma glucose (FPG) 100 to <126 mg/dl (5.6-6.9 mmol/L). Individuals 
with HbA1c ≥ 6.5% or FPG ≥ 126 mg/dl [7 mmol/L] or those who self-reported 
diagnosed diabetes were classified as having diabetes or else classified as normal blood 
glucose level(Bullard et al. 2013). 
Statistical Methods 
SAS, version 9.3 (SAS Institute, Cary, NC) was used for data management and 
statistical analyses. SAS survey procedures were used to take into account the complex 
weighted sampling design and yielded unbiased parameter estimates and standard errors. 
Sample weights, cluster, and strata variables provided by CDC were used. A statistically 
significant α level was considered at 0.05.  
Descriptive statistics were estimated using procedures for complex surveys in SAS (proc 
surveymeans and proc surveyfreq). The distribution of socio-demographic, lifestyle, 
anthropometric and outcome measures across tertiles of cluster scores were estimated. 
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Using the survey regression multivariable model, we then regressed each of these 
outcomes with the four z-score clusters. Secondly, the model was adjusted for age 
(continuous) and sex. Thirdly, we adjusted further for race and ethnicity, income-poverty 
ratio, smoking, alcohol, physical activity, fiber intake (continuous), dentist visits, WC 
and BMI (continuous). In the fourth model, diabetes status was further added in the 
analysis of hypertension, hyper triglycerides, low HDL-cholesterol, and central adiposity.    
Results: 
In this population, 37·8% had low HDL-cholesterol, 37·4% hypertriglyceridemia, 
60.02% hypertension, 52.01 % elevated central adiposity, 38.2 % elevated plasma 
glucose and 41.8% MetS. The adverse health conditions were generally more common 
among  Non-Hispanic Whites, females, high school graduates (7-12 years education 
level), never or past smokers, current or former alcohol drinkers, individuals who were 
hypertensive, overweight,  sedentary, and  who did not have annual dental visits. The 
characteristics of the study population across extreme tertiles of four cluster scores are 
shown in Table 5.1. There were some notable differences in participant characteristics 
across Orange-Red and Orange-Blue clusters. The top tertile of Orange Red cluster 
(which included P gingivalis and Prevotella species) had larger proportions of 
individuals who were male, less educated, low income, Non-Hispanic Black, never 
smokers, normal triglycerides, hypertensive and insulin resistant compared to the  lowest 
tertile; the highest tertile of the Orange-Blue cluster (which included A naeslundii and E 
nodatum) had  individuals who were highly educated, high income, Non-Hispanic White, 
never smokers, current drinkers, visited the dentist regularly at least once a year, and had 
optimum high density lipoproteins, tri-glyceride and blood glucose levels. There were 
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higher proportions of individuals with diabetes and pre-diabetes in the top versus bottom 
tertiles (11·2 vs 8·1) in the Orange-Red cluster, however the opposite trend for diabetes 
(8·6 vs 11·1) was observed in the Orange-Blue cluster; no such differences were seen in 
other clusters (Table 5.1). 
Correlations between clusters scores are shown in Table 5.2. The highest 
correlation is in between Yellow-Orange (predominantly Streptococcus sps) and Red-
Green (T denticola, T forsythia, A actinomycetemcomitans and others) scores (0·91, p 
value=<0·0001) whereas lowest is in between Orange-Red and Orange-Blue clusters 
(0·34, p value=<0·0001). Mean values of serum IgG z-scores of four clusters by different 
outcome measures are shown in Table 3. Only Orange-Red scores were higher in 
individuals having MetS and those with elevated plasma glucose levels; increased 
Orange-Blue scores were observed in individuals who had no hypertension and normal 
plasma blood glucose.  
After full adjustment of potential confounders, no association was seen in four 
cluster scores with MetS and any of the individual components except for elevated 
plasma glucose. For each unit increase in Orange-Red cluster scores the odds of elevated 
plasma glucose 6% [OR: 1·06 (1·02-1·10)] with; with the National Cholesterol Education 
Program (NCEP)-Adult treatment panel III criteria (elevated plasma blood glucose level,  
≥110 mg/dl) (Lorenzo et al. 2007)(17)(Lorenzo et al. 2007)(Lorenzo et al. 2007) there 
were 7% higher odds [OR: 1·06 (1·02-1·12)] and 1 unit higher Orange-Blue cluster score 
was associated with 7% lower odds of hyperglycemia [OR:0·93 (0·88-0·98)]. No 
association was seen with Orange-Red and Yellow-Orange cluster scores (Table 5.4). 
139 
 
Similar analyses conducted among people with no missing teeth yielded qualitatively 
similar results (Table 5.5). 
Discussion: 
Elevated plasma glucose was more common among individuals with higher serum 
IgG antibody titer scores against organisms belonging to the Orange-Red cluster 
(indicating periodontal disease), and lower in titer scores against organisms from the 
Orange-Blue cluster after adjustment for several socio-demographic, anthropometric and 
behavioral factors. There was no association between antibody score clusters and MetS or 
other individual components of MetS (hypertension, dyslipidemia, central obesity).  
Periodontitis is not due to a single  pathogen, but results from a complex 
biological alteration of  the periodontal microenvironment, and a distributional shift of 
key periodontal pathogens(Berezow and Darveau 2011). Ebersole et al (Ebersole et al. 
2008) postulated that increased severity may be due to alterations in the pathogenicity of 
the periodontal bacteria in the plaque biofilm, which in turn may imbalance the host 
immune system and impact systemic inflammation. Although there is biological 
plausibility for the hypothesis, some study findings refute a causal role of direct 
periodontal pathogen invasion in the systemic disease (Lockhart et al. 2012). Moreover, 
periodontal pathogen coexists with hundreds of others, making it difficult to isolate the 
potential effect of a particular pathogen, and predisposing such studies to type 1 error 
(Wang et al. 2007). To overcome this limitation investigators have grouped the 
periodontal organisms together either using empirical (Socransky and Haffajee 2002) or 
theoretical (Desvarieux et al. 2013) approaches. Socransky et al grouped pathogens 
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related to periodontal disease status, while Desverieux et al grouped the periodontal 
organisms that were hypothesized to be related to cardiovascular disease. Similar 
analyses for type 2- diabetes were not found in the literature.  
In the current study, we used an empirical approach to cluster oral pathogens 
among individuals with hyperglycemia and measured the extent of association of these 
clusters with metabolic control.  This was an appropriate method to classify antibodies 
against the 19 oral microorganisms because the microorganisms are correlated with each 
other and their roles are not yet clearly defined. We obtained cluster scores by summing 
z-scores of the titers because we were interested in evaluating the relative (rather than 
absolute) contributions of the titers to the overall score.  
Both the total study participants (Table 5.4) as well as only dentate (Table 5.5), 
the Orange-Red cluster (associated with periodontal disease) include antibody titers 
against P.gingivalis and Prevotella sps and increased the odds while the elevated serum 
IgG antibody against Orange-Blue cluster score that included E. nodadum and A. 
naeslundii antibody lowered the odds of having elevated plasma glucose. This 
relationship was more distinct when elevated plasma level cut point was >110 mg/dl 
which will include only diabetes population.  P.gingivalis and Prevotella sps have been 
consistently associated not only with periodontal disease status but also different 
systemic diseases such as CVD, diabetes or arthritis. A. naeslundii has been consistently 
related to healthy periodontal and systemic states (Socransky and Haffajee 2002, 
Desvarieux et al. 2013). One study has reported higher microbial count of E. nodatum 
associated with periodontitis lesions (Haffajee, Teles, and Socransky 2006) but the 
antibody titers against E. nodatum were associated with periodontal health (Dye et al. 
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2009).  No prior studies used cluster methodology to study the relationship in past 
literatures; hence we could not compare our study findings with other studies. Clinically, 
periodontitis is diagnosed only for the dentate individuals. However, serum antibody 
titers against the periodontal bacteria may reflect current or past exposures to periodontal 
bacteria, hence measures the cumulative life time exposures. Excluding edentulous 
individuals did not alter the results (Table 5.5). There was no significant finding when the 
association was observed using three groups (Etiologic, putative and Health) (Table 5.6). 
Prior studies reported an association of periodontal disease independently with 
MetS (Nibali et al. 2013) and their individual components including hypertension 
(Desvarieux et al. 2010), hyperlipidemia (Moeintaghavi et al. 2005)and central 
obesity(Kim, Jin, and Bae 2011). Periodontal disease in these studies was assessed by 
clinical measures index (such as clinical attachment loss or pocket depth).  In the current 
study, upon full adjustment for potential confounders, no association was seen with 
serological markers of periodontal bacteria with MetS and any of other MetS (Table 5.4 
and 5.5). However, Pussinen et al., (2003) (Pussinen et al. 2003) reported the 
combination of serum IgG antibodies against P. gingivalis and A. actinomycetemcomitans 
had inverse association with serum HDL concentration.  
This present study has some drawbacks. First, the cross-sectional design does not 
explain when the serum IgG antibody titer response evolved.  Second is the possibility of 
unmeasured confounding factors because oral health behaviors were not evaluated. Third, 
this study evaluates 19 antibodies against periodontal microbiota; hence additional 
pathogens could modify the overall relationship. Research finding has shown that 
presence of high virulence strain of P. gingivalis may affect CHD (Yamazaki et al. 2007), 
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so use of serum antibody titers against P. gingivalis mixture and A. 
actinomycetemcomitans mixture could underestimate our analysis. Fourth, although 
highly sensitive C-reactive protein (Hs-CRP) is an indicator of systemic inflammation, 
we did not adjust for it or clinically defined periodontitis because they may be on the 
causal pathway and would create bias (Cole and Hernan 2002).  
The strengths of this study were first, this was a large, representative, population 
based sample, with careful measurement of potential confounders, reducing the 
likelihood of false negative or spurious results. To our knowledge, this is the largest study 
to evaluate the relation between titers against oral microorganisms and MetS and its 
individual components. Second, we adjusted for a number of potential confounders. 
Third, serum IgG antibody titers measure persistent periodontal infection and/ or 
recurrence, (Papapanou et al. 2004, Rams, Listgarten, and Slots 2006); these serum IgG 
measures are a therefore a measure of cumulative life exposure to periodontal diseases. 
Fourth, cluster analysis resulted in reduced data and mutually exclusive groups, 
minimizing the chance of spurious results from multiple testing. Fifth, in the 
multivariable models we evaluated the clusters together. This approach mimics the 
biological processes that take place in the mouth because oral microorganisms are 
ubiquitous, and changes in microbial composition occur relative to other organisms in the 
mouth. Thus, the relative composition oral microorganisms may tilt the balance between 
health and disease (Socransky and Haffajee 2002, Oppermann, Weidlich, and Musskopf 
2012). Sixth, empirical clustering of serum IgG reduces the influence of individual 
antibody titers, making it a more stable measure of cumulative exposure to periodontal 
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pathogens, and possibly advantageous in the study the periodontal-systemic disease 
relations.  
In summary, we found that antibodies against periodontal microorganisms were 
moderately associated with elevated plasma glucose but not with MetS or its other 
components. These findings together with emerging evidence that gut microbiota are 
correlated with MetS traits (Zupancic et al. 2012), are motivation for the conduct of  
sophisticated  longitudinal studies with clinical, microbiological and immunological data 
to increase our understanding the relation between microorganisms in the mouth and gut 
and the metabolic state. This may lead to new approaches to address these conditions.   
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Table 5.1: Profile characteristics of metabolic syndrome components in lower vs upper tertiles of four cluster scores  
Variables an Orange-Red Red-Green Yellow-Orange Orange-Blue 
 
 Tertile1 Tertile3 Tertile1 Tertile3 Tertile1 Tertile3 Tertile1 Tertile3 
Sex (%) 
Male 3677 40.1 50.3 41.3 49.8 42.9 47.0 45.9 46.7 
Female 4171 59.9 49.7 58.7 50.2 57.1 52.4 54.1 53.3 
Education (%) 
≤ 6 years 1403 5.5 9.2 5.7 7.3 7.0 7.1 7.9 5.1 
7 – 12 years 4344 57.2 52.1 58.5 50.5 58.6 52.0 58.7 49.3 
≥ 13 years 2046 37.3 38.7 35.8 42.3 34.4 40.9 33.4 45.6 
bIncome to poverty ratio  
Lower (≤1.5) 2387 18.5 20.6 
 
19.3 
 
17.7 
 
22.4 18.4 
 
22.8 15.0 
Middle (≤3.0) 2214 28.8 28.8 30.6 30.4 28.8 30.8 33.0 27.2 
High (>3.0) 2496 52.7 50.6 50.1 51.9 48.8 50.8 44.1 57.8 
Race/ethnicity (%) 
Non-Hispanic Whites 4012 
 
87.6 71.9 
 
85.8 
 
76.2 
 
84.0 76.7 
 
80.4 
 
82.6 
Non-Hispanic Blacks 1817 5.6 13.4 6.8 10.8 7.4 11.2 9.8 8.3 
Mexican Americans 1699 2.2 4.9 2.8 4.1 2.9 3.8 3.1 3.6 
Other 320 4.6 9.8 4.6 8.9 5.7 8.3 6.7 5.5 
Cigarette Smoker (%) 
Never smoker 
 
3562 
 
39.5 
 
46.3 
 
37.5 
 
45.9 
 
38.7 
 
45.7 
 
38.6 
 
46.5 
Past smoker 2521 33.2 35.5 34.2 36.7 33.3 35.3 32.7 35.4 
Current Smoker 1765 27.3 18.2 28.3 17.4 28.0 19.0 28.7 18.1 
Alcohol (%) 
Never drinker 1480 
 
15.6 15.7 
 
14.7 16.1 
 
15.2 16.2 
 
17.2 13.6 
Past drinker 3185 38.3 37.4 38.5 38.9 38.7 37.6 39.6 38.3 
Current drinker 3031 46.1 46.9 46.7 45.0 46.1 46.2 43.2 48.1 
Dentist visit once in year 
(%) 
 
3010 
 
51.7 
 
52.0 
 
49.4 
 
52.2 
 
48.1 
 
54.6 
 
47.9 
 
55.3 
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Yes 
No 4588 48.2 8.1 50.6 47.8 51.9 45.4 52.0 44.7 
Physical Activity (%) 
Sedentary 3550 
 
53.6 51.7 54.4 50.3 
 
51.6 50.5 
 
51.3 54.5 
Active 927 12.3 11.4 11.1 12.3 12.0 11.8 12.1 12.4 
Vigorously active 500 6.8 7.8 7.2 7.8 7.6 8.2 6.8 8.1 
cCentral Obesity (%) 
Normal 3602 
 
50.1 
 
49.4 50.5 49.4 
 
51.9 51.2 
 
50.9 52.0 
Elevated 3904 49.9 50.6 49.5 50.6 48.2 48.8 49.1 48.0 
High density lipoproteins 
(%) 
Normal 4820 61.1 61.0 61.9 60.3 62.4 60.9 59.6 61.9 
Lower 3028 38.9 39.0 38.0 39.7 37.6 39.1 40.4 38.1 
Triglycerides (%) 
Normal 4911 61.9 65.2 62.6 62.5 62.7 63.8 61.3 64.0 
High 2937 38.1 34.8 37.1 37.5 37.3 36.2 38.7 36.0 
Hypertension (%) 
Yes 4552 50.1 54.1 50.2 53.6 51.3 51.7 53.7 53.0 
No 3035 49.9 45.9 49.8 46.4 48.7 48.3 46.3 47.0 
Insulin Resistance (%) 
Yes 1466 12.6 15.5 13.8 13.5 15.2 14.1 16.3 12.6 
No 6382 87.4 84.5 86.2 86.4 84.8 85.9 83.7 87.4 
Metabolic Syndrome (%) 
Yes 2800 32.1 33.3 31.3 34.6 31.2 33.7 33.1 31.3 
No 5048 67.9 66.7 68.7 65.4 68.8 66.3 66.9 68.7 
Diabetes Status (%) 
Diabetes 1090 
 
8.1 11.2 9.2 9.8 
 
10.4 10.5 
 
11.1 8.6 
Pre-diabetes 3334 35.9 38.5 37.1 37.6 38.1 36.2 39.9 35.1 
Normal 3424 56.1 50.3 53.7 52.6 51.5 53.3 49.0 56.4 
 Mean ± SD 
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AGE (years)  56.9±0.
5 
56.6±0.
6 56.8±0.5 
56.5±0.
6 
57.8±0.
6 
56.2±0.
6 
58.4±0.
6 
57.1±0.
1 
BMI (kg/m2)  26.9±0.
2 
27.8±0.
2 27.9±0.2 
27.7±0.
2 
26.9±0.
2 
27.5±0.
2 
26.9±0.
2 
27.3±0.
2 
Waist Circumference 
(cm) 
 94.7±0.
3 
96.6±0.
5 
95.1±0.0
3 
96.4±0.
4 
94.9±0.
4 
95.7±0.
4 
95.4±0.
3 
95.8±0.
4 
High density lipoprotein 
(mg/dl) 
 51.1±0.
6 
51.2±0.
6 51.5±0.6 
50.7±0.
6 
51.7±0.
6 
50.8±0.
6 
50.5±0.
5 
50.9±0.
5 
Systolic Blood Pressure 
(mmHg) 
 128.9±0
.5 
129.9±0
.6 
128.7±0.
6 
129.6±0
.6 
129.5±0
.6 
129.1±0
.7 
130.3±0
.7 
127.6±0
.4 
Diastolic Blood Pressure 
(mmHg) 
 75.5±0.
3 
77.3±0.
3 75.7±0.3 
76.8±0.
4 
75.3±0.
3 
76.6±0.
3 
75.9±1.
1 
76.4±0.
3 
Triglycerides (mg/dl)  155.6±2
.9 
145.6±3
.4 
152.6±2.
3 
151.9±3
.1 
152.2±2
.2 
149.0±2
.9 
155.3±2
.6 
150.2±0
.5 
HbA1c(%)  5.5±0.0 5.6±0.0 5.5±0.03 5.5±0.0 5.6±0.0 5.6±0.0 5.6±0.0 5.6±0.0 
Fasting plasma 
Glucose(mg/dl) 
 99.8±0.
6 
103.5±1
.1 
101.7±0.
8 
101.8±0
.9 
102.7±0
.9 
102.1±1
.1 
103.9±1
.1 
101.3±0
.9 
Fiber Intake (g/day)  16.1±0.
3 
17.0±0.
3 15.8±0.3 
17.3±0.
3 
16.0±0.
3 
16.9±0.
2 
16.3±0.
3 
16.5±0.
3 
a Total numbers may be different due to missing data 
bIncome-to-poverty ratio: (midpoint family income)/(poverty threshold values based on calendar years and inflation) 
cCentral adiposity present if waist for male subjects ≥101.6 cm and for female subjects ≥88.9 cm 
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Table 5.2: Correlation between the four Z cluster scores 
 Orange-
Red 
Red-
Green 
Yellow-
Orange 
Orange-Blue 
Orange-Red - 0.64** 0.68** 0.34** 
Red-Green 0.64** - 0.91** 0.49** 
Yellow-
Orange 
0.68** 0.91** - 0.50** 
Orange-Blue 0.34** 0.49** 0.50** - 
**P Value = <.0001 
Orange-Red: P melaninogenica, P intermedia, P nigrescens, P gingivalis 
Red-Green: T forsythia, T denticola, A actinomycetemcomitans, E corrodens, S noxia, V parvula, C 
rectus 
Yellow-Orange: S intermedius, S oralis, S mutans, F nucleatum, M micros, C ochracea  
Orange-Blue: E nodatum, A naeslundii 
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Table 5.3: Mean (Standard Error of Mean) values of serum IgG z-scores of four cluster scores 
 Orange-Red Red-Green Yellow-Orange Orange-Blue 
Hypertension  
Yes (4696) -0.25 (0.1) 0.03 (0.4) 0.03 (0.2) 0.05 (0.1) 
No (3128) -0.40  (0.1) -0.16 (0.4) -0.03  (0.2) 0.25 (0.1) 
P value 0.09 0.32 0.70 0.001 
Hypertriglyceridemia 
Yes (2973) -0.40 (0.1) -0.17 (0.4) -0.12 (0.3) 0.09 (0.1) 
No (4911) -0.28 (0.1) -0.004  (0.3) 0.07  (0.2) 0.18 (0.1) 
P value 0.32 0.43 0.28 0.14 
Low HDL- cholesterol 
Yes (2934) -0.34 (0.1) -0.09 (0.4) 0.01 (0.3) 0.12 (0.1) 
No (4820) -0.30 (0.1) -0.06 (0.4) -0.02 (0.2) 0.17 (0.1) 
P value 0.74 0.90 0.90 0.42 
Central Adiposity  
Yes (3904) -0.31 (0.1) -0.06 (0.4) 0.01 (0.2) 0.13 (0.1) 
No (3602) -0.31 (0.1) -0.02 (0.3) 0.04 (0.2) 0.17 (0.1) 
P value 0.99 0.83 0.86 0.46 
Elevated plasma glucose  
Yes (2988) -0.08 (0.1) 0.02(0.4) 0.04 (0.2) 0.07 (0.1) 
No (4845) -0.40 (0.1) -0.1(0.3) -0.01 (0.2) 0.19 (0.1) 
P value 0.0007 0.41 0.64 0.02 
Metabolic Syndrome      
Yes(2867) -0.21 (0.1) 0.07 (0.4) 0.09 (0.2) 0.10 (0.1) 
No (3829) -0.40 (0.1) -0.14 (0.3) -0.05 (0.2) 0.18 (0.1) 
P value 0.04 0.25 0.34 0.17 
#Adult Treatment Panel (ATP) III-Criteria 
#Elevated Fasting  plasma glucose (>110 mg/dl) 
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Yes (1466) -0.17 (0.1) -0.3 (0.4) -0.17 (0.2) -0.09 (0.1) 
No (6367) -0.35 (0.1) -0.03(0.3) 0.03 (0.2) 0.19 (0.1) 
P value 0.2146 0.2504 0.2727 0.0002 
#Metabolic  syndrome 
Yes (3277) -0.25 (0.1) 0.1 (0.4) 0.13 (0.3) 0.10 (0.1) 
No (4571) -0.36 (0.1) -0.15 (0.3) -0.06 (0.2)  0.17 (0.1) 
P value 0.26 0.25 0.31 0.22 
Orange-Red: P melaninogenica, P intermedia, P nigrescens, P gingivalis 
Red-Green: T forsythia, T denticola, A actinomycetemcomitans, E corrodens, S noxia, V parvula, C rectus 
Yellow-Orange: S intermedius, S oralis, S mutans, F nucleatum, M micros, C ochracea  
Orange-Blue: E nodatum, A naeslundii 
# Defined as per ATP III criteria 
 150 
Table 5.4: Odds Ratio (95% CI) between four cluster scores in relation to metabolic syndrome and its individual components 
 Orange-Red Red-Green Yellow- Orange Orange-Blue 
Hypertension 
Model1 1.02  (1.001-1.05)* 1.03 (0.99-1.06) 0.98 (0.95-1.01) 0.91  (0.87-0.95)* 
Model2 1.02 (0.99-1.04) 1.01 (0.98-1.04) 0.99 (0.96-1.04) 0.95 (0.92-1.00) 
Model3 1.01 (0.97-1.05) 1.02 (0.98-1.05) 0.99 (0.95-1.03) 0.96 (0.91-1.01) 
Model4 1.01 (0.97-1.05) 1.02 (0.98-1.06) 0.99 (0.95-1.03) 0.96 (0.92-1.02) 
Hypertriglyceridemia 
Model1 0.99 (0.97-1.02) 1.01 (0.98-1.04) 0.99 (0.96-1.02) 0.97 (0.93-1.03) 
Model2 0.98 (0.95-1.01) 1.0   (0.97-1.03) 1.003 (0.97-1.03) 0.99 (0.94-1.04) 
Model3 0.98 (0.94-1.02) 1.002 (0.96-1.04) 1.01 (0.96-1.05) 0.99 (0.92-1.05) 
Model4 0.97 (0.94-1.01) 1.01 (0.97-1.05) 1.004 (0.96-1.05) 0.99 (0.92-1.06) 
Low HDL-Cholesterol 
Model1 0.99 (0.97-1.01) 0.99 (0.96-1.03) 1.02 (0.98-1.06) 0.98 (0.94-1.03) 
Model2 0.99 (0.97-1.01) 0.99 (0.96-1.03) 1.02 (0.98-1.06) 0.98 (0.93-1.02) 
Model3 0.98 (0.95-1.01) 0.99 (0.96-1.04) 1.01 (0.97-1.06) 0.99 (0.94-1.06) 
Model4 0.98 (0.95-1.01) 1.002 (0.96-1.04) 1.01 (0.97-1.06) 0.99 (0.94-1.06) 
Central Obesity 
Model1 1.003 (0.97-1.04) 1.00 (0.98-1.03) 1.00 (0.97-1.04) 0.98 (0.94-1.03) 
Model2 1.02 (0.99-1.05) 0.99 (0.97-1.02) 0.99 (0.96-1.04) 0.99 (0.96-1.04) 
Model3 1.01 (0.96-1.07) 1.0 (0.95-1.05) 1.02 (0.95-1.08) 0.95 (0.88-1.03) 
Model4 1.01 (0.96-1.06) 0.99 (0.94-1.05) 1.02 (0.95-1.09) 0.95 (0.88-1.03) 
Elevated Plasma Glucose 
Model1 1.07  (1.03-1.1)* 1.01 (0.98-1.04) 0.97 (0.94-1.001) 0.94  (0.89-0.98)* 
Model2 1.06 (1.02-1.1)* 0.99 (0.97-1.03) 0.99 (0.96-1.02) 0.97  (0.927-1.02) 
Model3 1.06  (1.02-1.1)* 0.99 (0.96-1.03) 0.99 (0.96-1.03) 0.98  (0.93-1.03) 
Metabolic Syndrome  
Model1 1.02 (1.002-1.04)* 1.01 (0.99-1.04) 0.99 (0.96-1.02) 0.96 (0.92-0.99)* 
 151 
Model2 1.02 (0.99-1.04) 1.0 (0.97-1.03) 1.00 (0.97-1.04) 0.99 (0.95-1.03) 
Model3 1.02 (0.99-1.04) 1.003 (0.97-1.04) 0.99 (0.96-1.04) 0.99 (0.94-1.05) 
#Adult Treatment Panel (ATP) III-Criteria 
Elevated Plasma Glucose 
Model1 1.05  (1.01-1.10)* 0.99 (0.96-1.04) 0.99 (0.94-1.04) 0.91  (0.87-0.95)* 
Model2 1.04 (0.99-1.10) 0.98 (0.95-1.02) 1.01 (0.96-1.06) 0.94  (0.89-0.98)* 
Model3 1.07  (1.02-1.12)* 0.98 (0.94-1.02) 1.02 (0.97-1.07) 0.93  (0.88-0.98)* 
Metabolic 
Syndrome 
    
Model1 1.004 (0.99-1.02) 1.01 (0.99-1.04) 1.001 (0.97-1.04) 0.95 (0.91-0.99)* 
Model2 1.001 (0.98-1.02) 1.001 (0.97-1.03) 1.01 (0.97-1.05) 0.98 (0.94-1.03) 
Model3 0.99 (0.96-1.02) 1.002 (0.97-1.03) 1.02 (0.97-1.07) 0.98 (0.92-1.04) 
Model1 with no adjustment for confounders;  
Model2 adjusted for age (continuous) and sex;  
Model3 adjusted further for education, ethnicity, income-to-poverty, smoking, drinking alcohol,  
physical activity, BMI (continuous), waist circumference [WC], and dentist visit;  
Model4 further for diabetes 
* P Value <0.05 
Orange-Red: P melaninogenica, P intermedia, P nigrescens, P gingivalis 
Red-Green: T forsythia, T denticola, A actinomycetemcomitans, E corrodens, S noxia, V parvula, C rectus 
Yellow-Orange: S intermedius, S oralis, S mutans, F nucleatum, M micros, C ochracea  
Orange-Blue: E nodatum, A naeslundii 
# Defined as per ATP III criteria 
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Table 5.5: Odds Ratio (95% CI) between four cluster scores in relation to metabolic syndrome and its individual components 
among the dentate participants (N=3716) 
 
 Orange-Red Red-Green Yellow- Orange Orange-Blue 
Hypertension      
Model1 1.01  (0.97-1.05) 1.02 (0.98-1.06) 0.98 (0.93-1.02) 0.92  (0.87-0.98)* 
Model2 0.99 (0.96-1.04) 1.01 (0.97-1.05) 0.99 (0.95-1.04) 0.98 (0.92-1.04) 
Model3 0.99 (0.95-1.04) 1.01 (0.97-1.05) 0.99 (0.94-1.06) 0.98 (0.91-1.05) 
Model4 0.99 (0.94-1.04) 1.01 (0.97-1.05) 0.99 (0.94-1.06) 0.98 (0.91-1.05) 
Hypertriglyceridemia      
Model1  1.003 (0.97-1.04) 1.02 (0.98-1.06) 0.97 (0.93-1.01) 0.96 (0.90-1.04) 
Model2 0.99 (0.96-1.03) 1.01  (0.97-1.05) 0.98 (0.95-1.02) 0.98 (0.91-1.06) 
Model3 1.002 (0.96-1.05) 1.01 (0.97-1.06) 0.99 (0.94-1.03) 0.96 (0.89-1.05) 
Model4 0.99 (0.95-1.04) 1.02 (0.97-1.06) 0.98 (0.94-1.03) 0.97 (0.89-1.05) 
Low HDL-Cholesterol 
Model1 0.99 (0.96-1.02) 1.001 (0.96-1.05) 1.01 (0.96-1.06) 0.97 (0.91-1.04) 
Model2 0.99 (0.96-1.02) 1.001 (0.96-1.05) 1.01 (0.96-1.06) 0.97 (0.91-1.04) 
Model3 0.98 (0.95-1.01) 0.99 (0.95-1.04) 1.03 (0.97-1.09) 0.98 (0.91-1.06) 
Model4 0.97 (0.94-1.01) 0.99 (0.95-1.04) 1.03 (0.97-1.09) 0.98 (0.91-1.07) 
Central Obesity     
Model1   1.01 (0.97-1.05) 1.01(0.97-1.04) 0.98(0.94-1.03) 1.01 (0.95-1.07) 
Model2   1.02 (0.98-1.06) 1.01 (0.97-1.05) 0.98 (0.93-1.02) 1.04 (0.98-1.10) 
Model3   1.03 (0.95-1.11) 1.02 (0.95-1.08) 0.98 (0.90-1.07) 0.96 (0.87-1.06) 
Model4   1.03 (0.95-1.11) 1.01 (0.95-1.08) 0.98 (0.90-1.07) 0.96 (0.87-1.06) 
Elevated Plasma Glucose 
Model1    1.07  (1.03-1.11)* 1.03 (0.97-1.09) 0.95 (0.89-1.01) 0.97  (0.91-1.02) 
Model2    1.06 (1.02-1.11) 1.02 (0.96-1.08) 0.96 (0.90-1.03) 1.01  (0.95-1.07) 
Model3    1.06  (1.02-1.11)* 1.002 (0.95-1.06) 0.98 (0.92-1.05) 1.01  (0.95-1.08) 
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Metabolic Syndrome 
Model1    1.02 (0.99-1.06) 1.03 (0.99-1.07) 0.96 (0.91-1.01) 0.99 (0.93-1.05) 
Model2    1.02 (0.99-1.05) 1.02 (0.98-1.06) 0.97 (0.92-1.02) 1.03 (0.97-1.10) 
Model3    1.04 (1.001-1.09) 1.02 (0.98-1.06) 0.96 (0.91-1.01) 1.03 (0.96-1.11) 
#Adult Treatment Panel (ATP) III-Criteria 
#Elevated Plasma Glucose 
Model1    1.06  (1.01-1.11)* 1.03 (0.96-1.10) 0.95 (0.89-1.01) 0.92  (0.88-0.97)* 
Model2    1.06 (0.99-1.12) 1.01 (0.95-1.08) 0.96 (0.91-1.03) 0.96  (0.92-1.02) 
Model3    1.07  (1.02-1.13)* 0.99 (0.94-1.05) 0.98 (0.93-1.04) 0.96  (0.89-1.03) 
#Metabolic 
Syndrome 
    
Model1     1.002 (0.97-1.03) 1.02 (0.98-1.06) 0.98 (0.92-1.03) 0.98 (0.92-1.05)* 
Model2     1.0 (0.97-1.03) 1.01 (0.97-1.06) 0.98 (0.93-1.04) 1.02 (0.96-1.09) 
Model3     1.01 (0.97-1.05) 1.002 (0.96-1.05) 0.99 (0.94-1.05) 1.01 (0.93-1.09) 
Model1 with no adjustment for confounders;  
Model2 adjusted for age (continuous) and sex;  
Model3 adjusted further for education, ethnicity, income-to-poverty, smoking, drinking alcohol,  
physical activity, BMI (continuous), waist circumference [WC], and dentist visit;  
Model4 further for diabetes 
* P Value <0.05 
Orange-Red: P melaninogenica, P intermedia, P nigrescens, P gingivalis 
Red-Green: T forsythia, T denticola, A actinomycetemcomitans, E corrodens, S noxia, V parvula, C rectus 
Yellow-Orange: S intermedius, S oralis, S mutans, F nucleatum, M micros, C ochracea  
Orange-Blue: E nodatum, A naeslundii 
# Defined as per ATP III criteria 
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Table 5.6: Odds Ratio (95% CI) between three groups of z-scores in relation to metabolic syndrome and its individual 
components  
 
 
  Etiology Putative Health 
Hypertension       
Model1 1.03  (0.99-1.07) 1.00 (0.96-1.04) 0.95  (0.88-1.01) 
Model2 1.04 (0.99-1.04) 0.99 (0.95-1.04) 0.97 (0.90-1.04) 
Model3 1.02 (0.96-1.08) 1.00 (0.95-1.05) 0.98 (0.91-1.07) 
Model4 1.02 (0.96-1.08) 1.00 (0.95-1.05) 0.99 (0.91-1.07) 
Hypertriglyceridemia       
Model1 1.00 (0.96-1.05) 0.99 (0.97-1.02) 0.97 (0.91-1.05) 
Model2 1.01 (0.96-1.05) 0.99 (0.96-1.02) 0.98 (0.91-1.06) 
Model3 1.01 (0.96-1.05) 0.99 (0.96-1.03) 0.99 (0.90-1.08) 
Model4 1.00 (0.96-1.05) 0.99 (0.96-1.03) 0.99 (0.90-1.09) 
Low HDL-Cholesterol       
Model1 0.99 (0.94-1.03) 1.03 (1.00-1.07) 0.94 (0.88-1.00) 
Model2 0.99 (0.94-1.03) 1.03 (1.00-1.07) 0.94 (0.88-1.00) 
Model3 0.97 (0.92-1.02) 1.04 (1.00-1.08) 0.97 (0.90-1.04) 
Model4 0.97 (0.92-1.02) 1.04 (1.00-1.08) 0.97 (0.90-1.05) 
Central Obesity       
Model1 1.00 (0.96-1.04) 1.01 (0.98-1.04) 0.97 (0.91-1.04) 
Model2 1.00 (0.96-1.04) 1.01 (0.98-1.05) 0.97 (0.92-1.03) 
Model3 0.93 (0.86-0.99) 1.08 (1.02-1.15) 0.94 (0.86-1.03) 
Model4 0.92 (0.86-0.99) 1.08 (1.02-1.15) 0.95 (0.86-1.04) 
Elevated Plasma Glucose       
Model1 1.03  (0.99-1.07) 1.00 (0.97-1.03) 0.94  (0.88-1.01) 
Model2 1.03 (0.99-1.07) 0.99 (0.97-1.02) 0.96  (0.89-1.03) 
Model3 1.03  (0.99-1.08)* 0.99 (0.96-1.03) 0.98  (0.91-1.07) 
Metabolic Syndrome        
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Model1 1.02 (0.98-1.06) 1.01 (0.98-1.03) 0.96 (0.90-1.01) 
Model2 1.02 (0.99-1.06) 1.00 (0.97-1.03) 0.97 (0.91-1.03) 
Model3 1.01(0.96-1.06) 1.01 (0.97-1.04) 0.99 (0.92-1.06) 
ATP  III Criteria       
Elevated Plasma Glucose       
Model1 1.02  (0.96-1.08) 1.02 (0.97-1.06) 0.89  (0.84-0.95) 
Model2 1.02 (0.96-1.09) 1.01 (0.97-1.05) 0.90  (0.84-0.97) 
Model3 1.00  (0.94-1.07) 1.02 (0.97-1.07) 0.94  (0.87-1.02) 
Metabolic Syndrome       
Model1 1.01(0.97-1.05) 1.01 (0.98-1.05) 0.96 (0.91-1.02) 
Model2 1.01(0.97-1.05) 1.01 (0.98-1.05) 0.97 (0.92-1.03) 
Model3 0.98(0.94-1.03) 1.03 (0.98-1.07) 1.00 (0.92-1.08) 
Model1 with no adjustment for confounders;  
Model2 adjusted for age (continuous) and sex;  
Model3 adjusted further for education, ethnicity, income-to-poverty, smoking, drinking alcohol,  
physical activity, BMI (continuous), waist circumference [WC], and dentist visit;  
Model4 further for diabetes 
* P Value <0.05 
Orange-Red: P melaninogenica, P intermedia, P nigrescens, P gingivalis 
Red-Green: T forsythia, T denticola, A actinomycetemcomitans, E corrodens, S noxia, V parvula, C rectus 
Yellow-Orange: S intermedius, S oralis, S mutans, F nucleatum, M micros, C ochracea  
Orange-Blue: E nodatum, A naeslundii 
# Defined as per ATP III criteria    
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CHAPTER 6 
DISSERTATION SUMMARY 
Periodontal disease, a polybacterial infection, is associated with different systemic 
diseases including hyperglycemia and cardiovascular risk factors. From the literature, 
there is emerging evidence that effect of periodontal infection on cardiovascular 
outcomes depends upon the type of bacteria predominating the infection(Desvarieux et al. 
2013, Desvarieux et al. 2010, Desvarieux et al. 2005, Ebersole et al. 2008, Kebschull, 
Demmer, and Papapanou 2010, Lockhart et al. 2012), but this has not been evaluated for 
type 2 diabetes thoroughly.  However, the microbiological evidence supports that 
periodontal bacteria or their antibodies are associated with diabetes(Casarin et al. 2013, 
Field et al. 2012, Ohlrich, Cullinan, and Leichter 2010, Vlachojannis et al. 2010, Yuan et 
al. 2001, Zhou et al. 2013).  
There are several questions but a dearth of knowledge in the area of periodontal 
research in relation to the systemic outcomes.  Through our dissertation research 
questions, we have tried to find some answer for some of gaps that existed in the 
periodontal research with a systemic association such 
1. How will we characterize the polybacterial infection or the antibody response of the poly 
bacterial challenges through the biofilm? 
2. What is the extent of association of the elevated antibody titers that formed due to 
specific periodontal bacteria with respect to T2DM, pre-diabetes and Mets and each of its 
individual components?
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3. Does periodontal destruction modify the association of host response against the 
periodontal bacteria and diabetes? 
We characterized the antibody response of the polybacterial challenges by using 
both the data derived clustering approach and the theoretical grouping approach. From 
the empirical approach, we found that the predominance of the elevated serum IgG 
Orange-Red cluster that included P gingivalis and Prevotella sps was associated with 
higher diabetes prevalence whereas elevated Orange-Blue clusters that included the E. 
nodatum and A neslundii antibodies lowered the odds of having type 2 diabetes , while 
predominance of the elevated Red-Green cluster that included A. actinomycetemcomitans 
mix, S. noxia, E. corrodens, V. parvula, T. forsythia, T. denticola, C. rectus antibodies 
was slightly associated with lower odds of having diabetes. Yellow-orange cluster which 
consist majority of Streptococcus sps antibodies were not associated with diabetes or pre-
diabetes. From the theoretical grouping approach, we found the elevated etiologic group 
that consists P gingivalis, A. actinomycetemcomitans mix, T. forsythia, and T. denticola, 
to be mainly associated with pre-diabetes condition while the putative or Health related 
groups were not associated with diabetes, pre-diabetes , MetS or any of its individual 
components.  
Mainly our study finding shows that serological markers of periodontal bacteria 
are related to diabetes prevalence and monitoring the type of periodontal bacteria 
antibodies in the serum may be important in finding the individuals with high risk of 
diabetes and pre-diabetes. Combination of clinical periodontal destruction measures and 
serological markers can provide more information on the hyperglycemia condition.  
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Strengths and Limitations 
There were several strengths in this study. First, plasma IgG antibodies against the 
periodontal pathogen of A Actinomycetecomitans and P. gingivalis have been found to be 
stable for 15 years  (Lakio et al. 2009).  IgG antibodies against periodontal pathogen 
therefore represent the cumulative lifetime infection of periodontal disease and host 
response towards it. Second, we had enough power, sample size and data on serum 
antibodies of 19 different periodontal bacteria to analyze on the immune -inflammatory 
response to these periodontal bacteria in relation to diabetes, pre-diabetes as well as other 
key markers of cardiovascular risk factors adjusting for known confounders. Third, large 
sample size and clustering of serum IgG markers reduced the chances of type 1 error and 
gave confidence in the interpretation of the findings. We believe that this study will 
provide a perspective to understand the magnitude of host immune response to different 
periodontal bacteria in different clinical biomarkers of inflammatory diseases. 
However, our study also has some drawbacks. First, it should be noted that our 
study being a cross sectional study cannot identify temporality or causality.  Studies 
evaluating the accuracy of the dental examination in NHANES III and NHANES (2001-
2004) showed that periodontitis prevalence was underestimated in of  in those surveys 
because of the  examination protocol and periodontal disease definitions that were used 
which may impact validity in surveillance and researches (Eke et al. 2010). Third, our 
study dataset includes information from 1988 -1994, the smoking habits, nutritional 
behaviors, diabetes awareness might have changed amply since then, hence the external 
validity of the findings should be assessed with more current information (Dye, Morin, 
and Robison 2006, Dye et al. 2007, Morin, Dye, and Hooper 2005). Fourth, there were 
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many missing data (about 25%) for the CAL and pocket depth which might have 
underestimated the estimation of interaction between the clusters and clinical periodontal 
measures with diabetes.  Fifth, the periodontal examination was done not done on the full 
mouth in NHANES III survey which might have also under estimated the prevalence of 
periodontitis in the US population(Papapanou 2012). 
Clinical Implication of our study and Recommendation to the clinicians 
Our findings have a strong implication for clinical management of high risk 
population for diabetes and periodontal disease. Elevated serum antibody titers of 
selective periodontal bacteria (such as P. gingivalis and Prevotella sps.) could increase 
the odds of having diabetes. The presence of elevated titers of Orange-Blue cluster could 
significantly reduce the odds of having diabetes even in the presence of higher pocket 
depth destruction. This suggests that combination of serological markers and clinical 
periodontal measures may be useful to predict the hyperglycemia condition.  Dental visits 
combined with the test of selected serological markers such as P gingivalis, Prevotella 
species, E nodatum and A neslundii may be used to screen the high risk individuals for 
the diabetes or pre-diabetes.   
Recommendation to the public health professions 
In recent years, the prevalence of chronic diseases such as type 2 diabetes, 
obesity, hypertension, lipidemia, MetS are in increasing. Oral health can be important 
lifestyle modulator that is associated with diabetes risk and can also be used to predict the 
risk of systemic health of an individual. More research is necessary to understand the 
biological pathways for the association of periodontal disease with different chronic 
systemic outcomes. Several evidences support that oral infection that is often hidden and 
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neglected and could be one of seeds of infection that can ultimately lead to systemic 
inflammation which is the key of several chronic systemic diseases including 
hyperglycemia. Hence, we recommend that Oral health is a priority in the research and 
policy of overall public health. 
 Current work and suggestions for future research  
  All of the aims encompassed by my dissertation relate to US participants. This is 
the first attempt to cluster the antibody titers against periodontal bacteria and explore 
these clusters in relation to systemic outcomes. We found the specific serological markers 
are associated with a protective role or potential risk of systemic diseases while some are 
unrelated. We would like emphasize that further research with new sophisticated 
molecular technology, epidemiological methods and clinical periodontal examination in 
the recent population are needed to validate our findings in different population.  
Recent reports of gut microbiota being associated with diabetes, MetS and other 
systemic conditions such as obesity strengthens the possibility of linkage of periodontal 
bacteria (Zupancic et al. 2012) and underscores the need of further research to identify 
the systemic pathways. Future research could explore the correlation of the gut 
microbiota with periodontal microbiota. Further exploration of the inter-relationship with 
the systemic outcomes could characterize the microbiota role in systemic health.  
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APPENDIX A – PERIODONTAL CLINICAL MEASURES AND FOUR CLUSTERS 
 
Table A.1: Association of the z-scores of serum antibody clusters with diabetes stratified 
by the periodontal status 
 
Serum Antibody  
z-scores Clusters 
Odds Ratio (95% Confidence Interval) 
Periodontal status 
Model*  Yes  No  
Red-Green   
Model1 1.03 (0.95, 1.11) 1.02 (0.93, 1.11) 
Model2 1.00 (0.92, 1.09) 1.03 (0.93, 1.13) 
Model3 1.01 (0.92, 1.10) 1.00 (0.92, 1.09) 
Model4 0.99 (0.87, 1.12) 1.00 (0.92, 1.10) 
Orange-Red   
Model1 1.14 (1.05, 1.25) 1.12 (1.03, 1.22) 
Model2 1.09 (1.00, 1.20) 1.01 (0.92, 1.12) 
Model3 1.10 (1.00, 1.21) 1.01 (0.90, 1.14) 
Model4 1.14 (1.02, 1.27) 0.91 (0.81, 1.12) 
Yellow-Orange   
Model1 0.96 (0.86, 1.06) 0.95 (0.86, 1.06) 
Model2 1.00 (0.90, 1.11) 0.98 (0.88, 1.08) 
Model3 0.98 (0.88, 1.10) 1.01 (0.93, 1.11) 
Model4 1.04 (0.89, 1.21) 1.06 (0.94, 1.18) 
Orange-Blue   
Model1 0.83 (0.74, 0.92) 0.86 (0.75, 0.98) 
Model2 0.85 (0.76, 0.95) 0.98 (0.85, 1.13) 
Model3 0.85 (0.76, 0.95) 0.95 (0.82, 1.12) 
Model4 0.75 (0.64, 0.88) 0.93 (0.77, 1.13) 
*Bold p value <0.05  
Model1 with no adjustment for confounders; Model2 adjusted for age (continuous), sex, 
education, ethnicity, income-to-poverty; Model3 adjusted further for smoking and 
drinking alcohol; Model4 further for physical activity, BMI (continuous), waist 
circumference [WC],dentist visit and fibers intake.  
Orange-Red: P. melaninogenica, P. intermedia, P. nigrescens, P. gingivalis 
Red-Green: T. forsythia, T. denticola, A. actinomycetemcomitans, E. corrodens, S. noxia, 
V. parvula, C. rectus 
Yellow-Orange: S. intermedius, S. oralis, S. mutans, F. nucleatum, M. micros, C. 
ochracea 
Orange-Blue: E. nodatum, A. naeslundii 
 
